Nov 16, 09
|
| NEW STORY |
| 14:30 ET |
Ignite Institute Receives Support from Commonwealth of Virginia, Fairfax County, $200 Million in Initial Funding and Financial Backing, Locks in Key Regional Partner
|
 |
Aug 17, 09
|
| 01:15 ET |
US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
|
|
Jul 21, 09
|
| 10:01 ET |
First Anniversary of New War on Cancer Marks Many Advances
|
|
May 18, 09
|
| 07:00 ET |
Here to Help(TM): Unique Program Combines Direct Personal Assistance With Web-Based Resources to Improve Opioid Dependence Treatment Outcomes
|
|
Dec 22, 08
|
| 06:00 ET |
Drais Pharmaceuticals and Diatos Partner to Develop and Commercialize DTS-108 for Treatment of Cancer
|
|
Nov 25, 08
|
| 12:44 ET |
Gene Network Sciences Announces Creation of Spin-off Entity Focused on Quantitative Finance and E-Commerce
|
|
Nov 12, 08
|
| 08:00 ET |
US FDA Approves 30-Minute Onset of Action for Focalin(R) XR, Bringing Potential Benefits to ADHD Patients During Early Morning Period
|
|
Oct 28, 08
|
| 07:30 ET |
Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement Capability
|
|
Oct 27, 08
|
| 16:02 ET |
Monogram Announces a 6-to-1 Reverse Stock Split
|
|
Oct 26, 08
|
| 11:30 ET |
Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay
|
|
Oct 23, 08
|
| 18:15 ET |
Monogram Announces Conference Call
|
|
Oct 22, 08
|
| 08:00 ET |
VeraTag(TM) Assays Featured at EORTC-NCI-AACR Symposium
|
|
Oct 15, 08
|
| 08:30 ET |
Stem Cell Trendsetters in Neurology and Psychiatry Analyzed by NeuroInsights
|
|
Oct 07, 08
|
| 05:00 ET |
Monogram Reaffirms Guidance for Year and Provides Update on Oncology Programs
|
|
Oct 03, 08
|
| 16:30 ET |
Monogram Receives NASDAQ Notification
|
|
Oct 01, 08
|
| 07:30 ET |
Gene Network Sciences Announces Drug Development Collaboration with Biogen Idec
|
|
Sep 29, 08
|
| 13:25 ET |
Monogram Biosciences to Present at the JMP Securities Healthcare Conference
|
|
Sep 23, 08
|
| 07:00 ET |
Monogram and Dana-Farber Cancer Institute Initiate Evaluation of HERmark(TM) Breast Cancer Assay in Metastatic Breast Cancer
|
|
Sep 19, 08
|
| 10:48 ET |
Academy Award Winner Louis Gossett Jr. Joins Tens of Thousands of Americans Rallying in 80 Communities, Celebrating Recovery from Addiction
|
|
Sep 18, 08
|
| 08:00 ET |
IDIS to Sponsor Inaugural Conference on Pre-Launch Access to Drugs
|
|
Sep 17, 08
|
| 08:00 ET |
Tethys Bioscience Announces Acquisition of Lipomics Technologies
|
|
Sep 15, 08
|
| 06:00 ET |
Unibioscreen and Drais Pharmaceuticals Partner to Develop and Commercialize UNBS 5162 for Treatment of Cancer
|
|
Aug 26, 08
|
| 07:00 ET |
IDIS Opens New American Office in Response to Industry's Growing Need for Pre-Launch Named Patient Programs
|
|
Aug 25, 08
|
| 12:12 ET |
First Major Medical Meeting Convening for MRI-guided Focused Ultrasound to Treat Cancer, Stroke, Fibroids, Other Conditions
|
|
Aug 21, 08
|
| 09:00 ET |
Monogram Appoints Oncologist to Board of Directors
|
|
Aug 20, 08
|
| 09:00 ET |
Medical Policy Guideline for Trofile(TM) Established By Wellpoint, Inc.
|
|
| 08:45 ET |
Alzheimer's Disease and Emerging Treatments Analyzed in Neurotech Insights
|
|
Aug 13, 08
|
| 09:58 ET |
John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technology's Potential to Help 'Millions of Patients'
|
|
Aug 11, 08
|
| 08:02 ET |
InterWest Partners Announces Closing of $650 Million Venture Fund
|
|
Aug 07, 08
|
| 15:12 ET |
Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
|
|
| 14:30 ET |
Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads
|
|
| 13:30 ET |
Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients
|
|
Aug 06, 08
|
| 13:05 ET |
Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy
|
|
Aug 04, 08
|
| 08:30 ET |
Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors
|
|
Jul 29, 08
|
| 15:49 ET |
Monogram Announces 2008 Second Quarter Financial Results
|
|
Jul 23, 08
|
| 06:00 ET |
Monogram Announces Issuance of Key Patents Related to VeraTag(TM) Technology
|
|
Jul 16, 08
|
| 13:15 ET |
Monogram Biosciences Announces Second Quarter 2008 Financial Results Conference Call
|
|
Jul 08, 08
|
| 08:00 ET |
Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day
|
|
| 04:00 ET |
Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay
|
|
Jul 01, 08
|
| 06:00 ET |
Monogram Biosciences to Present at the Collins Stewart Fourth Annual Growth Conference
|
|
Jun 18, 08
|
| 06:00 ET |
Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies
|
|
Jun 17, 08
|
| 05:07 ET |
Organizing Tips for the ADHD Family
|
|
Jun 16, 08
|
| 06:00 ET |
Sensitivity Enhancements to Monogram's Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy
|
|
Jun 07, 08
|
| 13:09 ET |
Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test
|
|
Jun 05, 08
|
| 06:00 ET |
Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay
|
|
Jun 02, 08
|
| 14:45 ET |
Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting
|
|
May 29, 08
|
| 09:00 ET |
Florida EMS and Fire Vehicles to Stock Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE ("Cyanokit") for Cyanide Poisoning
|
|
May 20, 08
|
| 10:45 ET |
Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone
|
|
| 10:45 ET |
Nebulized Formoterol Fumarate Has Comparable Pharmacokinetic and Pharmacodynamic Profile to Dry Powder Formulation
|
|
| 09:15 ET |
Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients
|
|
May 16, 08
|
| 12:02 ET |
Monogram Announces HERmark(TM) Oral Presentation at the 44th ASCO Annual Meeting
|
|
| 09:31 ET |
Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008
|
|
May 08, 08
|
| 07:00 ET |
Neurotechnology Industry Reports Record Global Growth of $130.5 Billion in 2007
|
|
May 07, 08
|
| 15:26 ET |
Bipartisan Group of Senators and Representatives Introduce Bill to Battle Brain-Related Illness
|
|
May 01, 08
|
| 16:11 ET |
HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics
|
|
| 16:00 ET |
Monogram Announces 2008 First Quarter Financial Results
|
|
Apr 21, 08
|
| 13:30 ET |
Monogram Biosciences Announces First Quarter 2008 Financial Results Conference Call
|
|
Apr 15, 08
|
| 16:45 ET |
FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
|
|
Apr 14, 08
|
| 21:30 ET |
Monogram Biosciences to Present at the JMP Securities Seventh Annual Research Conference
|
|
Apr 08, 08
|
| 06:04 ET |
Navigenics Proposes Standards for Personal Genomics Services, Coupled With Prospective Outcomes Studies, to Safeguard Consumers
|
|
| 06:02 ET |
Navigenics'(TM) Genome Analysis Used In Research Trial on the Impact of Providing Genetic Risk Assessments
|
|
| 06:00 ET |
Navigenics(TM) Launches Health Compass Service, a Personal Genetic Assessment for Optimal Health
|
|
| 06:00 ET |
New York Medicaid Program Establishes Coverage for Trofile(TM)
|
|
Apr 07, 08
|
| 06:00 ET |
Prestigious Scientific Leaders Join InterWest Advisory Committee
|
|
Apr 01, 08
|
| 06:00 ET |
Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
|
|
Mar 31, 08
|
| 06:00 ET |
Monogram HIV Antibody Assay Is Key Component of Innovative Vaccine Development Program
|
|
Mar 25, 08
|
| 06:00 ET |
Monogram Announces Promotion of Gordon Parry, PhD, to Vice President, Research and Development, Oncology
|
|
Mar 19, 08
|
| 06:00 ET |
Stephen Holmes of InterWest Appointed to Prestigious Venture Capital Valuation Board
|
|
Mar 17, 08
|
| 02:00 ET |
California Medicaid Establishes Coverage for Trofile(TM)
|
|
Mar 10, 08
|
| 09:00 ET |
Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts
|
|
Feb 11, 08
|
| 10:01 ET |
Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008
|
|
Feb 07, 08
|
| 16:00 ET |
Monogram Announces 2007 Year-End Financial Results
|
|
| 06:00 ET |
Data Presented on Monogram HIV Tropism Tests at Retrovirus Conference sets New Standards of Assay Sensitivity
|
|
Feb 04, 08
|
| 06:00 ET |
DHHS Guidelines Support Use of Trofile(TM) Assay Prior to CCR5 Inhibitor Use
|
|
Jan 30, 08
|
| 19:39 ET |
Monogram Biosciences Announces Fourth Quarter 2007 Financial Results Conference Call
|
|
Jan 09, 08
|
| 14:52 ET |
Dey, L.P. Settles State of Alabama Pricing Litigation
|
|
Dec 19, 07
|
| 16:00 ET |
Study Reaffirms Superiority of Trofile(TM) Assay
|
|
Dec 14, 07
|
| 08:00 ET |
HERmark(TM) Assay Results in Metastatic Breast Cancer Presented at the San Antonio Breast Cancer Symposium
|
|
Dec 10, 07
|
| 06:00 ET |
Monogram Announces Posters to be Presented at the 30th San Antonio Breast Cancer Symposium
|
|
Nov 29, 07
|
| 08:30 ET |
Dr. Ralph Snyderman, Chancellor Emeritus, Duke University, and Founder and Chairman of Proventys, Inc., Receives 2007 Leadership in Personalized Medicine Award
|
|
Nov 28, 07
|
| 08:00 ET |
Dey, L.P. Partners with COPD Foundation in Support of National Heart, Lung and Blood Institute (NHLBI)'s COPD Learn More Breathe Better Awareness Campaign
|
|
Nov 08, 07
|
| 13:49 ET |
Monogram Biosciences to Present at the Piper Jaffray 19th Annual Healthcare Conference
|
|
| 13:36 ET |
Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
|
|
Nov 07, 07
|
| 07:00 ET |
Monogram Obtains Coverage for Trofile(TM) Assay from California ADAP Program
|
|
Nov 06, 07
|
| 06:00 ET |
Navigenics Launches With Preeminent Team of Advisers, Partners and Investors
|
|
Nov 02, 07
|
| 07:00 ET |
Neurotechnology Industry Organization Unveils Top 10 Neuroscience Trends of 2007
|
|
Oct 24, 07
|
| 16:01 ET |
Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD
|
|
| 16:01 ET |
Two Clinical Trials for Nebulized Formoterol Fumarate on Long-Term and Cardiovascular Safety in Treating COPD
|
|
| 16:00 ET |
Monogram Announces Third Quarter 2007 Financial Results
|
|
Oct 17, 07
|
| 17:15 ET |
Monogram Biosciences Announces Third Quarter 2007 Financial Results Conference Call
|
|
Oct 16, 07
|
| 08:30 ET |
Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007
|
|
Oct 12, 07
|
| 17:31 ET |
FDA Approves Administration of LEXIVA(R) with Lower Dose of 'Boosting' Medication Ritonavir
|
|
Oct 10, 07
|
| 13:10 ET |
Monogram Biosciences to Present at the JMP Securities Healthcare Conference
|
|
Oct 08, 07
|
| 07:30 ET |
Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD
|
|
Oct 01, 07
|
| 07:00 ET |
Pfizer Receives E.U. Approval of Maraviroc; Monogram Initiates European Operations
|
|
Sep 27, 07
|
| 09:12 ET |
Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma
|
|
Sep 24, 07
|
| 07:00 ET |
Monogram Announces First Medicare Payment for Trofile(TM)
|
|
Sep 21, 07
|
| 08:00 ET |
Trial Date Set for Patent Infringement Suit Against Sepracor's Brovana(TM)
|
|
Sep 19, 07
|
| 07:00 ET |
Leading Policymakers, Scientists, Industry Executives Discuss Implementation of Evidence-Based, Personalized Medicine
|
|
| 07:00 ET |
Studies Highlight Superior Performance of Trofile(TM) Assay
|
|
Sep 18, 07
|
| 12:10 ET |
Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
|
|
| 08:30 ET |
Personalized, Online Help for Prescription Painkiller and Heroin Dependence: Confidential Treatment in a Doctor's Private Office
|
|
Sep 12, 07
|
| 12:12 ET |
Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults
|
|
| 11:10 ET |
Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
|
|
| 10:38 ET |
Joint NJ/NY Rally for Addiction Recovery to Be Hub of Events Nationwide
|
|
Sep 07, 07
|
| 13:15 ET |
Monogram Biosciences to Present at the ThinkEquity Partners' Fifth Annual Growth Conference
|
|
Sep 05, 07
|
| 07:00 ET |
Medicare Contractor Establishes Reimbursement Coding Guidance for Monogram's Trofile Assay
|
|
Aug 27, 07
|
| 14:06 ET |
Joint NJ/NY Rally for Addiction Recovery to be Hub of Events Nationwide
|
|
Aug 23, 07
|
| 07:00 ET |
Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
|
|
Aug 13, 07
|
| 08:49 ET |
Introducing Addiction411: Online Tool to Educate the MySpace Generation about Opioid Addiction
|
|
Aug 10, 07
|
| 08:00 ET |
Introducing Addiction411: Online Tool to Educate the MySpace Generation About Opioid Addiction
|
|
Aug 06, 07
|
| 18:32 ET |
Monogram Biosciences Announces Conference Call to Discuss Commercial Introduction of Trofile(TM) Assay
|
|
| 13:05 ET |
Monogram Announces Commercial Introduction of Trofile(TM) Assay
|
|
Jul 26, 07
|
| 16:00 ET |
Monogram Announces Second Quarter 2007 Financial Results
|
|
Jul 25, 07
|
| 07:00 ET |
New Head-to-Head Study Comparing LEXIVA(R) and Atazanavir Show Similar Efficacy and Lipid Changes
|
|
| 06:00 ET |
Maraviroc Reduces HIV Viral Load in Treatment-Naive Patients, 48 Week Data Show
|
|
Jul 20, 07
|
| 18:07 ET |
Monogram Biosciences Announces Second Quarter 2007 Financial Results Conference Call
|
|
| 06:00 ET |
European Committee Issues Positive Opinion of Pfizer's Celsentri(R) (Maraviroc) for Treatment-Experienced Patients Infected with CCR5-tropic HIV-1
|
|
Jul 09, 07
|
| 01:15 ET |
Exelon(R)Patch, the First and Only Skin Patch for the Treatment of Alzheimer's Disease, Receives First Worldwide Approval in US
|
|
Jun 25, 07
|
| 07:00 ET |
Monogram Biosciences to Present at The C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
|
|
Jun 23, 07
|
| 11:00 ET |
Phase IIIb Clinical Data Validate the Overall and Cardiovascular Safety Profile of Cycloset(TM) (A Quick Release Formulation of Bromocriptine Mesylate) in Patients with Type 2 Diabetes
|
|
Jun 20, 07
|
| 18:00 ET |
Monogram Provides Update on Trofile(TM) Assay
|
|
Jun 18, 07
|
| 18:31 ET |
Medi-Cal Expands Coverage of Baseline HIV Resistance Testing
|
|
| 08:00 ET |
VeroScience Late-Breaking Abstract on Cycloset(TM) (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
|
|
Jun 04, 07
|
| 06:00 ET |
GlaxoSmithKline Launches Educational Campaign in Detroit to Address 'Silent Epidemic' of Genital Herpes Among African American Adults
|
|
May 31, 07
|
| 09:38 ET |
FDA Approves ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for Critical Therapeutics, DEY Marketing Partner for Chronic Treatment of Asthma
|
|
| 07:00 ET |
Monogram Presents Results of First eTag Breast Cancer Studies
|
|
May 30, 07
|
| 10:00 ET |
BioBank Central Launches Online Forum to Drive Global Connectivity Among Biobanking Community
|
|
May 21, 07
|
| 08:00 ET |
Clinical Trial Data for Perforomist(TM) (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference
|
|
May 20, 07
|
| 13:45 ET |
Clinical Trial Data for Perforomist(TM) (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference
|
|
May 17, 07
|
| 11:00 ET |
Neurotechnology Industry Report Says Revenues Grew 10% to $120.5 Billion in 2006; U.S. Economic Impact of Brain-related Illness Reached $1 Trillion
|
|
May 16, 07
|
| 16:35 ET |
Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2007
|
|
May 11, 07
|
| 14:25 ET |
FDA Approves Dey, L.P.'s Perforomist(TM) (Formoterol Fumarate) Inhalation Solution for Maintenance Treatment of COPD
|
|
May 07, 07
|
| 08:00 ET |
Preterm Infants with Respiratory Distress Syndrome: Incidence Rates of Death when Treated with Surfactant Replacement Therapies
|
|
May 02, 07
|
| 16:00 ET |
Monogram Announces First Quarter 2007 Financial Results
|
|
Apr 26, 07
|
| 17:10 ET |
Monogram Announces Conference Call
|
|
Apr 25, 07
|
| 07:30 ET |
Community Anti-Drug Coalitions Across Tennessee (CADCAT) to Host Public Forum on Substance Abuse Prevention, Treatment and Recovery
|
|
Apr 24, 07
|
| 20:24 ET |
FDA Advisory Committee Recommends Accelerated Approval of Pfizer's Maraviroc for Treatment-Experienced Patients Infected with CCR5-tropic HIV-1
|
|
| 14:27 ET |
Dey, L.P. Reaches Settlement with Commonwealth of Massachusetts on Pricing Litigation
|
|
Apr 17, 07
|
| 07:00 ET |
Community Anti-Drug Coalitions Across Tennessee (CADCAT) to Host Public Forum on Substance Abuse Prevention, Treatment and Recovery
|
|
Mar 29, 07
|
| 14:01 ET |
Dey, L.P. Reaches Settlement with State of Nevada on Pricing Litigation
|
|
| 10:00 ET |
Neurotechnology Executives Tap Political Leaders to Help Patients With Brain- Related Illnesses
|
|
Mar 23, 07
|
| 13:24 ET |
Personalized Medicine Coalition Announces Support for Secretary Leavitt's Personalized Health Care Initiative
|
|
Mar 21, 07
|
| 17:12 ET |
Dey, L.P. Reaches Settlement with State of Hawaii on Pricing Litigation
|
|
Mar 15, 07
|
| 11:59 ET |
Message Carriers To Showcase HBO's New Documentary ADDICTION at 'Town Hall Meeting'
|
|
Mar 13, 07
|
| 07:00 ET |
Atlanta to Showcase HBO's New Documentary ADDICTION at 'Town Hall Meeting'
|
|
Mar 09, 07
|
| 05:00 ET |
U.S. Court of Appeals Reinstates Permanent Injunction Against Abbott Laboratories for Infringing Innogenetics' Patent
|
|
Mar 08, 07
|
| 10:29 ET |
Atlanta to Showcase HBO's New Documentary ADDICTION at 'Town Hall Meeting'
|
|
Mar 07, 07
|
| 15:11 ET |
Hartford's HBO ADDICTION Premier draws recovery advocates, community leaders and people in recovery to support recovery from alcohol and other drug addiction
|
|
| 11:00 ET |
The Alliance for Recovery to Showcase HBO's New Documentary ADDICTION for Local Media and Treatment Professionals
|
|
Mar 06, 07
|
| 10:11 ET |
The Alliance for Recovery to Showcase HBO's New Documentary ADDICTION for Local Media and Treatment Professionals
|
|
Mar 05, 07
|
| 07:00 ET |
The Miami Coalition, The Hispanic Crime Prevention Program, Center for Administration of Justice, Florida International University and The F.I.U. Community-Based Intervention Research Group to Showcase HBO's New Documentary ADDICTION at 'Town Hall Meeting
|
|
| 06:00 ET |
Scientific Data Highlights Pivotal Role of Monogram's Molecular Diagnostics in Development and Use of New HIV Treatments
|
|
Mar 02, 07
|
| 07:00 ET |
San Antonio Fighting Back, Inc. to Showcase HBO's New Documentary ADDICTION at 'Town Hall Meeting'
|
|
Mar 01, 07
|
| 15:06 ET |
Monogram Provides Update on Trofile(TM) Assay - Pfizer Reports Significant Reduction in Viral Load in Clinical Trial of Maraviroc
|
|
Feb 27, 07
|
| 09:43 ET |
San Antonio Fighting Back, Inc. to Showcase HBO's New Documentary ADDICTION at 'Town Hall Meeting'
|
|
Feb 13, 07
|
| 07:18 ET |
Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
|
|
Feb 08, 07
|
| 16:00 ET |
Monogram Announces Year-End 2006 Financial Results
|
|
Feb 05, 07
|
| 13:38 ET |
Monogram Biosciences Announces Fourth Quarter 2006 Financial Results Conference Call
|
|
Jan 17, 07
|
| 13:48 ET |
Personalized Medicine Coalition Supports President Bush's Call to Congress to Pass the Genetic Information Nondiscrimination Act
|
|
Jan 12, 07
|
| 07:00 ET |
Monogram Biosciences Prices Private Placement of Convertible Senior Unsecured Notes
|
|
Jan 11, 07
|
| 03:02 ET |
Court Permanently Halts Abbott's Sale of HCV Genotyping Products for Infringing Innogenetics' Patent
|
|
Jan 04, 07
|
| 12:43 ET |
Genomas Announces Physiogenomic Study That Reveals Potential Cause of Metabolic Side Effects in Patients Treated With Psychotropic Drugs
|
|
| 03:22 ET |
Court Affirms $7 Million in Damages for Innogenetics in Patent Infringement Suit
|
|
Jan 02, 07
|
| 14:24 ET |
Monogram Biosciences To Present at the 25th Annual JPMorgan Healthcare Conference
|
|
Dec 29, 06
|
| 15:44 ET |
Levin Amendment Expands Access to 'Miracle Drug' to Treat Heroin Addiction
|
|
| 13:04 ET |
Bush Signs Law: More Patients May be Treated for Opioid Dependence/Addiction with Buprenorphine
|
|
Dec 11, 06
|
| 09:56 ET |
Congress Passes Legislation Increasing Treatment for Opioid Dependence/Addiction using Buprenorphine
|
|
Dec 08, 06
|
| 09:00 ET |
UCSF Pharmacy School Receives Major Grant From Amgen Foundation For Medicare Part D Outreach
|
|
Dec 01, 06
|
| 06:00 ET |
Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
|
|
Nov 28, 06
|
| 12:17 ET |
Dey, L.P. Reaches Settlement with State of Ohio on Pricing Litigation
|
|
| 10:12 ET |
Dr. Elizabeth G. Nabel, Director of the National Heart, Lung, and Blood Institute, Receives 2006 Leadership in Personalized Medicine Award
|
|
Nov 21, 06
|
| 06:00 ET |
Monogram Biosciences to Present at Personalized Medicine: A World of Opportunities
|
|
Nov 20, 06
|
| 06:00 ET |
Monogram Biosciences to Present at the Lazard Capital Markets Third Annual Life Sciences Conference
|
|
Nov 14, 06
|
| 15:47 ET |
Dey, L.P. Reaches Settlement with State of Idaho on Pricing Litigation
|
|
| 12:00 ET |
New Report Cites Emerging Impact of Personalized Medicine on Healthcare
|
|
Nov 13, 06
|
| 14:00 ET |
SyntheMed Announces Listing on Frankfurt Stock Exchange
|
|
Oct 30, 06
|
| 08:30 ET |
SyntheMed to Present at 8th Annual Rodman and Renshaw Healthcare Conference
|
|
Oct 26, 06
|
| 16:03 ET |
Monogram Announces Third Quarter 2006 Financial Results
|
|
Oct 23, 06
|
| 19:57 ET |
Monogram Biosciences Announces Third Quarter 2006 Financial Results Conference Call
|
|
| 08:30 ET |
SyntheMed to Present at the C.E. Unterberg, Towbin Life Sciences Conference
|
|
Oct 16, 06
|
| 20:36 ET |
Monogram Biosciences to Present at the BIO Investor Forum 2006
|
|
Oct 13, 06
|
| 08:30 ET |
SyntheMed Incorporated to Present at BIO InvestorForum 2006
|
|
Oct 12, 06
|
| 12:00 ET |
GlaxoSmithKline Sponsors HIV Medicine Association Minority Fellowship Program
|
|
Oct 03, 06
|
| 07:30 ET |
Detroit Deaths from Fentanyl-Laced Heroin Overdoses Could Be Reduced by Medical Treatment
|
|
| 06:00 ET |
Monogram Announces $10 Million Revolving Line of Credit
|
|
Sep 28, 06
|
| 17:30 ET |
New Data Reinforce Efficacy of TRIZIVIR(R) Alone in Treatment-Naive HIV Patients with Low Viral Load
|
|
| 17:00 ET |
GlaxoSmithKline and Vertex Pharmaceuticals Announce Virologic and Drug Resistance Results from Protease Inhibitor Study
|
|
| 01:15 ET |
New Data for FTY720 -- Aiming to Become the First Orally Effective Multiple Sclerosis Treatment -- Show Sustained Benefits Over Two Years
|
|
Sep 21, 06
|
| 08:30 ET |
Chicago Deaths from Fentanyl-Laced Heroin Overdoses Could Be Reduced by Medical Treatment
|
|
Sep 19, 06
|
| 07:30 ET |
Available Medical Treatments Could Counter Growing Prescription Painkiller Abuse Among Young Adults, Teens
|
|
Sep 13, 06
|
| 17:00 ET |
Phase II Data Showing Clinical Benefits of Novel Once-Daily Oral Multiple Sclerosis Therapy FTY720 (Fingolimod) Published in New England Journal of Medicine
|
|
Sep 11, 06
|
| 13:15 ET |
Statement from Dey, L.P. Regarding Pricing Litigation by the U.S. Department of Justice
|
|
| 07:30 ET |
SyntheMed Appoints John Benson as Controller
|
|
Sep 08, 06
|
| 22:14 ET |
Jury Finds Abbott Willfully Infringed Innogenetics HCV Patent
|
|
Sep 07, 06
|
| 07:30 ET |
Nationwide Service to Match Opioid-Addicted Patients with Physicians Offering Private In-Office Medical Treatment
|
|
Sep 06, 06
|
| 07:00 ET |
SyntheMed Announces Positive Pivotal Clinical Trial Results for REPEL-CV(R)
|
|
Aug 31, 06
|
| 10:14 ET |
Alfacell Updates Progress on Clinical Development Program for ONCONASE(R) in Malignant Mesothelioma
|
|
| 07:00 ET |
Midstate Deaths from Fentanyl-Laced Heroin Overdoses Could be Reduced by Medical Treatment
|
|
| 07:00 ET |
Philadelphia Deaths from Fentanyl-Laced Heroin Overdoses Could be Reduced by Medical Treatment
|
|
Aug 23, 06
|
| 08:48 ET |
SyntheMed Secures CE Mark Approval for REPEL-CV(R)
|
|
Aug 17, 06
|
| 17:00 ET |
Four Studies Affirm Significance of Monogram's Trofile(TM) HIV Co-Receptor Tropism Assay
|
|
| 12:45 ET |
Head-to-Head Study Comparing LEXIVA(R) (fosamprenavir calcium) to Kaletra(R) Presented at IAC 2006 and Published in The Lancet
|
|
Aug 14, 06
|
| 08:00 ET |
GlaxoSmithKline and Shionogi Complete Initial Clinical Study for HIV Integrase Inhibitor
|
|
Aug 13, 06
|
| 11:18 ET |
Updated HIV Treatment Guidelines Now Include Three GSK HIV Medications for Initial Antiretroviral Treatment Regimens
|
|
Aug 12, 06
|
| 08:00 ET |
Four Studies Affirm Significance of Monogram's Trofile(TM) HIV Co-Receptor Tropism Assay
|
|
Jul 25, 06
|
| 07:00 ET |
Monogram Announces Second Quarter 2006 Financial Results
|
|
| 06:00 ET |
Monogram Announces Allowance of U.S. Patent Related to eTag(TM) Technology
|
|
Jul 21, 06
|
| 13:34 ET |
Monogram Biosciences Announces Second Quarter 2006 Financial Results Conference Call
|
|
Jul 19, 06
|
| 10:00 ET |
Exelon(R) Patch, the first transdermal therapy for Alzheimer's disease, may provide a promising new approach to treatment
|
|
Jul 05, 06
|
| 08:00 ET |
Monogram Biosciences to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
|
|
Jun 27, 06
|
| 19:39 ET |
The U.S. Food and Drug Administration Approves Exelon(R) (rivastigmine tartrate) as the First Medication Indicated to Treat Parkinson's Disease Dementia
|
|
Jun 13, 06
|
| 08:30 ET |
Surging Heroin Addiction a Major Public Health Threat in Washington, D.C.
|
|
Jun 12, 06
|
| 08:00 ET |
Monogram Announces Settlement of CVR Liability
|
|
Jun 06, 06
|
| 08:00 ET |
Monogram Biosciences to Present at the Pacific Growth Equities' 2006 Life Sciences Growth Conference
|
|
May 31, 06
|
| 08:40 ET |
Opioid Addiction, a Major Public Health Threat in Atlanta, Often Overlooked and Untreated
|
|
| 08:38 ET |
Addiction to Prescription Painkillers and Heroin Surges in Pittsburgh, Most Widely Abused Drugs Citywide
|
|
May 26, 06
|
| 11:17 ET |
Monogram Announces Intention to Pay Any CVR Liability in Cash
|
|
May 24, 06
|
| 08:00 ET |
Monogram Announces Allowance of U.S. Patents for Its HIV Entry and Co-Receptor Tropism Technology
|
|
May 22, 06
|
| 08:00 ET |
Monogram Announces the Closing of Pfizer's $25 million Investment in Monogram
|
|
May 17, 06
|
| 17:24 ET |
FDA Advisory Committee Recommends Approval of Exelon(R) (rivastigmine tartrate) in the Treatment of Dementia Associated with Parkinson's Disease
|
|
May 08, 06
|
| 08:05 ET |
Monogram Announces First Quarter 2006 Financial Results
|
|
| 08:00 ET |
Pfizer to Invest $25 Million in Monogram
|
|
May 05, 06
|
| 18:14 ET |
Monogram Biosciences Announces First Quarter 2006 Financial Results Conference Call
|
|
Apr 26, 06
|
| 13:35 ET |
Monogram Biosciences to Present at the Deutsche Bank 31st Annual Health Care Conference
|
|
Apr 25, 06
|
| 16:27 ET |
Dey, L.P. Reaches Settlement with State of Missouri on Pricing Litigation
|
|
Mar 15, 06
|
| 12:19 ET |
TRACON Pharmaceuticals Assembles Industry-Leading Management Team to Support Development of Targeted Cancer Therapy Pipeline
|
|
Feb 28, 06
|
| 19:14 ET |
Monogram Biosciences to Present at the SG Cowen & Co. 26th Annual Health Care Conference
|
|
Feb 22, 06
|
| 08:03 ET |
Monogram Announces Year End 2005 Financial Results
|
|
Feb 21, 06
|
| 11:17 ET |
Monogram and Merck to Collaborate on Phase III Trials of Merck's Investigational HIV-1 Integrase Inhibitor
|
|
Feb 15, 06
|
| 18:30 ET |
Monogram Biosciences Announces Fourth Quarter 2005 Financial Results Conference Call
|
|
| 07:01 ET |
Monogram and Dana-Farber Cancer Institute Enter Collaboration Agreement
|
|
Feb 14, 06
|
| 08:07 ET |
Dey, L.P. Names Christy Taylor New SVP for Sales, Marketing and Business Development
|
|
Feb 09, 06
|
| 13:00 ET |
Data Highlighting the Role of Molecular Diagnostics Presented at Major HIV/AIDS Meeting
|
|
Feb 01, 06
|
| 07:03 ET |
National Survey Finds Nearly Half of Public Unaware Prescription Painkiller Abuse is as Harmful as Using Heroin
|
|
Jan 12, 06
|
| 08:00 ET |
More Than 900 Hospitals Sign with U.S. Surgical Under Novation Supply Agreements
|
|
Jan 05, 06
|
| 02:30 ET |
Merck KGaA Names Engle New Generics Group Regional Director, North America
|
|
Jan 04, 06
|
| 16:53 ET |
Monogram Biosciences to Present at the 24th Annual JPMorgan Healthcare Conference
|
|
Dec 15, 05
|
| 07:01 ET |
Monogram Presents Data Demonstrating Cost-Effectiveness of PhenoSense GT(TM) and Leadership in Advancing HIV Resistance Testing
|
|
Dec 01, 05
|
| 07:01 ET |
Monogram's eTag(TM) Technology Featured in British Journal of Cancer
|
|
Nov 30, 05
|
| 10:08 ET |
Number of Pills Affects Adherence to HIV Treatment Regimens
|
|
Nov 18, 05
|
| 09:46 ET |
FDA Approves Updated Labeling for GSK's LEXIVA
|
|
Nov 16, 05
|
| 11:49 ET |
World COPD Day: 12 Million Americans Unaware They Are at Risk for Fourth Leading Cause of Death
|
|
Nov 04, 05
|
| 08:49 ET |
Icagen Reports Third Quarter 2005 Financial Results
|
|
Nov 03, 05
|
| 08:09 ET |
Dr. Janet Woodcock of U.S. Food and Drug Administration to be Presented with First Leadership in Personalized Medicine Award
|
|
| 08:09 ET |
New Survey Shows Americans Want Genetic Information in Health Care, But Fear Privacy, Ethical, Emotional Implications
|
|
Nov 01, 05
|
| 17:54 ET |
Icagen to Present at Two Upcoming Conferences
|
|
Oct 27, 05
|
| 09:02 ET |
Icagen Announces Third Quarter 2005 Financial Results Conference Call
|
|
Sep 19, 05
|
| 09:00 ET |
Icagen to Present at the 2005 UBS Global Life Sciences Conference
|
|
Aug 04, 05
|
| 09:07 ET |
New Study Suggests Patients With Schizophrenia Improved With Treatment Change to RISPERDAL(R) CONSTA(R)
|
|
Aug 03, 05
|
| 12:44 ET |
President Bush Signs Bill Lifting Restriction on Office-Based Treatment with Buprenorphine for Opioid Dependence/Addiction
|
|
Jul 27, 05
|
| 14:56 ET |
Congress Passes Legislation to Lift Restriction on Medical Groups that Prescribe Buprenorphine for Opioid Dependence/Addiction
|
|
| 11:00 ET |
Patient Satisfaction With Once-Daily Dosing Of HIV Fixed-Dose Combination Tablet EPZICOM
|
|
Jul 26, 05
|
| 11:00 ET |
Epidemiology Study Reports New Information on Hypersensitivity Reactions to Abacavir
|
|
| 11:00 ET |
Long-Term Safety Data Of LEXIVA/R In HIV Patients Co-Infected With Hepatitis
|
|
Jun 16, 05
|
| 12:11 ET |
Many Patients With Schizophrenia Who Transitioned to RISPERDAL(R) CONSTA(R) Avoided Relapse and Experienced Symptom Improvement
|
|
Jun 07, 05
|
| 17:12 ET |
MedQuist Eliminates Use of AAMT Line Unit of Measure
|
|
May 27, 05
|
| 07:00 ET |
FDA Grants Approval to Market Focalin XR(TM) for the Treatment of ADHD in Adults, Adolescents and Children
|
|
Apr 28, 05
|
| 14:43 ET |
DEY, L.P. Donates Time and Resources to Brighten Seneca Center
|
|
Apr 26, 05
|
| 09:17 ET |
Neve Campbell Helps Launch National Program for People Living with Epilepsy
|
|
Apr 11, 05
|
| 09:12 ET |
Mass. Biotechnology Council and MassBioEd Announce $9M Major Public/Private Partnership to Advance Science Education in the State
|
|
Apr 08, 05
|
| 08:01 ET |
Sen. Kennedy, State Legislative Leaders, Mass Biotechnology Council and MassBioEd to Launch Major High School Science Education Initiative with an Event at the Statehouse
|
|
Apr 01, 05
|
| 09:08 ET |
Genzyme Corporation Becomes First Corporate Sponsor of BioTeach Program ------------------------------------------------ Makes five-year, $250,000 commitment
|
|
Mar 30, 05
|
| 07:05 ET |
Ardais(R) and Cytomyx Announce Translational Medicine Collaboration
|
|
Mar 22, 05
|
| 10:47 ET |
Personalized Medicine Coalition Supports FDA's Pharmacogenomic Data Submissions Guidance
|
|
Feb 25, 05
|
| 09:00 ET |
Ardais(R) and ATCC to Deliver Scaleable Biospecimen Management Solution for Translational Medicine
|
|
Feb 18, 05
|
| 08:16 ET |
Cyclacel & U. of Edinburgh Scientists Solve 3-D Structures of PCNA Complexes: Important Target for New Cancer Treatments
|
|
| 08:00 ET |
US Patent Granted to Cyclacel for Novel Cyclin Dependent Kinase Inhibitor Series
|
|
Feb 01, 05
|
| 08:17 ET |
University of Arkansas for Medical Sciences Adopts Ardais(R) Biospecimen Management System
|
|
Jan 26, 05
|
| 10:21 ET |
Stephen Elledge, Ph.D., of Harvard/Partners Center for Genetics and Genomics Receives Premier Award from Genetics Society of America
|
|
Jan 14, 05
|
| 12:39 ET |
Icagen and Abbott Renew Drug Discovery Collaboration
|
|
| 08:01 ET |
Napa Chamber of Commerce Names DEY, L.P. Business of the Year
|
|
Jan 12, 05
|
| 09:01 ET |
Scandius BioMedical's Stratis (TM) ST ACL Reconstruction System launched and successfully used in initial surgeries
|
|
Jan 03, 05
|
| 17:18 ET |
DEY, L.P. Donates $100,000 to the American Red Cross Tsunami Disaster Relief Effort
|
|
Dec 09, 04
|
| 07:01 ET |
New Study in the New England Journal of Medicine Shows Exelon May Help Parkinson's Disease Patients Who Suffer From Dementia
|
|
Dec 06, 04
|
| 17:47 ET |
Icagen Reports Positive Results of Phase II Clinical Trial of ICA-17043 for The Treatment of Sickle Cell Anemia
|
|
| 08:33 ET |
Bristol-Myers Squibb Launches ChoiceDM(TM) A1C Home Test -- First At-Home Test to Measure Long Term Blood Sugar Control
|
|
Nov 22, 04
|
| 09:00 ET |
Transport Pharmaceuticals Secures $27 Million in Venture Financing to Continue Development of Unique Drug Delivery Platform
|
|
Nov 19, 04
|
| 08:01 ET |
Chest Symposium Offers Guidance on COPD Best Clinical Practices for Inhalation Therapy, Dangers of Pharmacy Compounded Respiratory Products
|
|
Nov 16, 04
|
| 08:00 ET |
Dey, L.P. to Fund 2005 Nationwide COPD Patient Education Days Through National Emphysema/COPD Association (NECA)
|
|
Nov 09, 04
|
| 16:12 ET |
Novartis Institutes for BioMedical Research Unveils Redesigned Water Tower and Announces Educational Collaborations
|
|
Nov 08, 04
|
| 09:11 ET |
Science Selects Cyclacel Work as Editor's Choice
|
|
| 09:09 ET |
Beneficial Effects of Seliciclib (CYC202) Reported in Models of Kidney Disease
|
|
| 09:06 ET |
FDA Grants Scandius BioMedical Market Clearance for Novel Technology Designed to Simplify Common Sports-Related Surgery
|
|
| 08:07 ET |
Dey, L.P. Reaches Settlement with State of Arkansas on Pricing Litigation
|
|
Oct 27, 04
|
| 17:00 ET |
Novartis and the Broad Institute of MIT and Harvard Announce Unique Public/Private Collaboration to Uncover Genetic Basis for Type 2 Diabetes
|
|
Oct 26, 04
|
| 16:45 ET |
Novartis and Orion Pharma Launch First Parkinson's Disease Study to Explore Potential of Delaying Motor Complications with Stalevo (R)
|
|
Oct 25, 04
|
| 08:06 ET |
New Studies Suggest Investigational Once-Daily ADHD Treatment Is Safe and Effective in Both Children and Adults
|
|
Oct 21, 04
|
| 09:03 ET |
New Coalition Launched to Advance Personalized Medicine
|
|
Sep 02, 04
|
| 09:01 ET |
Icagen Receives Milestone Payment from McNeil Consumer & Specialty Pharmaceuticals
|
|
Aug 24, 04
|
| 14:05 ET |
Maine Medical Center Adopts Ardais(R) Biospecimen Management System
|
|
Aug 12, 04
|
| 07:02 ET |
Ardais(R) Corporation Raises Additional $4 Million to Reach Cash Flow Breakeven
|
|
Aug 02, 04
|
| 09:06 ET |
Vital Therapies, Inc. Receives Orphan Drug Designation for Key Component in Liver Assist Program
|
|
Jul 26, 04
|
| 07:03 ET |
Cyclacel Announces Postponement of Initial Public Offering
|
|
Jul 15, 04
|
| 09:01 ET |
BioTrove, Inc. Licenses Genomics Application from Stanford University for Nanotiter Plates
|
|
Jul 07, 04
|
| 09:31 ET |
New Office-Based Treatment for Prescription Drug and Heroin Addiction
|
|
Jul 02, 04
|
| 07:21 ET |
Cyclacel Announces Registration for Initial Public Offering
|
|
Jun 29, 04
|
| 09:00 ET |
Icagen and McNeil Consumer & Specialty Pharmaceuticals Enter into Development And Commercialization Agreement for Sickle Cell Disease Treatment
|
|
Jun 16, 04
|
| 08:32 ET |
Icagen Expands Senior Management Team
|
|
Jun 14, 04
|
| 09:01 ET |
Spherics, Inc. Begins Phase I Clinical Trial with Spherazole(TM), Bioadhesive-Based Itraconazole
|
|
Jun 07, 04
|
| 09:10 ET |
Spherics, Inc. Appoints Avinash Nangia, Ph.D. as Vice President of Research and Development
|
|
| 09:06 ET |
Researchers Present Results from Studies of Therion's Therapeutic Cancer Vaccines in Patients with Pancreatic Cancer
|
|
Jun 03, 04
|
| 09:03 ET |
BioTrove, Inc. Appoints Alan Barber as Chief Financial Officer
|
|
Jun 02, 04
|
| 08:33 ET |
RISPERDAL (R) (risperidone) Shown to Rapidly Reduce Manic Symptoms Associated With Bipolar I Disorder
|
|
May 25, 04
|
| 08:05 ET |
NECA's COPD Patient Needs Assessment Survey Presented at American Thoracic Society
|
|
May 24, 04
|
| 08:32 ET |
Therion Biologics Corporation Receives FDA Agreement to Initiate Phase III Clinical Trial With PANVAC(TM)-VF In Advanced Pancreatic Cancer
|
|
| 08:18 ET |
Scientists From Australia and New Zealand Discuss Stem Cell Research and Clinical Trials at 3rd Annual Conference in Cambridge, Massachusetts
|
|
May 19, 04
|
| 11:01 ET |
MorphoSys and Novartis Forge Strategic Antibody Alliance
|
|
May 12, 04
|
| 09:00 ET |
Novartis Teams Up with Parkinson's Disease Groups to Launch New Resource for the 1.5 Million People Living with Parkinson's Disease
|
|
May 06, 04
|
| 09:01 ET |
BioTrove, Inc. Appoints Michael Olex as Vice President of Manufacturing
|
|
May 05, 04
|
| 12:01 ET |
RISPERDAL(R) CONSTA(TM) IMPROVES SYMPTOM CONTROL IN MANY PEOPLE WITH SCHIZOPHRENIA
|
|
| 12:00 ET |
MANY STABILIZED, YOUNG ADULTS WITH SCHIZOPHRENIA MAY BENEFIT FROM EARLY TREATMENT WITH RISPERDAL(R) CONSTA(TM)
|
|
| 07:31 ET |
New Study Suggests Investigational ADHD Treatment is Safe and Effective in Adults
|
|
May 03, 04
|
| 09:04 ET |
'Jubiloso/Lamentoso: An Evening of Great Music from Composers who Lived with Bipolar Disorder' Raises Awareness of a Serious Mental Illness
|
|
Apr 26, 04
|
| 09:05 ET |
BioTrove, Inc. Appoints Alan Carter as Vice President of Worldwide Sales
|
|
Apr 19, 04
|
| 08:08 ET |
Dynogen Secures $50 Million Series B Financing to Advance Its Pipeline Of Genitourinary and Gastrointestinal Development Programs
|
|
| 08:07 ET |
Duke University Medical Center and Ardais Launch Biorepository for Clinical Research in Cancer
|
|
Apr 15, 04
|
| 09:11 ET |
BioTrove, Inc. Completed a $13.7 Million Round of Financing With the Closing of a Second Traunch of $2.8 Million
|
|
Apr 14, 04
|
| 08:08 ET |
U.S. Genomics Licenses Locked Nucleic Acid (LNA (TM)) Chemistries from Exiqon
|
|
Apr 06, 04
|
| 08:05 ET |
Ardais Announces Expansion of Aventis Collaboration to Support Target Validation Efforts
|
|
Mar 25, 04
|
| 09:01 ET |
BioTrove Launches SNP Genotyping Capability -- The First Application of the Living Chip(TM) Nano-Fluidics Technology Platform
|
|
Mar 22, 04
|
| 09:22 ET |
BioTrove's Momentum Signs First Contract with Large Pharmaceutical Customer
|
|
Mar 11, 04
|
| 08:34 ET |
VaxInnate Corporation Raises $23.1 Million in Series B Financing
|
|
Mar 10, 04
|
| 10:59 ET |
Feinstein Kean Healthcare Program Wins Paul G. Rogers/NCPIE Medication Communicator Award
|
|
| 08:32 ET |
Scion Pharmaceuticals Announces Appointment of Valentin Gribkoff, Ph.D., as Vice President of Biology
|
|
Mar 09, 04
|
| 11:12 ET |
Scion Pharmaceuticals to Present at SG Cowen Health Care Conference
|
|
Feb 19, 04
|
| 08:01 ET |
Novartis Institutes for BioMedical Research Selects Feinstein Kean Healthcare as Agency of Record
|
|
Feb 02, 04
|
| 11:43 ET |
Icagen Raises $19.5 Million to Advance Ion Channel Drug Discovery And Development Programs
|
|
| 08:30 ET |
Icagen Raises $19.5 Million to Advance Ion Channel Drug Discovery and Development Programs
|
|
Dec 23, 03
|
| 16:01 ET |
Icagen Initiating Phase I Clinical Development Program for ICA-69673, a Novel Drug Candidate for Epilepsy
|
|
Dec 22, 03
|
| 08:31 ET |
Dynogen Pharmaceuticals, Inc. Enters into Agreement with Mitsubishi Pharma for Irritable Bowel Syndrome Compound
|
|
Dec 10, 03
|
| 08:10 ET |
Study Suggests RISPERDAL(R) CONSTA(TM), New Treatment For Schizophrenia, May Further Relieve Symptoms of Stable Patients
|
|
Dec 09, 03
|
| 08:00 ET |
Treating Schizophrenia Patients With RISPERDAL(R) CONSTA(R) May Reduce Hospitalization Rates And Cost Of Care
|
|
Dec 05, 03
|
| 08:00 ET |
FDA Approves Risperdal (R) for Treatment of Bipolar Mania
|
|
Dec 03, 03
|
| 15:58 ET |
Risperdal (R) Consta (R), First and Only Long-Acting, Newer-Generation Schizophrenia Treatment, Now Available
|
|
Nov 20, 03
|
| 14:01 ET |
Scientists Report on Promising New Approaches to Induce Cancer Cell Suicide
|
|
| 10:15 ET |
Three Molecular-Targeted Compounds Show Promise Against Cancers in Early Clinical Studies
|
|
| 08:30 ET |
Icagen and Abbott Laboratories Renew Drug Discovery Collaboration
|
|
Nov 19, 03
|
| 10:50 ET |
Scientists Discover Potential Approaches to Enhance Existing Cancer Therapies
|
|
| 10:49 ET |
Proteins May Help Identify Patients Who Will Respond Better to Different Treatments in Certain Cancers
|
|
| 10:47 ET |
New Drug Target and Biomarker for Advanced Childhood Cancer Discovered; Advances with Two Kinase Targets Reported
|
|
| 10:01 ET |
New Drug Target and Biomarker for Advanced Childhood Brain Cancer Discovered; Advances with Two Kinase Targets Reported
|
|
Nov 18, 03
|
| 12:47 ET |
Circadian Clock Genes May Provide Targets for New Cancer Drugs
|
|
Nov 13, 03
|
| 08:31 ET |
Nephros Therapeutics Appoints Richard Stead, MD as Chief Medical Officer and Karen Brennan as Senior Director of Clinical Operations
|
|
Nov 12, 03
|
| 11:27 ET |
Feinstein Kean Healthcare Expands Pharmaceutical and Consumer Health Practice Leadership
|
|
Nov 05, 03
|
| 09:30 ET |
Feinstein Kean Healthcare Wins Two 2003 Mature Media Awards
|
|
Nov 04, 03
|
| 09:45 ET |
Interim Results of Alzhemed(TM) Open-Label Phase II Extension Study Demonstrates Cognitive Benefits in Patients With Alzheimer's Disease
|
|
Oct 30, 03
|
| 08:05 ET |
FDA Approves RISPERDAL(R) CONSTA(TM) For Treating Schizophrenia
|
|
Oct 29, 03
|
| 19:10 ET |
FDA Approves RISPERDAL(R) CONSTA(TM) for Treating Schizophrenia
|
|
Sep 17, 03
|
| 08:32 ET |
Now Available, New Stalevo Addresses Top Parkinson's Disease Concern
|
|
Sep 10, 03
|
| 09:15 ET |
Feinstein Kean Healthcare Expands Pharmaceutical Communications Practice
|
|
| 08:31 ET |
Scion Announces Appointment of Ray Winquist, Ph.D., F.A.H.A., as Vice President of Pharmacology
|
|
Sep 09, 03
|
| 08:25 ET |
ArQule Completes Acquisition Of Cyclis Pharmaceuticals, An Ampersand Ventures' Portfolio Company
|
|
Sep 03, 03
|
| 08:03 ET |
Icagen Completes Patient Enrollment For Phase II Sickle Cell Anemia Clinical Trial
|
|
Aug 26, 03
|
| 09:15 ET |
First of its Kind Study Aims to Answer Important Questions About Girls and ADHD
|
|
Aug 22, 03
|
| 09:02 ET |
Data Show Exelon(R) Reduces Behavioral Disturbances Associated with Alzheimer's Disease
|
|
Aug 11, 03
|
| 08:06 ET |
BioTrove, Inc. Launches Momentum(TM) Technology - Ultra High-Throughput Mass Spectrometry System - For Functional Assay Development
|
|
Aug 07, 03
|
| 15:24 ET |
Trileptal(R) (oxcarbazepine) is Approved for Use as Monotherapy in Children With Epilepsy
|
|
Aug 01, 03
|
| 08:31 ET |
Jennifer Viera Joins Feinstein Kean Healthcare as Account Director
|
|
Jul 02, 03
|
| 15:05 ET |
Neurochem Clinical Advisory Board Recommends Initiation of Phase III For Alzhemed(TM)
|
|
| 09:04 ET |
Georges Haas, Ph.D. Joins Scion Pharmaceuticals' Board of Directors
|
|
Jun 23, 03
|
| 09:02 ET |
Neurochem Conference Call and Web Cast on Alzhemed(TM) Phase II Study for Alzheimer's Disease at 10:00 A.M. Et Today
|
|
| 08:25 ET |
Neurochem Reports Promising Findings From Alzhemed(TM) Phase II Study For Alzheimer's Disease
|
|
Jun 19, 03
|
| 09:00 ET |
Cyclis Provides Update on Research Programs and Business Activities at BIO 2003
|
|
Jun 13, 03
|
| 08:30 ET |
FDA Approves Stalevo (TM) for Treatment of Parkinson's Disease
|
|
Jun 11, 03
|
| 07:01 ET |
Renal Amyloidosis Worsens Familial Mediterranean Fever prognosis
|
|
Jun 02, 03
|
| 09:14 ET |
Study Published in Psychiatric Journal Supports Efficacy of First Long-Acting, Newer-Generation Schizophrenia Treatment
|
|
May 30, 03
|
| 14:30 ET |
Neurochem to Present at The Annual UBS Warburg Global Specialty Pharmaceuticals Conference
|
|
| 08:01 ET |
BioTrove Names Robert H. Ellis as Chief Operating Officer
|
|
May 19, 03
|
| 18:02 ET |
Walk a Mile in Their Shoes: Psychiatrists Get Firsthand Look at Coping with Schizophrenia
|
|
May 14, 03
|
| 08:33 ET |
Spherics, Inc. Appoints Ze'ev Shaked, Ph.D., as Chief Executive Officer and Director
|
|
| 08:09 ET |
Xantos Biomedicine Accesses the Ardais BIGR(TM) Library for Clinical Validation of its Targets in Inflammatory and Degenerative Diseases
|
|
May 07, 03
|
| 17:01 ET |
Neurochem Licenses its Diabetes Technology to Innodia Inc.
|
|
| 08:01 ET |
U.S. Genomics Secures $25 Million in Equity Financing
|
|
May 06, 03
|
| 09:39 ET |
New, More Convenient Form of Leading Schizophrenia Medication Risperdal (R) Now Available
|
|
May 05, 03
|
| 05:45 ET |
BioMarin Announces First Quarter 2003 Financial Results
|
|
May 02, 03
|
| 11:07 ET |
Data Show Schizophrenia Patients who Miss Just a Few Days of Medication are at Increased Risk for Hospitalization
|
|
Apr 24, 03
|
| 10:07 ET |
ALS Therapy Development Foundation Appoints Clinical Advisory Board
|
|
Apr 22, 03
|
| 10:30 ET |
ALS Therapy Development Foundation to Present at Massachusetts Biotechnology Council Annual Meeting
|
|
Apr 15, 03
|
| 10:03 ET |
Zapaq Inc. Announces Fundamental U.S. Patent on Tools for Discovering Memapsin 2 (beta-secretase) Inhibitors to Treat Alzheimer's Disease
|
|
Apr 10, 03
|
| 13:32 ET |
Francesca DeVellis Returns to Feinstein Kean Healthcare as Vice President, Biotechnology Communications
|
|
| 11:02 ET |
Neurochem's Data Safety Monitoring Board Recommends Continuation of Pivotal Phase II/III Clinical Trial for Fibrillex(TM)
|
|
Apr 01, 03
|
| 08:01 ET |
BioTrove, Inc. Relocates Corporate Headquarters to Woburn, Massachusetts
|
|
Mar 26, 03
|
| 08:03 ET |
U.S. Genomics Names Stephen P. DeFalco, Former PerkinElmer Executive, as New Chief Executive Officer and Chairman
|
|
| 01:30 ET |
Majority Interest in Idenix Pharmaceuticals, an MPM Capital Portfolio Company, to be Acquired by Novartis Pharma AG
|
|
Mar 12, 03
|
| 08:32 ET |
Peptimmune, Inc. Secures $41.2 Million in Venture Capital Financing
|
|
Mar 03, 03
|
| 09:04 ET |
Cyclis to Present at Life Science Ventures Conference
|
|
Feb 24, 03
|
| 08:31 ET |
Nephros Therapeutics Announces Senior Executive Appointments
|
|
Feb 18, 03
|
| 09:03 ET |
Cyclis Pharmaceuticals Reports Studies Defining New Mechanism for Potential Cancer Therapies
|
|
| 08:05 ET |
BioStratum and DakoCytomation Announce License Agreement for Cancer Diagnostic Antibody
|
|
Feb 12, 03
|
| 06:00 ET |
Altus(R) and Dr. Falk Pharma Announce Alliance to Develop and Market TheraCLEC(TM) in Europe
|
|
Feb 09, 03
|
| 13:00 ET |
BioMarin Announces Fourth Quarter and Year-end 2002 Financial Results
|
|
Feb 05, 03
|
| 16:21 ET |
BioMarin Announces Public Offering of 6,000,000 Shares of Common Stock
|
|
Jan 30, 03
|
| 10:30 ET |
Evotec OAI to Support Dynogen Pharmaceuticals in the Discovery and Development of Novel Pharmaceuticals
|
|
| 09:08 ET |
Neurochem Lead Investigator Awarded NIH Grant to Support U.S. Phase II Clinical Trials of Cerebril(TM)
|
|
Jan 27, 03
|
| 09:05 ET |
Neurochem to Present at the Annual U.S. Bancorp Piper Jaffray Healthcare Conference
|
|
Jan 07, 03
|
| 13:00 ET |
Neurochem to Present at The 21st Annual JP Morgan H&Q Healthcare Conference
|
|
Jan 06, 03
|
| 08:30 ET |
Neurochem Appoints Dr. Philippe Calais as New President
|
|
Dec 23, 02
|
| 08:30 ET |
ZymoGenetics and Amgen Settle Patent Infringement Lawsuit for the Rheumatoid Arthritis Drug Enbrel(R) (etanercept)
|
|
Dec 20, 02
|
| 17:05 ET |
BioMarin Files Shelf Registration Statement
|
|
| 09:00 ET |
Icagen and Bristol-Myers Squibb Renew Drug Discovery And Development Collaboration
|
|
Dec 19, 02
|
| 18:33 ET |
Therion Biologics and the National Institute of Allergy and Infectious Diseases, NIH, Initiate Human Clinical Trials of Preventive Smallpox Vaccine
|
|
Dec 03, 02
|
| 17:06 ET |
ZymoGenetics Highlights Development Programs at Analyst & Investor Briefing
|
|
Nov 21, 02
|
| 16:00 ET |
ZymoGenetics to Hold Analyst & Investor Briefing In New York City on December 3rd
|
|
Nov 11, 02
|
| 10:00 ET |
BioStratum Incorporated to Present at BIO-Europe 2002 and BIO-Scandinavia 2002
|
|
Nov 07, 02
|
| 16:15 ET |
ZymoGenetics Reports Third Quarter 2002 Financial Results
|
|
| 09:00 ET |
Dey L.P. Provides $25,000 Grant to National Emphysema/COPD Association
|
|
Nov 06, 02
|
| 09:03 ET |
BioTrove Raises $5.25 Million in Venture Financing
|
|
Nov 05, 02
|
| 08:00 ET |
Neurochem Presents Further Scientific Evidence of Disease Modifying Activity With its Drug Candidate for the Treatment of Alzheimer's Disease and Cerebral Amyloid Angiopathy
|
|
Nov 04, 02
|
| 10:39 ET |
BioStratum Incorporated Presents at the American Society of Nephrology's 35th Annual Meeting and Scientific Exposition
|
|
Oct 31, 02
|
| 00:30 ET |
BioMarin Announces Third Quarter 2002 Financial Results
|
|
Oct 29, 02
|
| 10:02 ET |
Neurochem Announces Webcast of Presentation at the 4th Annual Mass Opportunities Investor Conference
|
|
Oct 28, 02
|
| 06:30 ET |
IBEX Technologies Announces Potential New Diagnostic Test To Predict The Progression Of Osteoarthritis
|
|
| 06:30 ET |
IBEX Technologies Announces The Discovery of a Novel Arthritis Target
|
|
Oct 25, 02
|
| 09:14 ET |
Investigational New Drug In The U.S. For Cerebril(TM) Takes Effect And Signals Initiation Of Phase II Clinical Trial
|
|
| 08:32 ET |
Cyclis to Present at MASS Opportunities Investment Conference
|
|
Oct 22, 02
|
| 10:57 ET |
U.S. Genomics Awarded Patent for DNA Analysis Methods
|
|
Oct 16, 02
|
| 08:29 ET |
Cyclis to Present at the VentureWire Lifescience Portfolio Conference
|
|
Oct 09, 02
|
| 08:28 ET |
Cyclis Completes Licensing Agreement with Beth Israel Deaconess Medical Center and Dana-Farber Cancer Institute
|
|
| 08:04 ET |
ZymoGenetics Adds Interleukin-21 (IL-21) to Its Product Development Pipeline
|
|
Oct 07, 02
|
| 09:01 ET |
Icagen Announces Fast Track Status for ICA-17043 - A Novel Treatment for Sickle Cell Anemia
|
|
| 08:30 ET |
ZymoGenetics, Inc. and Alexandria Real Estate Equities, Inc. Complete $52 Million Sale Leaseback Transaction
|
|
Oct 02, 02
|
| 10:00 ET |
BioStratum Announces Strategic Management Changes and Appointments
|
|
Sep 30, 02
|
| 10:04 ET |
Neurochem Announces Positive Developments for its Alzheimer's Disease Program
|
|
| 08:32 ET |
Barrier Therapeutics Appoints Anne VanLent as Executive Vice President and Chief Financial Officer
|
|
| 00:30 ET |
BioMarin Proceeds With Neutralase (TM) Phase III Clinical Trial
|
|
Sep 25, 02
|
| 10:01 ET |
BioStratum Announces Agreements with Genzyme for Alport Syndrome Technology and Research
|
|
Sep 23, 02
|
| 17:54 ET |
Icagen Presents Results of Phase Ib Clinical Trial for ICA-17043 -- A Novel Treatment for Sickle Cell Disease
|
|
Sep 18, 02
|
| 08:30 ET |
Nephros Therapeutics Completes $17 Million Financing to Accelerate Clinical Development of Proprietary RAD System to Treat Acute Renal Failure
|
|
Sep 17, 02
|
| 08:32 ET |
ZymoGenetics Files Investigational New Drug Application For Recombinant Human Factor XIII To Treat Congenital Deficiency
|
|
| 08:30 ET |
Therion Biologics Licenses ICAM-1 from Boehringer Ingelheim
|
|
Sep 12, 02
|
| 00:30 ET |
BioMarin Adopts Stockholder Rights Plan
|
|
Sep 09, 02
|
| 08:30 ET |
Therion Biologics Corporation Strengthens Management Team
|
|
Sep 04, 02
|
| 08:47 ET |
U.S. Genomics Awarded $499,500 DARPA Contract to Examine Applicability Of Genomic Mapping Technology
|
|
| 08:31 ET |
Cyclis Receives Notice of Allowance for Key U.S. Patent Relating to CO-501
|
|
Sep 03, 02
|
| 10:04 ET |
BioStratum Incorporated Presents at the European Association for the Study of Diabetes Annual Meeting
|
|
Aug 29, 02
|
| 10:37 ET |
Neurochem Files Investigational New Drug Application For Alzhemed(TM) to Treat Alzheimer's Disease
|
|
Aug 27, 02
|
| 08:33 ET |
Spherics, Inc. Appoints Mathias Woker to VP, Business Development; Mark Iampietro to Director of Quality Assurance; and Daniel Magiera to Principal Scientist in Analytical Chemistry
|
|
Aug 22, 02
|
| 00:30 ET |
BioMarin Completes Acquisition of Glyko Biomedical Ltd.
|
|
Aug 19, 02
|
| 08:30 ET |
Barrier Therapeutics Appoints Charles Nomides as New Chief Operating Officer
|
|
Aug 15, 02
|
| 08:01 ET |
J. Craig Venter, Ph.D., Joins the Board of Directors at U.S. Genomics
|
|
Aug 14, 02
|
| 08:32 ET |
Spherics, Inc. Raises $10 Million in Series B Financing
|
|
Aug 08, 02
|
| 08:30 ET |
ZymoGenetics Reports Second Quarter 2002 Financial Results
|
|
Aug 06, 02
|
| 15:28 ET |
Chickenpox Vaccination Now Required for Kindergarten, 1st Grade and 7th Grade Enrollment in Pennsylvania
|
|
| 15:28 ET |
Chickenpox Vaccination Now Required for School Enrollment in Michigan
|
|
Aug 01, 02
|
| 02:00 ET |
OGS Announces Board Change
|
|
| 00:30 ET |
BioMarin Announces Second Quarter 2002 Financial Results
|
|
Jul 31, 02
|
| 00:30 ET |
BioMarin Receives U.S. Patent Covering Aldurazyme(TM) for Treatment of MPS I
|
|
Jul 30, 02
|
| 08:01 ET |
Cyclis to Present at IBC Drug Discovery Technology 2002 Conference
|
|
| 04:00 ET |
Roche Licenses Compounds to Treat Alzheimer's Disease from Memory Pharmaceuticals
|
|
Jul 29, 02
|
| 08:31 ET |
ZymoGenetics Announces License Agreement for Interleukin-13 Receptor With Wyeth
|
|
Jul 26, 02
|
| 02:00 ET |
OGS Announces Positive CPMP Opinion for Zavesca(TM)* for Type 1 Gaucher Disease in European Union
|
|
| 02:00 ET |
OGS and Actelion Announce Marketing and Distribution Partnership For Zavesca(TM)* in Europe
|
|
Jul 24, 02
|
| 02:00 ET |
OGS Announces Decision by Ethics Committee in Israel to End Temporary Suspension of Vevesca (OGT 918) Trials
|
|
Jul 23, 02
|
| 09:15 ET |
Parents' Misperceptions about Chickenpox May Influence Vaccine Decisions
|
|
| 08:33 ET |
Neurochem Scientists Report On Multiple Research And Therapeutic Programs For Alzheimer's Disease
|
|
Jul 22, 02
|
| 10:06 ET |
FDA Grants BioStratum Fast Track Status for Company's Lead Drug Candidate, Pyridorin (TM)
|
|
Jul 18, 02
|
| 12:06 ET |
ZymoGenetics Receives U.S. Patent on ADAM33 Protein
|
|
Jul 17, 02
|
| 07:59 ET |
Cyclis Pharmaceuticals Completes $5 Million Initial Financing to Develop Small Molecule Cancer Drugs Based on Activated Checkpoint Therapy
|
|
Jul 15, 02
|
| 00:30 ET |
BioMarin Appoints New CFO and Three New Board Members
|
|
Jul 12, 02
|
| 02:00 ET |
OGS and Cystic Fibrosis Foundation Therapeutics Inc. Launch a Major Proteomics Initiative to Advance Management of Cystic Fibrosis
|
|
Jul 08, 02
|
| 00:30 ET |
BioMarin Creates Science Advisory Board
|
|
Jul 05, 02
|
| 00:30 ET |
BioMarin Schedules Annual Meeting for August 13, 2002
|
|
Jun 25, 02
|
| 00:30 ET |
BioMarin Announces Positive Findings from Phase 1 Trial and Extension Study of Aryplase(TM) for MPS VI
|
|
Jun 24, 02
|
| 08:32 ET |
ZymoGenetics Announces Novo Nordisk A/S Has Converted Its Non-Voting Shares of ZymoGenetics Stock into Voting Shares
|
|
| 02:00 ET |
OGS Receives Complete Response Letter from the FDA on Vevesca (OGT 918)
|
|
Jun 17, 02
|
| 10:00 ET |
BioStratum Incorporated Presents at the American Diabetes Association's 62nd Scientific Sessions Meeting
|
|
Jun 15, 02
|
| 13:00 ET |
New Study Suggests that Weight Loss with Xenical(R) (orlistat) Improves Glycemic Control in Type 2 Diabetes Patients Taking Maximal Doses of Anti-Diabetic Medications
|
|
| 13:00 ET |
Three Studies Presented at American Diabetes Association Meeting Suggest Weight Loss with Xenical(R) (orlistat) Provides Additional Benefits for Type 2 Diabetes Patients When Combined with Current Therapies
|
|
Jun 14, 02
|
| 00:30 ET |
BioMarin Announces Upcoming Clinical Trial Data Presentations Regarding Aldurazyme(TM) for MPS I and Aryplase(TM) for MPS VI
|
|
Jun 13, 02
|
| 08:31 ET |
Coley Pharmaceutical Group Initiates Phase I/II Clinical Trial of CpG 7909 in Melanoma Patients
|
|
Jun 10, 02
|
| 07:31 ET |
ZymoGenetics and Regeneron Sign License Agreement for Ig-Fusion Protein Technology
|
|
Jun 06, 02
|
| 10:48 ET |
Memory Pharmaceuticals to Present at Bio 2002 in Toronto June 9-12, 2002
|
|
Jun 03, 02
|
| 08:31 ET |
ZymoGenetics Provides Update on Manufacturing Plans
|
|
May 29, 02
|
| 08:30 ET |
BioMimetic Pharmaceuticals Initiates Pivotal Clinical Study with Platelet-derived Growth Factor for the Treatment of Periodontal Diseases
|
|
May 24, 02
|
| 12:48 ET |
OGS Appoints New Chief Executive Officer
|
|
May 23, 02
|
| 08:29 ET |
ZymoGenetics and Arriva Pharmaceuticals Sign Agreement for Alpha 1-Antitrypsin -US patent covers commercial production of AAT in yeast-
|
|
May 19, 02
|
| 19:12 ET |
Columbia/ECOG Researchers Stabilize PSA Levels and Clinical Progression in Prostate Cancer Patients Following Treatment with Therapeutic Vaccines
|
|
May 15, 02
|
| 08:32 ET |
Point Reports First Quarter 2002 Financial Results
|
|
| 00:30 ET |
BioMarin Provides Update on NeuroTrans(TM) Brain Delivery Program
|
|
May 10, 02
|
| 16:22 ET |
Barrier Therapeutics Raises $46 Million in Private Financing
|
|
May 08, 02
|
| 08:33 ET |
ZymoGenetics Reports First Quarter 2002 Financial Results - Completion of IPO Highlights Quarter -
|
|
May 07, 02
|
| 00:30 ET |
BioMarin Announces First Quarter 2002 Financial Results
|
|
May 02, 02
|
| 09:56 ET |
Oxford GlycoSciences Plc Monotherapy study 001 results on Vevesca (OGT 918) presented at EWGGD
|
|
| 09:56 ET |
Oxford GlycoSciences Plc Switch/Combination Study 004 Results on Vevesca (OGT 918) Presented at EWGGD
|
|
Apr 29, 02
|
| 10:10 ET |
BioStratum Raises $20 Million in Private Financing; Makes Strategic Acquisition of BioCrine AB
|
|
| 08:30 ET |
ZymoGenetics Reports New Preclinical Findings on Zfgf5, a Novel Growth Factor Implicated in Cartilage Repair
|
|
Apr 24, 02
|
| 09:53 ET |
OGS Temporarily Halts Vevesca (OGT 918) Treatment in Israel as a Precaution Pending Investigation of an Unexplained Adverse Event
|
|
Apr 22, 02
|
| 00:30 ET |
BioMarin Initiates Phase 2 Trial of Aryplase (TM) Enzyme Replacement Therapy for MPS VI
|
|
Apr 19, 02
|
| 10:01 ET |
Karl Tryggvason, M.D., Ph.D. Awarded 2002 Louis-Jeantet Prize for Medicine
|
|
Apr 11, 02
|
| 08:31 ET |
Coley Pharmaceutical Group Strengthens Management Team and Expands Board of Directors
|
|
Apr 10, 02
|
| 15:17 ET |
New Study Shows Restrictions Hurt Medicaid Patients
|
|
Apr 04, 02
|
| 08:50 ET |
Neurochem Presents Phase I Clinical Trials Results and Proof-of-Concept Data for Drug Candidate Alzhemed (TM) for Alzheimer's Disease
|
|
Apr 03, 02
|
| 08:29 ET |
Therion Biologics Adds to Board of Directors
|
|
Mar 29, 02
|
| 09:01 ET |
Abbott Laboratories and Icagen Expand Drug Discovery Collaboration
|
|
Mar 27, 02
|
| 08:31 ET |
Therion Names Mark Leuchtenberger, Former Vice President of Biogen International, as President and CEO
|
|
Mar 25, 02
|
| 08:59 ET |
Memory Pharmaceuticals Completes $40 Million Private Financing to Accelerate Neurological Drug Discovery and Development
|
|
Mar 21, 02
|
| 02:02 ET |
Oxford GlycoSciences Plc Preliminary Audited Results For the Year Ended 31 December 2001
|
|
| 02:00 ET |
Oxford GlycoSciences Plc Update on Vevesca (OGT 918)
|
|
Mar 18, 02
|
| 08:19 ET |
U.S. Genomics Awarded Pioneering Patent for Direct, Linear Analysis of DNA
|
|
Mar 15, 02
|
| 16:30 ET |
HMSR, Inc. Completes Merger with Point Therapeutics, Inc.
|
|
Mar 14, 02
|
| 02:00 ET |
OGS and BioInvent form Therapeutic Antibodies Alliance
|
|
Mar 13, 02
|
| 08:29 ET |
BTG and ISREC Release New Data Supporting Use of Adenoviral Treatment For Colorectal Cancer
|
|
Mar 11, 02
|
| 08:31 ET |
ZymoGenetics Reports Fourth Quarter and Year End 2001 Financial Results
|
|
| 08:29 ET |
James E. Barrett, Ph.D. Named Senior Vice President, Research and Development of Memory Pharmaceuticals
|
|
Mar 07, 02
|
| 16:38 ET |
ZymoGenetics Files Patent Infringement Suit Against Immunex
|
|
| 02:10 ET |
2002 R&D UPDATE
|
|
| 02:00 ET |
OGS CEO to Step Down by Year-End
|
|
Mar 05, 02
|
| 11:30 ET |
OGS Appoints Donald W. DeGolyer to Main Board as President of Global Therapeutics
|
|
Feb 28, 02
|
| 16:15 ET |
High School Students Experience a Day in the Life of Feinstein Kean Healthcare
|
|
Feb 27, 02
|
| 10:16 ET |
BioStratum Incorporated to Present at BioSquare 2002
|
|
Feb 25, 02
|
| 00:30 ET |
BioMarin Announces Fourth Quarter and Year-end 2001 Financial Results
|
|
Feb 21, 02
|
| 08:29 ET |
BTG Acquires New Class of Compounds with Potent Activity Against HIV
|
|
Feb 20, 02
|
| 08:30 ET |
U.S. Genomics to Collaborate with Dr. Pui-Yan Kwok, Leading Geneticist at Washington University, for Genetic Research, Technology Development
|
|
Feb 19, 02
|
| 09:51 ET |
Neurochem Receives U.S. Patent for Amyloid Program
|
|
Feb 12, 02
|
| 10:20 ET |
BioStratum Successfully Files IND for Anticancer Product Angiocol (TM), Receives Clearance to Initiate Phase I Clinical Trial
|
|
Feb 08, 02
|
| 02:00 ET |
GeneProt Licences OGS' Automated Proteomics Patents
|
|
Feb 07, 02
|
| 07:01 ET |
OGS Opens New Office in New Jersey
|
|
| 01:00 ET |
BioMarin to Consolidate Share Structure by Acquiring Glyko Biomedical
|
|
Feb 01, 02
|
| 01:00 ET |
ZymoGenetics, Inc. Announces Initial Public Offering of Common Stock
|
|
Jan 29, 02
|
| 12:15 ET |
Neurochem Scientists Release Findings on In Vivo Inhibition of Amyloid Formation and Deposition in Alzheimer's Disease Research Program
|
|
Jan 28, 02
|
| 08:30 ET |
U.S. Genomics and The Wellcome Trust Sanger Institute to Collaborate on Genetic Discovery
|
|
Jan 24, 02
|
| 09:04 ET |
James J. Cappola, M.D, Ph.D. Joins NitroMed as Senior Vice President Clinical and Regulatory Affairs
|
|
Jan 22, 02
|
| 09:04 ET |
Gardiner F.H. Smith Named Vice President, Business Development of Memory Pharmaceuticals
|
|
Jan 15, 02
|
| 09:00 ET |
Restoragen, Inc. Appoints Ashleigh W. Palmer as Chief Executive Officer
|
|
Jan 14, 02
|
| 09:38 ET |
BioMarin to Acquire Developer of Unique Brain Delivery Technology
|
|
Jan 09, 02
|
| 02:00 ET |
Oxford GlycoSciences, Medarex and Genmab Announce Comprehensive Campaign To Treat Breast Cancer
|
|
Jan 08, 02
|
| 08:59 ET |
NitroMed Appoints Former Novartis CEO Jerry Karabelas, Ph.D. to Board of Directors
|
|
Jan 04, 02
|
| 16:00 ET |
BioMarin Announces Personnel Changes
|
|
| 08:59 ET |
ZymoGenetics Appoints Dr. Mark Young as Senior Vice President, Technical Operations
|
|
Jan 02, 02
|
| 08:30 ET |
Therion Biologics and the Ludwig Institute Initiate Clinical Study of Cancer Vaccine in Europe
|
|
Dec 26, 01
|
| 09:01 ET |
Altus Completes Second Round of Private Financing, Totaling Over $50 Million
|
|
Dec 17, 01
|
| 08:32 ET |
Applied Molecular Evolution Appoints James B. Breitmeyer, M.D., Ph.D. Chief Medical Officer
|
|
Dec 14, 01
|
| 02:01 ET |
OGS Announces Extension of Proteomics Agreement with Pfizer
|
|
Dec 13, 01
|
| 01:00 ET |
BioMarin Completes $96.6 Million Public Offering of Common Stock
|
|
Dec 12, 01
|
| 08:59 ET |
Feinstein Kean Healthcare Appoints Michael Lampe to Director in Marketing and Scientific Communications Group
|
|
Dec 07, 01
|
| 09:14 ET |
BioMarin Prices $84 Million Public Offering of Common Stock
|
|
Dec 06, 01
|
| 19:33 ET |
OGS Announces Achievement of Major Protein Patenting Milestone
|
|
Dec 03, 01
|
| 09:02 ET |
ZymoGenetics Appoints Robert S. Whitehead as Chief Business Officer
|
|
Nov 30, 01
|
| 06:15 ET |
Aradigm Corporation Announces Appointment of Bryan Lawlis as Chief Operating Officer and the Departure of Igor Gonda as Chief Scientific Officer
|
|
Nov 27, 01
|
| 07:59 ET |
Therion Biologics Strengthens Position in Cancer Immunotherapy with Acquisition of Key Patents from the U.S. Public Health Service
|
|
Nov 26, 01
|
| 08:29 ET |
Keryx President, Benjamin Corn, M.D., Assumes Additional Role Of Chief Executive Officer
|
|
Nov 20, 01
|
| 02:00 ET |
OGS Enters Exclusive Alliance with Teva for the Marketing and Distribution of Vevesca (OGT 918) in Israel
|
|
Nov 15, 01
|
| 12:33 ET |
BioStratum Incorporated to Present at BIO-Scandinavia 2001
|
|
| 08:29 ET |
U.S. Genomics Appoints David Hoey as Vice President of Business Development
|
|
Nov 14, 01
|
| 09:05 ET |
Icagen Expands Senior Management Team
|
|
Nov 13, 01
|
| 11:01 ET |
Neurochem's Data Show Early Inflammatory Response during Amyloid Deposition in Alzheimer's Disease Model
|
|
| 08:30 ET |
Keryx Reports Third Quarter 2001 Financial Results
|
|
Nov 09, 01
|
| 17:27 ET |
BioMarin Announces Filing of Registration Statement with SEC
|
|
| 08:59 ET |
ZymoGenetics to Discuss Novel Therapeutic Approaches for the Treatment of Autoimmune Disease
|
|
| 07:59 ET |
U.S. Patent Issued for Neurochem
|
|
Nov 07, 01
|
| 12:32 ET |
VITEX Speaks at the World Health Organization's Forum on Blood Safety
|
|
Nov 06, 01
|
| 09:25 ET |
BioMarin Completes Acquisition of Enzyme Products From IBEX Technologies
|
|
| 08:20 ET |
Applied Molecular Evolution, Inc. Reports Financial Results for the Third Quarter 2001
|
|
Nov 01, 01
|
| 10:21 ET |
** November Is National Alzheimer's Disease Month ** New Nationwide Survey of More Than 2,500 People Uncovers Barriers to Early Detection of Alzheimer's Disease
|
|
Oct 31, 01
|
| 11:53 ET |
AACR-NCI-EORTC International Conference Highlights Therion Vaccines as Innovative Approach to Cancer Immunotherapy
|
|
| 08:29 ET |
U.S. Genomics Appoints Michael B. Olex as Senior Vice President of Operations and Manufacturing
|
|
| 08:29 ET |
VITEX Reports Third Quarter 2001 Financial Results
|
|
Oct 30, 01
|
| 10:57 ET |
BioStratum Incorporated to Present at AACR-NCI-EORTC International Conference
|
|
| 10:15 ET |
Hematech Relocates Research Laboratory to Sioux Falls, South Dakota
|
|
| 09:18 ET |
Coley Pharmaceutical Group Begins Phase I/II Trial of CpG 7909 in Combination with Herceptin (R) to Treat Breast Cancer
|
|
| 07:59 ET |
Therion Completes $36.5 Million Private Financing to Advance Clinical Development of Therapeutic Cancer Vaccines
|
|
Oct 26, 01
|
| 10:36 ET |
Study Results Suggest Dexmethylphenidate HCl Is An Effective Treatment For ADHD
|
|
| 09:48 ET |
New Data Suggest Ritalin(R) LA (Methylphenidate Hydrochloride Extended-Release Capsules) is an Effective Once-Daily Treatment For ADHD
|
|
| 01:01 ET |
BioMarin Announces Third Quarter 2001 Financial Results
|
|
Oct 25, 01
|
| 13:47 ET |
VITEX to Present at Massachusetts Opportunities Investment Conference on October 30
|
|
| 10:01 ET |
BioStratum Names Seymour Mong, Ph.D., Vice President of Research
|
|
Oct 24, 01
|
| 11:31 ET |
Neurochem Announces Clinical Advisory Board for Promising Alzheimer's Therapeutic
|
|
| 10:01 ET |
Colbar's Second Tissue Engineering Product, Dermicol, To Enter U.S. Clinical Trials In 2002
|
|
| 09:30 ET |
Feinstein Kean Healthcare Announces Promotion of Mark Alvino to Senior Vice President
|
|
Oct 22, 01
|
| 17:21 ET |
INACTINE(TM) System Inactivates Virus that Causes Foot and Mouth Disease
|
|
| 12:45 ET |
VITEX to Announce Third Quarter 2001 Financial Results on October 31, 2001
|
|
| 09:03 ET |
Icagen and Bristol-Myers Squibb Renew Drug Discovery and Development Collaboration
|
|
Oct 17, 01
|
| 02:00 ET |
Vevesca (OGT 918) Accepted for Filing by FDA
|
|
Oct 16, 01
|
| 08:59 ET |
Nationwide Survey of More Than 2,500 People Uncovers Barriers To Early Detection Of Alzheimer's Disease
|
|
Oct 15, 01
|
| 14:13 ET |
Neurochem Receives $1.4 Million Grant from FDA and OMP Designation in Europe for Fibrillex(TM)
|
|
| 08:33 ET |
INACTINE(TM) System May Eliminate Need to Gamma Irradiate Cells For TAGvHD Prevention
|
|
Oct 10, 01
|
| 01:00 ET |
BioMarin To Acquire Enzyme Products From IBEX Technologies
|
|
Oct 09, 01
|
| 20:55 ET |
INACTINE(TM) System May Address Concerns of Prion Proteins in Red Blood Cells
|
|
| 08:29 ET |
VITEX to Present at UBS Warburg Global Life Sciences Conference on October 12
|
|
Oct 04, 01
|
| 09:59 ET |
BioStratum Incorporated to Present at UBS Warburg Global Life Sciences Conference
|
|
Oct 03, 01
|
| 10:46 ET |
Altus Raises $35 Million in Private Financing
|
|
| 08:29 ET |
Keryx Appoints Barry Cohen to Vice President of Business Development
|
|
Oct 02, 01
|
| 09:37 ET |
Ritalin (R) LA, a New Once-Daily Treatment for ADHD, Receives FDA Approvable Letter
|
|
Sep 26, 01
|
| 08:59 ET |
Psychiatric Genomics, Inc. Appoints New Chief Financial Officer
|
|
Sep 24, 01
|
| 02:01 ET |
Oxford GlycoSciences Plc Interim Results for the Six Months Ended 30 June 2001
|
|
| 02:00 ET |
Latest Clinical Results on OGT 918 for Gaucher Disease in Long-Term Follow Up and Dose Comparison Studies Presented at ESGLD Meeting
|
|
Sep 20, 01
|
| 08:31 ET |
Keryx Appoints Professor Rony Seger, Ph.D. as its Chief Scientific Officer
|
|
Sep 18, 01
|
| 08:29 ET |
Applied Molecular Evolution to Optimize Anti-IL-9 Antibody For MedImmune
|
|
| 07:59 ET |
RTP Pharma Inc. Enters Exclusive Alliance With Baxter Healthcare Corporation On RTP Pharma Inc.'s Injectable IDD (TM) Technology
|
|
Sep 11, 01
|
| 08:04 ET |
Memory Pharmaceuticals Acquires Rights From Bayer to a Promising Drug Candidate for Dementia
|
|
| 06:01 ET |
Restoragen, Inc.'s Betatropin(TM) Improves Glucose Levels In Type 2 Diabetics Over 7-Day Treatment Period
|
|
Sep 10, 01
|
| 13:50 ET |
ZymoGenetics, Inc. Files Registration Statement for an Initial Public Offering of Common Stock
|
|
Sep 06, 01
|
| 08:30 ET |
Keryx Biopharmaceuticals Granted Fast Track Status by the U.S. Food and Drug Administration
|
|
| 01:00 ET |
BioMarin Announces Positive MPS VI Phase I Trial Results
|
|
Sep 05, 01
|
| 08:29 ET |
Applied Molecular Evolution Awarded $1 Million NIH Research Grant for the Treatment of Cocaine Overdose and Addiction
|
|
| 08:00 ET |
Tony Scullion Named Chief Executive Officer of Memory Pharmaceuticals
|
|
Sep 04, 01
|
| 01:00 ET |
ZymoGenetics and Serono to Collaborate on a Novel Therapeutic Approach For Autoimmune Disease
|
|
Aug 28, 01
|
| 08:31 ET |
Applied Molecular Evolution Names Stanley T. Crooke, M.D., Ph.D., to Its Board of Directors
|
|
Aug 23, 01
|
| 06:15 ET |
Aradigm Corporation Announces $14.6 Million Private Placement
|
|
Aug 22, 01
|
| 10:46 ET |
Novartis and Celgene Receive FDA Approvable Letter for Dexmethylphenidate HCl, the First Chemically Advanced Form of Ritalin (R) for ADHD
|
|
| 08:31 ET |
Therion Expands Clinical Capabilities with Appointment of Two Senior Executives
|
|
| 02:11 ET |
OGS Announces Grant of Expanded High-Throughput Proteomics Patent
|
|
Aug 21, 01
|
| 11:29 ET |
OGS announces completion of New Drug Application submission for Vevesca(TM) (OGT 918) with the US Food and Drug Administration
|
|
Aug 16, 01
|
| 14:02 ET |
Plaintiffs' Attorneys Drop Ritalin Class Action Litigation in Puerto Rico
|
|
Aug 15, 01
|
| 09:02 ET |
SafeScience, Inc. Reports Second Quarter 2001 Financial Results
|
|
Aug 14, 01
|
| 08:35 ET |
VITEX Reports Second Quarter 2001 Financial Results
|
|
| 06:02 ET |
VITEX Completes Divestiture of Plasma Operations
|
|
Aug 13, 01
|
| 09:37 ET |
Keryx Reports Second Quarter 2001 Financial Results
|
|
Aug 07, 01
|
| 08:29 ET |
Applied Molecular Evolution, Inc. Reports Financial Results for the Second Quarter 2001
|
|
| 08:29 ET |
VITEX to Announce Second Quarter 2001 Financial Results on August 14, 2001
|
|
Aug 06, 01
|
| 14:07 ET |
Spherics Appoints David J. Livingston, Ph.D., MBA, as President and Chief Executive Officer
|
|
Aug 01, 01
|
| 08:02 ET |
SkyePharma Acquires 40.2% Interest in RTP Pharma Inc
|
|
Jul 31, 01
|
| 08:29 ET |
Novasite Pharmaceuticals Enters Small Molecule Discovery Agreement With Aventis Pharmaceuticals
|
|
Jul 27, 01
|
| 01:00 ET |
BioMarin Announces Second Quarter 2001 Financial Results
|
|
Jul 26, 01
|
| 16:58 ET |
VITEX to Present at Adams, Harkness & Hill's 21st Annual Summer Seminar
|
|
| 06:01 ET |
Third Wave Reports Second Quarter Results
|
|
| 01:01 ET |
BioMarin Completes Treatment Stage of MPS-VI Trial
|
|
Jul 25, 01
|
| 02:00 ET |
OGS Announces Development of Second Generation Proteomics Platform
|
|
Jul 23, 01
|
| 08:59 ET |
Plaintiffs' Attorneys Walk Away from Ritalin Litigation in Florida
|
|
| 08:59 ET |
Potential for Huge Rewards but High Risks Identified in The Boston Consulting Group's Report on Genetics in Drug Research and Development
|
|
| 08:59 ET |
SafeScience Completes Patient Enrollment For Phase II Pancreatic Cancer Clinical Trial
|
|
Jul 19, 01
|
| 09:04 ET |
ZymoGenetics Names George B. Rathmann as Chairman of the Board
|
|
| 08:59 ET |
Third Wave Technologies to Host Second-Quarter 2001 Conference Call
|
|
| 08:00 ET |
Nycomed Amersham Imaging and Neurochem Collaborate to Create Alzheimer's Diagnostic
|
|
Jul 18, 01
|
| 12:14 ET |
U.S. Genomics Awarded Patent Using Fluorophores in Direct, Linear DNA Analysis
|
|
| 08:59 ET |
SafeScience, Inc. Retains Nasdaq Smallcap Market Listing
|
|
| 08:07 ET |
BioMicro Systems Receives U.S. Patent Allowance For Microfluidic Passive Fluid Control Technology
|
|
Jul 17, 01
|
| 07:02 ET |
ArQule, Inc. Reports Financial Results for Second Quarter Ended June 30, 2001
|
|
| 02:00 ET |
Neurochem Provides Update on Clinical Treatment for Secondary Amyloidosis
|
|
Jul 13, 01
|
| 02:01 ET |
OGS Initiates Vevesca(TM) Clinical Study At New York University -- Acknowledged 'Centre of Excellence' for The Diagnosis and Treatment of Gaucher Disease
|
|
Jul 12, 01
|
| 02:01 ET |
OGS' Marketing Authorisation Application for Vevesca(TM) (OGT 918) Accepted for Review by European Agency
|
|
Jul 11, 01
|
| 12:51 ET |
SafeScience Closes Business Venture Transaction
|
|
Jul 10, 01
|
| 17:27 ET |
ArQule, Inc. to Report Second Quarter Financial Results on July 17, 2001
|
|
| 08:37 ET |
VITEX Added to the Russell 3000 Index
|
|
| 08:31 ET |
Applied Molecular Evolution Added to Russell 3000 Index
|
|
Jul 06, 01
|
| 08:29 ET |
Coley Pharmaceutical Group Publishes Discovery of Novel Interferon-Inducing CpG Molecule in European Journal of Immunology
|
|
Jul 05, 01
|
| 09:01 ET |
Restoragen, Inc. Reports Positive Results From Trials of Betatropin(TM) in Type 2 Diabetics
|
|
Jul 02, 01
|
| 06:01 ET |
Third Wave Scientists Publish Advance In Gene Expression Monitoring With Revolutionary RNA Invader(R) Assay
|
|
Jun 29, 01
|
| 17:21 ET |
SafeScience Signs Definitive Agreements For Joint Venture
|
|
Jun 26, 01
|
| 08:31 ET |
Applied Molecular Evolution Files Patent Infringement Suit Against MorphoSys
|
|
Jun 25, 01
|
| 01:00 ET |
BioMarin Files CTX to Conduct Clinical Trial of Vibriolysin Topical to Treat Serious Burns
|
|
Jun 21, 01
|
| 12:00 ET |
UroGenesys Changes Name to Agensys and Expands into Therapeutic Product Development
|
|
| 07:26 ET |
MorphoSys and ImmunoGen Expand Existing Collaboration License of HuCAL(R) For Target Research
|
|
Jun 20, 01
|
| 09:02 ET |
SafeScience Receives Conditional Registration for Elexa 4(R) Plant Defense Booster
|
|
| 02:01 ET |
OGS and NeoGenesis Announce High-Throughput, 'Target-to-Drug Lead' Collaboration
|
|
Jun 15, 01
|
| 02:00 ET |
Marconi and OGS Form Joint Venture to Provide Proteomics Data And Hosting Solutions
|
|
| 02:00 ET |
OGS Building 'Protein Atlas' to Provide First Definitive List and Structure of Human Protein-Coding Genes
|
|
Jun 14, 01
|
| 08:59 ET |
NitroMed Completes $31.4 Million Private Financing
|
|
Jun 13, 01
|
| 19:35 ET |
SafeScience, Inc. Forms Business Venture With Elan Corporation, Plc.
|
|
| 19:33 ET |
SafeScience, Inc. Receives Nasdaq Staff Determination and Requests Appeal
|
|
| 08:31 ET |
U.S. Genomics Receives First U.S. Patent for Molecular Motors
|
|
Jun 11, 01
|
| 08:29 ET |
Ronald J. Saldarini, Ph.D. Elected Chairman of Therion Board of Directors
|
|
Jun 07, 01
|
| 12:39 ET |
ArQule Announces Appointments of Vice President, Strategic Development and Vice President, Legal
|
|
| 08:15 ET |
ArQule Announces Appointment of Ariel Elia As Chairman of the Board of Directors
|
|
Jun 06, 01
|
| 08:59 ET |
Novasite Pharmaceuticals Launches GPCR Crystallization Effort Led by Dr. Krzysztof Palczewski
|
|
Jun 05, 01
|
| 08:32 ET |
Applied Molecular Evolution to Present at the Wall Street Analyst Forum on June 6th 2001
|
|
| 06:59 ET |
ZymoGenetics and BioMimetic Pharmaceuticals Sign Licensing Agreement for Clinical Development of PDGF
|
|
Jun 04, 01
|
| 10:48 ET |
Boston Consulting Group Quantifies Benefits of Genomic Technologies for Streamlined Drug Discovery
|
|
May 31, 01
|
| 10:22 ET |
FDA Grants Marketing Clearance For Oral Suspension of Trileptal (R) For Epilepsy (Seizure Disorder)
|
|
May 29, 01
|
| 07:01 ET |
British Biotech and ImmunoGen Begin Patient Enrollment for the Phase I/II Trial of BB-10901/huN901-DM1 in Small Cell Lung Cancer
|
|
May 24, 01
|
| 08:00 ET |
ArQule, Inc. to Webcast Analyst Day on May 30, 2001
|
|
May 23, 01
|
| 08:31 ET |
Point Therapeutics Receives $5.4 Million to Advance Clinical Tests of Small Molecule Treatment of Neutropenia in Cancer Patients
|
|
May 22, 01
|
| 09:04 ET |
Delta Pharmaceuticals Changes Name to Ardent Pharmaceuticals
|
|
| 07:01 ET |
Dyax Corp. and American Home Products Enter Into Exclusive License for Use of a Ligand for Purification of FVIII
|
|
May 18, 01
|
| 15:31 ET |
Judge Dismisses Class-Action Lawsuit Against Makers of Ritalin
|
|
| 11:26 ET |
The Biotechnology Institute Launches Special Issue of Your World on the Human Genome
|
|
May 17, 01
|
| 17:45 ET |
SafeScience, Inc. Reports First Quarter 2001 Financial Results
|
|
| 12:53 ET |
BioMarin Announces $45 Million Private Placement
|
|
May 16, 01
|
| 08:14 ET |
Phytera and Gemin X Sign Cancer Drug Discovery Collaboration
|
|
May 15, 01
|
| 08:33 ET |
Keryx Reports First Quarter 2001 Financial Results
|
|
May 14, 01
|
| 16:01 ET |
Georgetown Researchers Achieve Increased Cancer Patient Survival Following Treatment with Therapeutic Vaccines
|
|
| 12:13 ET |
ImmunoGen, Inc. Announces Webcast for Its Analyst Briefing Held at the 2001 Annual Meeting of the American Society of Clinical Oncology
|
|
| 07:34 ET |
ImmunoGen Reports Promising Results from Phase I/II Human Clinical Study with Product Candidate for Colorectal, Pancreatic and Non-Small-Cell Lung Cancers
|
|
May 11, 01
|
| 09:32 ET |
Applied Molecular Evolution Adopts Stockholder Rights Plan
|
|
| 08:31 ET |
In New Study, Rapid Switching From Donepezil to Rivastigmine Was Well Tolerated; Findings Presented at The American Geriatrics Society Annual Meeting in Chicago
|
|
May 10, 01
|
| 16:25 ET |
ImmunoGen, Inc. Reports Third Quarter Results, Beating Expectations by $0.01
|
|
| 08:29 ET |
Vitex Reports First Quarter 2001 Financial Results
|
|
| 01:01 ET |
BioMarin and Genzyme Report Continued Improvements in MPS-I Patients After 2 Years of Treatment with Aldurazyme (TM)
|
|
May 08, 01
|
| 13:01 ET |
VITEX to Announce First Quarter 2001 Results on May 10, 2001
|
|
| 09:18 ET |
ImmunoGen Begins Enrollment in a Third Phase I/II Human Clinical Study with Lead Product for Colorectal, Pancreatic and Non-Small-Cell Lung Cancers
|
|
May 07, 01
|
| 07:30 ET |
Vitex and Oxford University to Collaborate on Promising Prion Technology
|
|
May 03, 01
|
| 07:25 ET |
ImmunoGen Schedules Third Quarter 2001 Financial Results on May 10, 2001
|
|
May 01, 01
|
| 08:32 ET |
Icagen Expands Senior Management Team
|
|
| 08:29 ET |
Applied Molecular Evolution, Inc. Reports Financial Results For the First Quarter 2001
|
|
Apr 27, 01
|
| 08:28 ET |
Judge Dismisses Class-Action Lawsuit Against Makers of Ritalin
|
|
| 01:00 ET |
BioMarin Announces First Quarter 2001 Financial Results
|
|
Apr 26, 01
|
| 17:43 ET |
Judge Dismisses Class-Action Lawsuit Against Makers of Ritalin
|
|
| 10:01 ET |
BioStratum Incorporated Adds Former Glaxo President D'Alonzo and Memorial Sloan-Kettering President Emeritus Marks to Board of Directors
|
|
| 08:35 ET |
Hyseq Announces First Quarter Financial Results
|
|
| 06:59 ET |
Dyax Corp. Announces First Quarter 2001 Financial Results
|
|
Apr 25, 01
|
| 08:36 ET |
Hyseq Appoints Two Top Executives: Senior Vice President and Chief Financial Officer, Peter S. Garcia and Senior Vice President of Human Resources, Linda A. Fitzpatrick
|
|
Apr 24, 01
|
| 07:59 ET |
BioMarin Completes Important Milestone in the Manufacturing of Aldurazyme (TM)
|
|
Apr 18, 01
|
| 13:30 ET |
Dyax Corp. to Host First Quarter Conference Call
|
|
| 08:29 ET |
BioStratum Incorporated Elects Harry H. Penner to Board of Directors
|
|
Apr 12, 01
|
| 09:16 ET |
Novartis' Alzheimer's Disease Web Site Receives Awards for Content, Interactive Design and Best Pharmaceutical Site
|
|
Apr 05, 01
|
| 02:00 ET |
OGS and the Institute for Systems Biology Announce ICAT based Proteomics Platform Alliance
|
|
Apr 04, 01
|
| 11:45 ET |
SafeScience Reports 2000 Year-End and Fourth Quarter Financial Results
|
|
| 08:59 ET |
U.S. Genomics Announces $17 Million Private Financing to Advance Pioneering Technology for Direct, Linear Analysis of DNA
|
|
Apr 03, 01
|
| 10:08 ET |
ImmunoGen, Inc. Announces Webcast of Presentation at Tucker Anthony Sutro's Health Care Conference 2001
|
|
| 10:03 ET |
PTC Therapeutics Inc. Announces Appointments to Board of Directors
|
|
Mar 29, 01
|
| 11:23 ET |
Keryx Reports Fourth Quarter and Year End 2000 Financial Results
|
|
| 07:29 ET |
ImmunoGen and Raven Biotechnologies Announce Target and Antibody Discovery Collaboration in Ovarian Cancer
|
|
Mar 27, 01
|
| 16:53 ET |
Icagen Raises $23 Million to Advance Ion Channel Drug Discovery and Development Programs
|
|
Mar 23, 01
|
| 08:30 ET |
SafeScience Announces Cancer Drug Shows Positive Activity in Phase II Clinical Trial
|
|
Mar 21, 01
|
| 08:31 ET |
Hyseq Promotes Ted W. Love as CEO and President George B. Rathmann to Remain as Chairman
|
|
Mar 20, 01
|
| 09:20 ET |
Pyrosequencing AB and Mosaic Technologies Enter Cross-License Agreement To Leverage DNA Sequencing technologies
|
|
| 08:31 ET |
IAVI and Therion Form Collaboration to Advance Preventative Vaccines for AIDS
|
|
Mar 19, 01
|
| 09:59 ET |
Ardais Raises $33.5 Million in Private Financing
|
|
| 02:01 ET |
XTL Biopharmaceuticals Ltd Receives Milestone Payments From Corporate Partner for Use of Trimera System
|
|
Mar 17, 01
|
| 17:30 ET |
NitroMed Initiates Confirmatory BiDil (R) Trial in African American Heart Failure Patients
|
|
Mar 15, 01
|
| 08:29 ET |
Pyrosequencing AB Announces Major Improvement in Efficiency For Allele Frequency Studies
|
|
| 02:01 ET |
Oxford GlycoSciences Plc Preliminary Unaudited Results for the Year Ended 31 December 2000
|
|
Mar 14, 01
|
| 16:20 ET |
Judge Dismisses Complaint Against Makers of Ritalin
|
|
| 09:47 ET |
Judge Dismisses Complaint Against Makers of Ritalin
|
|
Mar 13, 01
|
| 17:49 ET |
Judge Dismisses Complaint Against Makers of Ritalin
|
|
| 08:31 ET |
Oxford GlycoSciences to Host Fourth Quarter 2000 Conference Call
|
|
| 08:29 ET |
Second Generation Vitaxin Enters Phase I Clinical Trials with MedImmune
|
|
Mar 12, 01
|
| 08:29 ET |
EPIX Medical, InSightec and Brigham and Women's Hospital Enter Technology Development Collaboration
|
|
Mar 09, 01
|
| 08:41 ET |
VITEX Signs Letter of Intent to Divest Plasma Operations
|
|
| 02:00 ET |
XTL Biopharmaceuticals Acquires Stake in iviGene Corporation
|
|
Mar 08, 01
|
| 15:37 ET |
Applied Molecular Evolution to Present at the Informed Investors San Diego Biotechnology Stocks Forum
|
|
| 10:01 ET |
Biostratum Names Gary M. Gordon, MD, Vice President of Business Development
|
|
| 07:59 ET |
NitroMed Receives FDA Letter on BiDil (R) NDA, a Treatment for Heart Failure in Black Patients
|
|
| 07:01 ET |
Dyax Corp. Announces Management Changes
|
|
Mar 07, 01
|
| 09:04 ET |
Cystic Fibrosis Foundation Announces $25 Million Alliance with Altus Biologics Inc. in Developing Treatment for Pancreatic Insufficiency
|
|
| 08:29 ET |
Abbott Laboratories and Icagen Extend and Expand Drug Discovery Collaboration
|
|
Mar 06, 01
|
| 08:29 ET |
Applied Molecular Evolution, Inc. Reports Financial Results for the Fourth Quarter and Year End 2000
|
|
Mar 05, 01
|
| 16:20 ET |
Alzheimer's Disease Expert and ABC Television Personality Linda Dano Available For Interviews
|
|
| 15:29 ET |
Exelon (R) (rivastigmine tartrate) Fact Sheet
|
|
| 15:26 ET |
Linda Dano and the National Family Caregivers Association Team Up to Provide Information, Resources and Support to Caregivers of Alzheimer's Disease Patients
|
|
| 08:31 ET |
Alan Carpenter, Ph.D. Joins EPIX Medical as E.V.P. of Research and Development
|
|
| 08:30 ET |
VITEX Completes $10 Million Equity Placement
|
|
| 08:04 ET |
Hematech Receives Milestone Payment from its Polyclonal Antibody Collaboration with Kirin
|
|
| 07:35 ET |
ImmunoGen Appoints New Chief Financial Officer
|
|
Mar 02, 01
|
| 01:00 ET |
BioMarin Announces Completion of Enrollment of Phase III Trial of Aldurazyme (TM) for MPS-I
|
|
Feb 28, 01
|
| 07:01 ET |
Dyax Signs 50th Licensee for Phage Display
|
|
Feb 27, 01
|
| 09:01 ET |
Feinstein Kean Healthcare Expands and Strengthens Senior Account Staff
|
|
Feb 23, 01
|
| 17:08 ET |
SafeScience, Inc. Discontinues Consumer and Commercial Product Lines to Focus on Drug Development
|
|
Feb 22, 01
|
| 08:29 ET |
Maret Pharmaceuticals Appoints Leonard R. Borrmann, Pharm.D., as Chief Executive Officer
|
|
| 07:01 ET |
Dyax Corp. Announces Fourth Quarter and Year End 2000 Financial Results
|
|
| 01:00 ET |
BioMarin Announces Fourth Quarter and Year 2000 Financial Results
|
|
Feb 21, 01
|
| 09:02 ET |
Anadys Pharmaceuticals Establishes German Operations To Access RNA Biology Through EMBL
|
|
Feb 20, 01
|
| 16:04 ET |
Therion Biologics and National Cancer Institute Initiate Human Clinical Trials of Next-Generation Product for Colorectal Cancer
|
|
| 08:32 ET |
Repair's President and CEO to Speak at BIO CEO & Investor Conference in New York
|
|
| 08:29 ET |
VITEX Appoints Joseph M. Limber To Its Board of Directors
|
|
Feb 16, 01
|
| 13:49 ET |
Dyax Corp. to Host Fourth Quarter and Year End 2000 Conference Call
|
|
| 12:15 ET |
Applied Genomics to Take Spotlight at Showcase Meeting
|
|
| 08:35 ET |
Hyseq CFO Announces Resignation to Pursue Other Opportunities
|
|
| 08:01 ET |
Hematech Appoints James Robl, Ph.D. President and Chief Scientific Officer
|
|
Feb 15, 01
|
| 16:06 ET |
EPIX Medical Reports Fourth Quarter and Year-End Results for 2000
|
|
| 08:29 ET |
SafeScience, Inc. Forms New Scientific Advisory Board
|
|
Feb 14, 01
|
| 17:21 ET |
ArQule To Present at the BIO CEO & Investor Conference
|
|
Feb 13, 01
|
| 14:01 ET |
UroGenesys Researchers Report Antibodies to Prostate Cancer Target Block Tumor Growth, Inhibit Metastases and Prolong Survival in Mice
|
|
| 13:01 ET |
Neurochem Reports Key Data on Role of Inflammation in Alzheimer's Disease
|
|
| 08:29 ET |
VITEX Reports Fourth Quarter and Year-End Results for 2000
|
|
| 06:59 ET |
Dyax Corp. and Debiopharm S.A. Report Initiation of Phase II Clinical Trial With EPI-HNE-4 for Cystic Fibrosis
|
|
Feb 12, 01
|
| 08:10 ET |
Keryx Awarded Critical U.S. Patent For Gene-Based Drug Discovery Involving Kinase Targeted Compounds
|
|
| 02:00 ET |
OGS Reports Progress with Vevesca(TM) Clinical Trials in Type 1 Gaucher Disease
|
|
Feb 09, 01
|
| 14:54 ET |
VITEX to Report Fourth Quarter and Year-End Results on February 13, 2001
|
|
Feb 08, 01
|
| 16:24 ET |
ImmunoGen, Inc. Reports Second Quarter Results
|
|
| 16:11 ET |
EPIX Medical CEO Joins Board of Medical Imaging Contrast Agents Association (MICAA)
|
|
| 08:05 ET |
Hyseq Announces Financial Results for The Fourth Quarter and Year Ended December 31, 2000
|
|
Feb 07, 01
|
| 09:22 ET |
Genomica Reports Fourth Quarter and Year 2000 Financial Results
|
|
Feb 06, 01
|
| 10:01 ET |
BioStratum Signs License Agreement Granting Kowa Company Exclusive Rights to Diabetes Drug Candidate in Japan and Selected Other Asian Markets
|
|
| 08:31 ET |
Keryx Biopharmaceuticals Appoints J. Wilson Totten, M.D. and Malcom I. Hoenlein to Board of Directors
|
|
Feb 05, 01
|
| 13:33 ET |
ImmunoGen, Inc. Announces Second Quarter Conference Call
|
|
| 08:30 ET |
Applied Molecular Evolution Names John F. Richards to its Board of Directors
|
|
| 07:01 ET |
Aradigm and Genentech Discontinue AERx (R) rhDNase Development Program and Will Execute New Broad-Based Feasibility Agreement
|
|
Feb 01, 01
|
| 13:21 ET |
ImmunoGen Comments on Recent SEC Lawsuit
|
|
| 08:59 ET |
CoPharma Announces Licensing Agreement with Dana-Farber Cancer Institute
|
|
| 07:30 ET |
BioMarin Announces Equity Financing Commitment of up to $50 Million
|
|
| 07:01 ET |
ArQule, Inc. Announces the Close of its Merger with Camitro Corporation
|
|
Jan 31, 01
|
| 11:40 ET |
Genomica Corporation to Report Fourth Quarter Earnings on February 7, 2001
|
|
| 08:59 ET |
Pan Pacific Pharmaceuticals, Inc. Appoints U.S. Scientific Advisory Board
|
|
| 07:59 ET |
ZymoGenetics Appoints James A. Johnson as Chief Financial Officer
|
|
Jan 30, 01
|
| 08:59 ET |
U.S. Patent Issued for RTP Pharma
|
|
| 08:32 ET |
Lynx and Phytera Announce Partnership to Identify Genes for Biosynthesis of Important Nutraceutical Compounds
|
|
Jan 29, 01
|
| 09:38 ET |
Pyrosequencing AB Extends Global Market Access With New Distribution Agreements
|
|
| 09:02 ET |
SafeScience Secures Global Patent Portfolio For GBC-590 Through Exclusive World-Wide Licensing Agreement
|
|
| 09:02 ET |
SafeScience to Focus on Biotechnology and Drug Development
|
|
| 08:31 ET |
Keryx Biopharmaceuticals Secures U.S. Patent For Use of KRX-101 Against Diabetic Retinopathy
|
|
Jan 25, 01
|
| 08:29 ET |
Hyseq Announces Markman Decision in Litigation Brought by Affymetrix Ruling Supports Hyseq's Defenses
|
|
| 07:50 ET |
ImmunoGen and Avalon Enter Genomics-Based Collaboration
|
|
| 06:59 ET |
Dyax Corp and Debiopharm S.A. Report Preliminary Results of Phase Ib Clinical Trial of EPI-HNE-4 for Cystic Fibrosis
|
|
Jan 24, 01
|
| 07:04 ET |
ArQule, Inc. Reports Financial Results for Fourth Quarter and Year Ended 2000 And Extension of Collaboration with Solvay Pharmaceuticals
|
|
Jan 23, 01
|
| 08:31 ET |
Phytera Achieves Milestone from Lilly Anti-fungal Drug Discovery Collaboration
|
|
Jan 22, 01
|
| 02:01 ET |
XTL Biopharmaceuticals and Dyax Collaborate to Unite Two Powerful Drug Discovery Technologies
|
|
Jan 18, 01
|
| 08:30 ET |
BioMarin and Genzyme Report Publication in the New England Journal of Medicine of Treatment with Aldurazyme (TM) in MPS-I Patients
|
|
Jan 17, 01
|
| 08:30 ET |
Merlin Technologies Appoints Raymond Baddour to Board of Directors
|
|
| 08:01 ET |
Corixa and CoPharma Collaborate to Develop and Commercialize Corixa's Novel Cardioprotectant
|
|
Jan 16, 01
|
| 17:19 ET |
ArQule and Camitro Agree to Merge
|
|
| 12:10 ET |
Dr. Ted Love Joins Hyseq as President
|
|
| 08:29 ET |
SafeScience, Inc. Announces $4.7 Million Private Placement of Securities
|
|
| 07:01 ET |
ArQule and Nanodesign Enter into Collaboration for Novel Drug Design Technology
|
|
Jan 12, 01
|
| 16:33 ET |
Applied Molecular Evolution to Host Analyst Event
|
|
| 08:29 ET |
ZymoGenetics Researchers Identify Novel Protein with Potential Role in Psoriasis
|
|
Jan 11, 01
|
| 11:01 ET |
BioMarin Exercises Option to Acquire Exclusive Rights to Proprietary Burn Product Candidate
|
|
Jan 09, 01
|
| 08:32 ET |
Schering AG Germany Acquires Japanese Rights to EPIX Medical's MS-325
|
|
Jan 08, 01
|
| 07:05 ET |
Dyax Corp. and Human Genome Sciences Enter into Exclusive BLyS Purification License
|
|
| 07:01 ET |
Lexicon Genetics Announces Milestone in LexVision(TM) Collaboration With Bristol-Myers Squibb
|
|
| 07:00 ET |
Abgenix and Dyax to Collaborate on Novel Antibody Technology
|
|
Jan 05, 01
|
| 06:59 ET |
Lexicon Genetics Names Key Individuals to Lead Human Resources and Corporate Communications Functions
|
|
Jan 04, 01
|
| 11:01 ET |
BioMarin Receives European Orphan Drug Designation for rhASB for MPS-VI
|
|
| 08:45 ET |
Dyax to Present Company Update at the JP Morgan Chase 19th Annual Healthcare Conference
|
|
| 08:36 ET |
Vitex and Pall Initiate Phase II Trial for Inactine(TM) Pathogen Inactivation For Red Blood Cells
|
|
Jan 03, 01
|
| 07:01 ET |
Lexicon Genetics and Abgenix Enter Drug Target Validation Collaboration
|
|
Dec 21, 00
|
| 08:30 ET |
Ischemia Technologies Completes Series B Equity Financing
|
|
Dec 20, 00
|
| 12:29 ET |
EPIX Medical Clarifies Inaccurate Information Regarding Possible Sale of Stock
|
|
| 09:05 ET |
Applied Molecular Evolution Enters Collaboration With Biosynexus to Optimize an Antibacterial Agent
|
|
| 02:01 ET |
XTL Biopharmaceuticals Ltd Reports Update From Preclinical Hepatitis C Virus Program and Hepatitis B Virus Clinical Trial
|
|
Dec 19, 00
|
| 08:45 ET |
PTC Therapeutics Awarded Phase I SBIR Grant to Develop Novel HIV Treatments
|
|
| 07:00 ET |
ArQule and ACADIA Pharmaceuticals Establish new Drug Discovery Collaboration
|
|
| 07:00 ET |
Lexicon Genetics Grants Roche Bioscience Renewal to Technology Sublicense
|
|
Dec 18, 00
|
| 10:31 ET |
New Findings Published In The Lancet Suggest Exelon (R) (rivastigmine tartrate) Improves Behavioral Disturbances In Patients With Dementia With Lewy Bodies
|
|
Dec 13, 00
|
| 10:08 ET |
PTC Therapeutics Inc. Announces Appointments to Scientific Advisory Board and Senior Management Team
|
|
Dec 12, 00
|
| 08:59 ET |
Anadys Pharmaceuticals Raises $21.2 Million In Private Financing
|
|
Dec 05, 00
|
| 13:15 ET |
First Human Data Presented for Vitex's Pathogen Inactivated Red Blood Cell Product at ASH Conference
|
|
| 13:01 ET |
First Human Data Reported on Safety and Viability of Virally Inactivated Red Blood Cells
|
|
Dec 01, 00
|
| 10:02 ET |
Linda Dano Reaches Out to Help Other Alzheimer's Disease Caregivers
|
|
| 09:20 ET |
Applied Molecular Evolution, Inc. Announces Stock Repurchase
|
|
Nov 29, 00
|
| 14:04 ET |
ArQule, Inc. Announces Exercise of Underwriters' Overallotment Option
|
|
| 08:29 ET |
Keryx Biopharmaceuticals Appoints Ron Bentsur Global Head of Investor Relations
|
|
Nov 28, 00
|
| 06:55 ET |
ArQule Announces Drug Discovery Collaboration with SmithKline Beecham
|
|
| 02:00 ET |
XTL Biopharmaceuticals Announces Issuance of Human Monoclonal Antibody Patent
|
|
Nov 27, 00
|
| 08:29 ET |
Dr. James Hope Joins Vitex as VP, Molecular Sciences
|
|
Nov 22, 00
|
| 12:31 ET |
Genzyme and Biomarin Announce PHASE III Trial of Aldurazyme(TM) For MPS-I
|
|
Nov 21, 00
|
| 12:21 ET |
ArQule, Inc. Announces Closing of Follow-On Public Offering
|
|
| 08:01 ET |
Harvard Center For Cancer Prevention Purchases Pyrosequencing's PSQ(TM) 96 System For DNA Analysis
|
|
Nov 20, 00
|
| 08:31 ET |
Deloitte & Touche Ranks Vitex 51st Out of 500 Fastest Growing Technology Companies
|
|
Nov 16, 00
|
| 09:30 ET |
Feinstein Kean Healthcare Expands and Strengthens Management Team
|
|
| 08:29 ET |
Vitex Strengthens Executive Management From Within
|
|
| 07:55 ET |
ImmunoGen Announces Pricing of Public Offering
|
|
| 06:59 ET |
Lexicon Genetics Sublicenses Positive-Negative Selection and Isogenic DNA Technologies to Eli Lilly and Company
|
|
Nov 15, 00
|
| 18:22 ET |
Ischemia Technologies Secures 6.8 MM in Series B Equity Financing
|
|
| 16:01 ET |
Paradigm Genetics and LION Bioscience Expand Strategic Alliance
|
|
| 10:49 ET |
Paradigm Genetics and LION Bioscience Expand New Strategic Alliance
|
|
Nov 14, 00
|
| 16:39 ET |
SafeScience Inc. Reports Third Quarter 2000 Financial Results
|
|
| 10:31 ET |
XTL Biopharmaceuticals and Pharming Group to Co-Develop Lactoferrin to Treat Hepatitis C
|
|
| 08:29 ET |
Keryx Reports Third Quarter 2000 Financial Results
|
|
Nov 13, 00
|
| 12:17 ET |
EPIX Medical's MS-325 Contrast Agent Provides Detailed MRI Images of Artery Walls
|
|
| 10:19 ET |
Indiana University Patient Trial Shows Cholinesterase Inhibitor Delays Progression of Mild to Moderately Severe Alzheimer's Disease
|
|
| 08:29 ET |
EPIX Announces Study Results for First MRI Contrast Agent Targeted at Imaging Blood Clots
|
|
| 08:08 ET |
SafeScience, Inc. to Host Third Quarter 2000 Conference Call
|
|
| 07:01 ET |
Aquila and Baylor College of Medicine Announce the Initiation of Clinical Trials of QS-21 Flu Vaccine
|
|
Nov 10, 00
|
| 08:29 ET |
Maret Pharmaceuticals Presents Promising Phase I/II Clinical MARstem Results at International Symposium on New Drugs in Cancer Therapy
|
|
| 07:59 ET |
Genomica Corporation Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2000
|
|
| 07:09 ET |
ImmunoGen Reports Preliminary Phase I/II Clinical Data on huC242-DM1/SB-408075
|
|
Nov 09, 00
|
| 14:39 ET |
Urgent: Alert For Media Covering The American Heart Association (AHA) Annual Meeting
|
|
| 08:55 ET |
Vitex Reports Third Quarter 2000
|
|
Nov 08, 00
|
| 08:29 ET |
Vitex Submits Marketing Application in UK for Solvent Detergent Transfusion Plasma
|
|
| 07:29 ET |
ImmunoGen Reports Favorable Preclinical Results for huN901-DM1/BB-10901
|
|
Nov 07, 00
|
| 07:59 ET |
Aquila Biopharmaceuticals Reports Financial Results For the Third Quarter of 2000
|
|
| 06:59 ET |
Applied Molecular Evolution, Inc. Reports Financial Results for Third Quarter 2000
|
|
Nov 06, 00
|
| 07:59 ET |
Mosaic Technologies, Inc. to Host Symposium on Bacterial Contamination of Blood Components
|
|
| 07:01 ET |
Dyax and Bracco Announce Diagnostic Imaging Collaboration
|
|
Nov 03, 00
|
| 13:18 ET |
Triangle Pharmaceuticals to Host Analyst Event
|
|
| 09:29 ET |
Genomica Corporation to Report Third Quarter Earnings on November 10, 2000
|
|
| 08:32 ET |
INACTINE(TM) Pathogen Inactivation Highlighted at American Association Of Blood Banks Meeting
|
|
Nov 02, 00
|
| 12:36 ET |
Pyrosequencing Makes Forbes Global's List of 300 Best Small Companies
|
|
| 08:31 ET |
ZymoGenetics Researchers Identify Novel Interleukin that Plays Key Role in Immune System Regulation
|
|
| 08:01 ET |
Genomica's Discovery Manager (TM) Software Licensed to Aventis Pharma
|
|
| 07:01 ET |
Lexicon Genetics Announces Major Expansion in The Woodlands
|
|
| 07:00 ET |
Triangle Pharmaceuticals, Inc. Reports Financial Results For The Third Quarter 2000
|
|
Nov 01, 00
|
| 13:25 ET |
NitroMed Issued Broad U.S. Patents Covering NO-Enhanced NSAIDs
|
|
| 08:59 ET |
Linda Dano and the National Family Caregivers Association Team Up To Provide Information, Resources and Support to Caregivers Of Alzheimer's Disease Patients
|
|
| 08:01 ET |
BioMarin Announces Election of New Chairman and Chief Executive Officer
|
|
| 07:59 ET |
Paradigm Genetics Announces Third Quarter 2000 Financial Results, Revenue Increases 829% Over 1999
|
|
Oct 31, 00
|
| 10:24 ET |
Pyrosequencing's PSQ (TM) 96 System DNA Sequencing Technology to Accelerate UC Davis Population Genetics Study
|
|
| 07:59 ET |
Psychiatric Genomics, Inc. Enters Next Phase of Development With Move to Larger Facilities
|
|
Oct 30, 00
|
| 07:01 ET |
BioMarin Announces Third Quarter 2000 Financial Results
|
|
| 07:01 ET |
Triangle Pharmaceuticals Reports Marked Anti-Hepatitis B Activity of Coviracil(R)(Emtricitabine)in Phase I/II Dose-Selection Trial
|
|
| 02:00 ET |
XTL Biopharmaceuticals Presents Interim Phase I Data on First Combination Monoclonal Antibody Therapy for Chronic HBV Infected Patients
|
|
Oct 26, 00
|
| 08:55 ET |
Hyseq Announces Third Quarter Results
|
|
| 08:21 ET |
Therion Biologics and Aventis Pasteur Expand Cancer Vaccine Alliance
|
|
| 07:45 ET |
ImmunoGen, Inc. Reports First Quarter Financial Results
|
|
| 06:59 ET |
Dyax Corp. Announces Third Quarter 2000 Financial Results
|
|
| 06:59 ET |
Lexicon Genetics Announces Third Quarter Financial Results
|
|
Oct 25, 00
|
| 08:30 ET |
Bartels Launches Legionella Urinary Antigen (LUA) ELISA Test Approved by FDA
|
|
| 07:59 ET |
Genomica Corporation Announces Launch of Java/Oracle-Based Linkmapper (TM) Software as Milestone in Applied Biosystems Alliance
|
|
| 07:04 ET |
Lexicon Genetics Announces Issuance of OmniBank Functional Genomics Patent
|
|
Oct 24, 00
|
| 14:48 ET |
Paradigm Genetics Appoints Christopher W.W. Beecher, Ph.D. As Director of Metabolic Profiling
|
|
| 11:37 ET |
Paradigm Genetics To Host Live Webcast of Third Quarter 2000 Financial Results Conference Call
|
|
| 08:34 ET |
Vitex Receives Fourth Patent for INACTINE(TM) Technology
|
|
| 08:29 ET |
Intracel Starts a Phase III Trial for KLH for the Treatment of Bladder Cancer
|
|
Oct 23, 00
|
| 14:05 ET |
Paradigm Genetics To Host Live Webcast of Third Quarter 2000 Financial Results Conference Call
|
|
| 07:01 ET |
ArQule Announces Filing of Registration Statement for Follow-On Offering
|
|
| 06:01 ET |
Novo Nordisk Completes Private Placement of Shares in ZymoGenetics
|
|
Oct 20, 00
|
| 08:29 ET |
AngioSense and Repair Enter Collaboration to Combine Angiogenesis and Needle- Free Delivery Device for Cardiovascular Disease
|
|
| 08:29 ET |
U.S. Environmental Protection Agency Approves Conditional Registaration of Elexa-4(R) From SafeScience
|
|
Oct 19, 00
|
| 16:51 ET |
EPIX Medical Reports Third Quarter 2000 Results
|
|
| 12:15 ET |
Paradigm Genetics Announces Certain Shareholders Sign New Lock-Up Agreement To Extend Lock-Up Period
|
|
| 08:00 ET |
Coley Pharmaceutical Group Initiates Phase II Clinical Trials of CpG Product
|
|
| 07:00 ET |
Aquila Initiates Additional Clinical Trials of Quilimmune-P (TM)
|
|
Oct 18, 00
|
| 06:59 ET |
Lexicon Genetics Grants Bristol-Myers Squibb Sublicense To Positive-Negative Selection and isogenic DNA Technologies
|
|
| 06:01 ET |
ArQule and Genome Therapeutics Establish New Collaboration for Discovery and Commercialization of Novel Anti-infective Therapeutics
|
|
Oct 17, 00
|
| 07:31 ET |
ImmunoGen Files Registration Statement for Stock Offering
|
|
Oct 16, 00
|
| 08:56 ET |
RHeoGene Receives $1.85 Million NIST Grant for Multiplexed Gene Regulation Technology
|
|
Oct 13, 00
|
| 22:28 ET |
Lexicon Genetics Sues Deltagen for Patent Infringement Under Four Additional United States Patents
|
|
Oct 12, 00
|
| 09:02 ET |
BioMarin Initiates Phase I/II Clinical Trial of Enzyme Replacement In MPS-VI Patients
|
|
| 06:29 ET |
ArQule, Inc. Reports Strong Financial Results for Third Quarter and Nine Months Ended September 30, 2000
|
|
| 05:30 ET |
Paradigm Genetics Meets Milestone by Delivering Customized Bioinformatics System to Bayer AG
|
|
Oct 10, 00
|
| 16:27 ET |
ArQule, Inc. to Report Third Quarter Earnings on October 12, 2000
|
|
| 12:29 ET |
Novasite Pharmaceuticals Awarded Second NIH Grant for $3.2 Million to Develop Expanded Target Drug Discovery(TM) Technology
|
|
| 08:59 ET |
CoPharma Appoints David Fanning Chief Business Officer
|
|
Oct 09, 00
|
| 16:17 ET |
EPIX Medical Clarifies Inaccurate Information Regarding Possible Sale of Stock
|
|
Oct 06, 00
|
| 09:01 ET |
Mosaic Technologies, Inc. Awarded $2 Million in Research Funding for High-Throughput DNA Sequencing System
|
|
Oct 05, 00
|
| 07:59 ET |
World-Renowned Karolinska Institute Adopts Pyrosequencing (TM) Technology For Disease-Related Research
|
|
| 07:01 ET |
Lexicon Genetics and Tularik Enter Into Functional Genomics Collaboration
|
|
Oct 02, 00
|
| 18:32 ET |
Vitex Approved for Phase II Inactine(TM) PEN110 Trials
|
|
| 10:26 ET |
MorphoSys Enters Cancer Collaboration with ImmunoGen
|
|
| 07:45 ET |
ArQule, Inc. Appoints Ariel Elia to Board of Directors
|
|
Sep 29, 00
|
| 08:29 ET |
Genomica Corporation Announces Pricing of Initial Public Offering
|
|
| 07:01 ET |
Lexicon Genetics Concludes Agreement With Merck Genome Research Institute
|
|
Sep 28, 00
|
| 08:59 ET |
Aradigm Reports Phase 2B Clinical Trial Initiated on AERx(R) Pain Management System
|
|
| 07:55 ET |
Coley Pharmaceutical Group Strengthens Leadership in Immune Stimulation With Acquisition of Key Patents from Isis Pharmaceuticals
|
|
| 07:29 ET |
Triangle Pharmaceuticals Announces Management Changes
|
|
Sep 27, 00
|
| 10:07 ET |
Genome Therapeutics Licenses Genomica's Discovery Manager(TM) Software
|
|
| 09:27 ET |
Keryx Biopharmaceuticals Provides Update on KRX-101 Clinical Development Program
|
|
| 08:31 ET |
Paradigm Genetics President and CEO John Ryals, Ph.D. Appointed To Biotechnology Industry Organization Executive Committee
|
|
Sep 26, 00
|
| 08:59 ET |
Novasite Pharmaceuticals Awarded Phase I SBIR Grant for Expanded Target Drug Discovery(TM) Technology
|
|
| 08:45 ET |
PTC Therapeutics Raises $15 Million to Develop Small Molecule Drugs Based on Integrated RNA Biology and Chemistry Platform
|
|
| 07:01 ET |
Vitex Names Samuel K. Ackerman, M.D., Chairman, Board of Directors David Tendler to Chair Executive Committee
|
|
Sep 22, 00
|
| 09:11 ET |
Biolink's Dialock(R) System Use and Acceptance Surge in Europe
|
|
Sep 21, 00
|
| 12:51 ET |
SafeScience Announces Completion of Enrollment for Phase II Colorectal Trial of GBC-590
|
|
| 12:22 ET |
MDS Proteomics Acquiring Protana, Creating the First Integrated and Fully Industrialized Functional Proteomics Company
|
|
| 09:21 ET |
David J. Enscore, Ph.D. Joins Spherics, Inc. as Vice President, Research and Development
|
|
| 08:01 ET |
National Cancer Center in Tokyo Implements Pyrosequencing(TM) Technology to Study Disease-Related DNA Sequences
|
|
| 07:30 ET |
Genaissance Pharmaceuticals Appoints Kenneth B. Kashkin, M.D. as Executive Vice President and Chief Medical Officer
|
|
| 07:29 ET |
HuC242-DM1/SB-408075 Enters Second Phase I/II Clinical Trial
|
|
Sep 19, 00
|
| 08:59 ET |
Domain Pharma Corporation Appoint Dean Goodermote Chief Executive Officer
|
|
| 07:59 ET |
Feinstein Kean Healthcare Announces Plans to Expand Operations with Opening of Denver Office in Early 2001
|
|
| 07:45 ET |
ArQule, Inc. and The R. W. Johnson Pharmaceutical Research Institute Add Compass Array(TM) Library to Collaboration Agreement
|
|
Sep 18, 00
|
| 17:31 ET |
EPIX Announces $45 Million Equity Financing Arrangement
|
|
| 08:31 ET |
Triangle Pharmaceuticals and Abbott Laboratories Report Drug Candidate DAPD Decreases Viral Load in Patients Infected With Resistant Virus When Added to Failing Drug Regimens
|
|
Sep 14, 00
|
| 13:20 ET |
SafeScience Announces Expanded Roster of Retail Outlets For Consumer Cleaning Products
|
|
| 10:08 ET |
Applied Molecular Evolution Signs Kauffman Licensing Agreement With Idexx For Diagnostic Development
|
|
| 06:59 ET |
Lexicon Genetics Obtains Affymetrix Technology to Accelerate Internal Drug Discovery Efforts
|
|
Sep 13, 00
|
| 16:35 ET |
Dyax Corp. Expands Antibody Discovery Capabilities
|
|
Sep 12, 00
|
| 08:36 ET |
Genomica Appoints Sean Ryan as Vice President of Sales
|
|
| 07:34 ET |
Genaissance Pharmaceuticals Reports First-Ever Link Between Gene Variants (Haplotypes) and Drug Response in the Proceedings of the National Academy of Sciences
|
|
Sep 11, 00
|
| 09:06 ET |
Keryx Reports Second Quarter 2000 Financial Results
|
|
| 07:30 ET |
Once-A-Day HAART Regimen Containing Coviracil(R)(Emtricitabine) Demonstrates Potent and Sustained Antiviral Activity Over 48-Weeks in HIV-Infected Patients
|
|
Sep 08, 00
|
| 09:54 ET |
Applied Molecular Evolution, Inc. Reports Financial Results for Second Quarter
|
|
Sep 07, 00
|
| 09:20 ET |
Promising Therapeutic Vaccine for Prostate Cancer Enters Expanded Clinical Studies
|
|
| 08:59 ET |
Anadys Pharmaceuticals Establishes Corporate Headquarters in San Diego And Appoints Key Senior Management Members
|
|
Sep 06, 00
|
| 10:33 ET |
ICAgen and Bristol-Myers Squibb Renew Drug Discovery And Development Collaboration
|
|
| 09:56 ET |
Lexicon Genetics Sublicenses Positive-Negative Selection Technology to Biogen
|
|
| 09:56 ET |
Paradigm Genetics Appoints Ellen T. Corliss Vice President of Corporate Communications
|
|
| 09:55 ET |
Aquila Biopharmaceuticals Receives Phase I SBIR Grant to Develop Lipid-based Vaccines for Staphylococcus aureus
|
|
Sep 01, 00
|
| 06:59 ET |
Ardais Corporation and Leading Medical Centers Launch Initiative to Accelerate Genomics-Based Drug Discovery
|
|
Aug 31, 00
|
| 09:36 ET |
Keryx Biopharmaceuticals, Inc. Announces Exercise of Over-Allotment Option
|
|
| 07:59 ET |
Intracel Analysis of Three OncoVAX(TM) Trials Extend Recurrence-Free Survival in Stage II Colon Cancer
|
|
Aug 29, 00
|
| 10:29 ET |
Viron Therapeutics Announces Preclinical Results on Novel Transplant Rejection Treatment
|
|
Aug 28, 00
|
| 08:37 ET |
Paradigm Genetics Awarded Phase II of $825,000 SBIR Grant For Gene Discovery Work
|
|
Aug 25, 00
|
| 08:52 ET |
ICAgen Honored as Third Fastest Growing Technology Company in North Carolina
|
|
Aug 23, 00
|
| 09:02 ET |
Published Study Provides Insight Into MARstem(TM) Mechanism for Hematopoiesis
|
|
| 08:59 ET |
Rene A. Braeckman, Ph.D. Joins Pan Pacific Pharmaceuticals, Inc.
|
|
| 06:59 ET |
Lexicon Genetics Formalizes Entry Into Japanese Drug Discovery Market
|
|
Aug 22, 00
|
| 16:37 ET |
Dyax Announces Exercise of Underwriters' Overallotment Option
|
|
Aug 21, 00
|
| 08:29 ET |
Paradigm Genetics, Inc. Exceeds by 20% Milestone Deliverables in Pharmacia Collaboration
|
|
Aug 17, 00
|
| 10:01 ET |
ArQule and Nanosyn Announce Microchemistry Technology Evaluation And Chemistry Services Agreement
|
|
| 09:23 ET |
ImmunoGen, Inc. Reports Year-End Financial Results
|
|
Aug 16, 00
|
| 08:59 ET |
ZymoGenetics Appoints Frank Collins, Ph.D. as Senior Vice President of Research
|
|
Aug 15, 00
|
| 08:46 ET |
Dyax Corp. Announces Pricing of Initial Public Offering
|
|
Aug 14, 00
|
| 18:29 ET |
SafeScience Reports Second Quarter 2000 Financial Results
|
|
| 08:29 ET |
Cambridge NeuroScience Reports Second Quarter 2000 Financial Results
|
|
| 08:05 ET |
Novelos and Phytera Agree to Develop and Commercialize Novel Cancer Drug
|
|
Aug 10, 00
|
| 08:59 ET |
Anadys Pharmaceuticals and Pharmacia Collaborate To Discover New Antifungal Drugs
|
|
| 07:31 ET |
Triangle Pharmaceuticals Announces the Continued Development of Coactinon (R) (Emivirine)
|
|
Aug 09, 00
|
| 11:04 ET |
NitroMed and Brigham and Women's Hospital Issued Broad U.S. Patent Covering NO-Coated Stent Technology
|
|
Aug 08, 00
|
| 09:53 ET |
HealthCite and AMGEN Announce Strategic Internet Alliance
|
|
| 05:59 ET |
ChiRex Reports Financial Results for Second-Quarter 2000
|
|
Aug 07, 00
|
| 08:59 ET |
Aquila Biopharmaceuticals Reports Financial Results For the Second Quarter of 2000
|
|
| 08:31 ET |
Mosaic Appoints Michael E. Furlong to Vice President of Business Development
|
|
Aug 03, 00
|
| 08:19 ET |
Hyseq Announces Second Quarter Results
|
|
Aug 02, 00
|
| 08:30 ET |
ICAgen Acquires Novel Ion Channel Gene Technology and Targets For Nervous System and Immunological Disorders
|
|
| 08:14 ET |
University of Nebraska Medical Center and Intracel Report Pilot Clinical Results with HumaRAD Fully Human Monoclonal Antibody-based Treatment of Head and Neck Cancer
|
|
| 06:59 ET |
Genaissance Pharmaceuticals, Inc. Announces Initial Public Offering of Common Stock
|
|
Aug 01, 00
|
| 13:30 ET |
Applied Molecular Evolution, Inc. Announces Exercise of Over-Allotment Option in Connection With Initial Public Offering
|
|
| 08:53 ET |
Paradigm Genetics Announces Second Quarter Financial Results
|
|
| 08:27 ET |
Hyseq Announces Markman Clarification in Litigation with Affymetrix
|
|
| 07:10 ET |
Lexicon Genetics and Arena Pharmaceuticals Target New Receptors for Pharmaceutical Development
|
|
Jul 31, 00
|
| 07:29 ET |
Triangle Pharmaceuticals, Inc. Reports Financial Results for Second Quarter 2000
|
|
Jul 28, 00
|
| 12:22 ET |
Genomica Wins Prestigious Innovation Award for Discovery Manager(TM) Software
|
|
| 09:29 ET |
Keryx Biopharmaceuticals, Inc. Announces Initial Public Offering
|
|
| 08:35 ET |
BioMarin Announces Second Quarter 2000 Financial Results
|
|
Jul 27, 00
|
| 09:27 ET |
Applied Molecular Evolution, Inc. Announces Pricing of Initial Public Offering
|
|
| 08:30 ET |
iSalvex.com Partners with Stoner & Company
|
|
| 07:31 ET |
ArQule Appoints New Vice President of Discovery Alliances
|
|
| 06:59 ET |
Lexicon Genetics Announces Second Quarter Financial Results
|
|
Jul 26, 00
|
| 08:28 ET |
Paradigm Genetics Reaches Gene Function Discovery Throughput of 150 Genes Per Week
|
|
Jul 25, 00
|
| 09:04 ET |
U.S. Patent Issued For RTP Pharma Innovative Technology
|
|
| 06:30 ET |
Lexicon Genetics Announces Functional Genomics Collaboration For The Discovery Of Novel Drug Targets For Schizophrenia
|
|
Jul 24, 00
|
| 09:02 ET |
Massachusetts Biotechnology Council Names Janice Bourque President and CEO
|
|
Jul 20, 00
|
| 18:31 ET |
EPIX Medical Reports Second Quarter 2000 Results
|
|
| 08:29 ET |
Paradigm Genetics Appoints Jeffrey R. Shuster Ph.D. to Director of Microbial Research
|
|
Jul 19, 00
|
| 18:12 ET |
EPIX Files Shelf Registration
|
|
| 07:45 ET |
ArQule, Inc. Reports Strong Financial Results for Second Quarter, 2000
|
|
Jul 18, 00
|
| 07:01 ET |
Triangle Pharmaceuticals, Inc. Appoints Robert Amundsen, Jr. as Chief Financial Officer and Andrew Finkle as General Counsel
|
|
Jul 17, 00
|
| 08:29 ET |
Ischemia Technologies Seeks FDA Clearance To Market Rapid Diagnostic Test For Chest Pain Patients
|
|
Jul 13, 00
|
| 17:00 ET |
EPIX Medical Promotes Pamela E. Carey to Vice President of Finance and Administration and Chief Financial Officer
|
|
| 08:31 ET |
ImmunoGen Joins Russell 3000(R) Index
|
|
Jul 12, 00
|
| 10:51 ET |
ChiRex Announces First License of Jacobsen Hydrolitic Kinetic Resolution Technology
|
|
| 08:55 ET |
Aquila's QS-21 Adjuvant Maintains Immune Response of HIV Vaccine at Low Antigen Doses
|
|
Jul 11, 00
|
| 08:31 ET |
Cambridge NeuroScience Obtains Exclusive Rights to Neuregulin-2 Growth Factor From Harvard University
|
|
| 08:31 ET |
Paradigm Genetics, Inc. Added to Russell 3000 Index
|
|
Jul 06, 00
|
| 08:01 ET |
Coley Pharmaceutical Group Expands Management Team
|
|
| 07:29 ET |
Lexicon Genetics and Howard Hughes Medical Institute Agree on Terms For Access to Knockout Mice
|
|
Jun 29, 00
|
| 09:02 ET |
Anadys Pharmaceuticals Inc. Established to Unite Pioneering Drug Discovery and Scientific Leaders From Scriptgen Pharmaceuticals, The European Molecular Biology Laboratory and The Scripps Research Institute
|
|
Jun 28, 00
|
| 15:36 ET |
Aquila Announces License Agreement With Beth Israel Deaconess Medical Center For Antibodies That Enhance Immune Function
|
|
| 06:34 ET |
Lexicon Genetics Announces Issuance of Key Gene Trapping Patent
|
|
Jun 27, 00
|
| 17:28 ET |
Genomica's Enhanced Discovery Manager(TM) Software Launched to Provide Critical Tools for Genomics Research
|
|
| 12:41 ET |
New Drug Works Well as Sole Epilepsy Therapy for Difficult-to-Treat Patients
|
|
| 12:38 ET |
New Study Demonstrates Safety, Efficacy and Tolerability of Oxcarbazepine as Adjunctive Therapy in Children with Uncontrolled Partial Seizures
|
|
| 08:24 ET |
Paradigm Genetics Applies Industrialized Gene Function Alteration To Two Major Fungal Pathogens
|
|
Jun 26, 00
|
| 16:05 ET |
LexVision(TM) Functional Genomics Program to Bring Meaning to the Genes in the Human Genome
|
|
| 08:29 ET |
NitroMed and the University of Texas at Austin Report Phase II Clinical Results of Potential Drug Therapy for Female Sexual Dysfunction
|
|
Jun 22, 00
|
| 12:05 ET |
Aquila Biopharmaceuticals Receives Phase I SBIR Grant to Develop Chlamydia Vaccine Using CD1 Technology
|
|
| 07:59 ET |
Coley Pharmaceutical Group Signs Collaboration With Ludwig Institute for Cancer Research
|
|
| 07:31 ET |
Lexicon Genetics Announces Expansion of Corporate Collaboration With Millennium Pharmaceuticals
|
|
Jun 21, 00
|
| 09:31 ET |
Novartis Announces Availability of First New Alzheimer's Disease Treatment in Over Three Years
|
|
Jun 20, 00
|
| 07:31 ET |
Lexicon Genetics Announces It Has Altered Over One-Third of the Genes in the Mouse Genome, an Important Milestone for Human Drug Discovery
|
|
Jun 19, 00
|
| 12:50 ET |
Genomica Licenses Discovery Manager(TM) Software to the National Institutes of Health's Craniofacial Epidemiology and Genetics Branch
|
|
Jun 15, 00
|
| 08:59 ET |
Michael Astrue Elected Chair of New MBC Directorate for 2000 - 2002
|
|
| 08:29 ET |
Paradigm Genetics, Inc. Reports First Quarter Financial Results
|
|
Jun 14, 00
|
| 18:39 ET |
Lexicon Genetics Reiterates Patent Infringement Claims Against Deltagen
|
|
Jun 13, 00
|
| 08:59 ET |
Domain Pharma Introduces Clintrial Connect(TM) for Electronic Clinical Trials
|
|
Jun 12, 00
|
| 06:31 ET |
Triangle Pharmaceuticals Presents Antiviral Activity of DAPD in HIV-Infected Patients with Multiple Drug Failure
|
|
| 06:30 ET |
Triangle Pharmaceuticals Reports Data From Phase I/II Study of a Protease Inhibitor, DMP-450 in HIV-Infected Patients
|
|
Jun 09, 00
|
| 05:30 ET |
Schering AG and EPIX Medical Establish Partnership For MRI Cardiovascular Contrast Agents
|
|
| 05:15 ET |
Schering AG Signed Agreements With EPIX Medical and Mallinckrodt to Develop and Market MS-325
|
|
Jun 08, 00
|
| 08:59 ET |
Genomica Appoints Charles W. Philipp as Vice President of Marketing
|
|
Jun 07, 00
|
| 11:51 ET |
NitroMed Reports Positive Preclinical Results with NO-Enhanced Anti-ulcerants
|
|
| 08:59 ET |
Maret Initiates Second Clinical Trial With MARstem(TM)
|
|
| 08:37 ET |
Mark Boguski Joins Rosetta Inpharmatics
|
|
Jun 06, 00
|
| 08:59 ET |
Reprogenesis Reports Preclinical Studies in PNAS on Tissue Engineered Product to Prevent (Re)stenosis
|
|
Jun 05, 00
|
| 14:35 ET |
SafeScience Announces Initiation of Phase II Trial for GBC-590 In Colorectal Carcinoma
|
|
| 14:16 ET |
Former Chairman and CEO of SafeScience Agrees Not to Sell Stock for Two Years
|
|
| 08:59 ET |
NitroMed Reports Positive Preclinical Results for Lead Female Sexual Dysfunction (FSD) Treatment Using Innovative Evaluation Technique
|
|
May 31, 00
|
| 09:29 ET |
Repair, Inc. Raises $2 Million Seed Financing to Develop Cardiovascular Disease Therapies with Drug Delivery and Angiogenesis Technologies
|
|
| 08:32 ET |
Paradigm Genetics, Inc. Announces Exercise Of Over-Allotment Option in Initial Public Offering
|
|
| 07:30 ET |
Lexicon Genetics' Knockout Technology Used To Develop First Animal Model for Canavan Disease
|
|
May 30, 00
|
| 08:59 ET |
ZymoGenetics Names George B. Rathmann, Ph.D. and Edward E. Penhoet, Ph.D. to Board of Directors
|
|
May 25, 00
|
| 14:00 ET |
PE Biosystems and Genomica Corporation Form Product Development and Reseller Alliance
|
|
May 24, 00
|
| 18:08 ET |
Lexicon Genetics Files Patent Infringement Suit Against Deltagen
|
|
| 08:48 ET |
Genaissance Appoints Paul Oestreicher, Ph.D. as Vice President, Public Affairs
|
|
| 08:23 ET |
Hyseq Names Dr. George B. Rathmann as President and CEO
|
|
May 23, 00
|
| 02:00 ET |
CeNeS Pharmaceuticals plc and Cambridge NeuroScience Inc. Agree to Merge
|
|
May 19, 00
|
| 14:28 ET |
Dyax Corp. Files Registration Statement for Proposed Initial Public Offering
|
|
| 12:54 ET |
The Medicines Company Files Registration Statement For Proposed Initial Public Offering
|
|
May 18, 00
|
| 08:29 ET |
BioMarin Appoints Robert A. Baffi, Ph.D., as Vice President Quality Assurance and Quality Control
|
|
| 08:29 ET |
Paradigm Genetics, Inc. Exceeds First Milestone in Monsanto Collaboration
|
|
May 17, 00
|
| 11:32 ET |
SafeScience Announces Issuance Of Foreign Patent For Modified Pectin Material For Treatment Of Cancer
|
|
| 10:01 ET |
Viron Therapeutics Announces Preclinical Results At American Society of Transplantation Meeting
|
|
| 08:56 ET |
The Medicines Company Receives Approvable Letter for ANGIOMAX(TM)
|
|
| 07:29 ET |
Hyseq Extends Cancer Gene Discovery Agreement With Chiron For Additional Two Years
|
|
May 16, 00
|
| 08:59 ET |
iSalvex.com Announces $4 Million in Series A Financing - Web-based exchange is unique solution to insurance salvage asset sales -
|
|
| 04:11 ET |
ImmunoGen, Inc. Appoints Mark Skaletsky of GelTex Pharmaceuticals, Inc. to Board of Directors
|
|
May 15, 00
|
| 08:45 ET |
Aquila Biopharmaceuticals Retains Financial Advisor To Evaluate Recent M&A Inquiries
|
|
May 12, 00
|
| 16:22 ET |
SafeScience Reports First Quarter 2000 Financial Results
|
|
| 09:19 ET |
Hyseq Surpasses Prior Biochip Sequencing Record
|
|
| 07:44 ET |
Hyseq Announces 5 kb Sequencing on the HyChip(TM)
|
|
May 11, 00
|
| 12:06 ET |
ACADIA Pharmaceuticals and ArQule Inc. Enter Licensing Agreement Covering Novel Serotonergic Lead Compounds
|
|
| 09:21 ET |
Paradigm Genetics Agreement With Monsanto Expanded to Include Renessen LLC
|
|
| 08:59 ET |
Therapeutic Prostate Cancer Vaccine Shows Promise in Early Clinical Study
|
|
May 10, 00
|
| 07:00 ET |
Lexicon Genetics Discovers Gene Controlling Onset Of Aging In Mice
|
|
| 06:30 ET |
CuraGen Receives Patent Covering High-Throughput Proteomics Technology
|
|
May 09, 00
|
| 12:23 ET |
EPIX European Patent Upheld
|
|
| 08:41 ET |
Scriptgen Appoints Devron R. Averett, Ph.D. to Senior Vice President of Research, Development, and Medical -Former Head of Molecular and Cellular Virology at Glaxo Wellcome to Lead Research and Development-
|
|
| 08:35 ET |
Cambridge NeuroScience Reports First Quarter 2000 Financial Results
|
|
| 02:01 ET |
EPIX Grants Patent License For Schering AG's Eovist
|
|
May 08, 00
|
| 08:29 ET |
BioMarin Announces Senior Management Changes
|
|
| 08:29 ET |
ImmunoGen and Genentech Form Multi-Product Collaboration to Develop Tumor-Activated Prodrugs
|
|
May 05, 00
|
| 15:05 ET |
Paradigm Genetics Announces Pricing of Initial Public Offering
|
|
| 08:29 ET |
ImmunoGen, Inc. and British Biotech plc Enter Collaboration to Develop and Commercialize huN901-DM1 for the Treatment of Small-Cell Lung Cancer
|
|
May 04, 00
|
| 08:32 ET |
ImmunoGen and Genentech Sign Exclusive License Agreement
|
|
May 03, 00
|
| 13:36 ET |
Aquila Biopharmaceuticals Announces Preliminary Results of Quilvax-M(TM) Mastitis Trial
|
|
| 11:35 ET |
SafeScience, Inc. Receives IRB Approval For Phase II Studies of GBC-590 For Treatment of Pancreatic Cancer at University of Rochester Cancer Center
|
|
| 06:31 ET |
Triangle Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2000
|
|
May 01, 00
|
| 09:01 ET |
Coley Pharmaceutical Group Reports First Phase I/II Human Clinical Data
|
|
| 08:59 ET |
RecoveryCare.com and DePuy Orthopaedics Announce Strategic Alliance to Offer Web-Based Resource to Orthopaedic Surgeons
|
|
Apr 28, 00
|
| 08:29 ET |
BioMarin Announces First Quarter 2000 Financial Results
|
|
| 07:24 ET |
Lexicon Genetics Announces First Quarter Financial Results
|
|
Apr 27, 00
|
| 16:59 ET |
EPIX Medical Reports First Quarter 2000 Results
|
|
| 11:35 ET |
AutoImmune Inc. Reports First Quarter 2000 Financial Results
|
|
| 08:59 ET |
Quorum Sciences Receives Grant to Advance Novel Approach for the Treatment and Prevention of Cystic Fibrosis
|
|
Apr 24, 00
|
| 09:02 ET |
Novartis Receives FDA Marketing Clearance for New Alzheimer's Disease Treatment
|
|
| 08:45 ET |
Aquila Biopharmaceuticals Reports Financial Results For the First Quarter Of 2000
|
|
Apr 20, 00
|
| 15:41 ET |
ImmunoGen, Inc. Reports Third Quarter Financial Results
|
|
| 07:45 ET |
ArQule, Inc. Reports Improved Financial Results for First Quarter, 2000 and Announces Withdrawal of Follow-On Offering
|
|
Apr 19, 00
|
| 09:02 ET |
SafeScience Announces Phase II Trial For GBC-590 Expanded to University of Chicago Medical Center
|
|
| 08:59 ET |
Enmed Bolsters Management Team
|
|
| 06:03 ET |
Chirex Announces Share Repurchase Program
|
|
| 05:55 ET |
ChiRex Reports Financial Results for First-Quarter 2000
|
|
Apr 18, 00
|
| 08:59 ET |
Paradigm Genetics Delivers High Throughput Screening Assay to Bayer AG
|
|
| 08:29 ET |
Aronex Pharmaceuticals Completes $8.1 Million Private Placement
|
|
Apr 17, 00
|
| 11:08 ET |
Coley Pharmaceutical Group Initiates Phase I/II Clinical Trials Of CpG 7909 for Cancer
|
|
| 07:02 ET |
ChiRex and GlaxoWellcome Reshape 1997 Supply Agreement With Intent For Long-Term Strategic Partnership
|
|
Apr 14, 00
|
| 11:16 ET |
SafeScience Launches Chemically Safe Garden Product Line for Consumers
|
|
| 08:31 ET |
Lexicon Genetics Announces Issuance of Patent On Novel Cancer Target
|
|
Apr 13, 00
|
| 06:30 ET |
CuraGen and Genentech Extend Broad-based Drug Discovery Collaboration
|
|
Apr 12, 00
|
| 08:29 ET |
XTL's Trimera(XTL) System Subject of Presentation at International Symposium On Viral Hepatitis and Liver Disease
|
|
Apr 11, 00
|
| 15:31 ET |
SafeScience Announces Commencement of GBC-590 Phase II Trial
|
|
| 12:48 ET |
Yale University and Genaissance Co-Sponsor Conference on Pharmacogenetics Revolution
|
|
| 12:46 ET |
SafeScience, Inc. Receives IRB Approval for Phase II Studies of GBC-590 for Treatment of Pancreatic Cancer at Christiana Hospital
|
|
Apr 07, 00
|
| 11:40 ET |
Triangle Pharmaceuticals Announces Clinical Hold on Study FTC-302
|
|
Apr 06, 00
|
| 20:13 ET |
Lexicon Genetics Incorporated Announces Pricing of Initial Public Offering
|
|
| 17:21 ET |
Lexicon Genetics Announces OmniBank(R) Internet Universal(TM) Agreement With American Home Products
|
|
| 15:28 ET |
Lexicon Genetics Names C. Thomas Caskey, M.D. Chairman
|
|
| 10:58 ET |
Triangle Pharmaceuticals Announces Receipt of Letter From South Africa's Medicines Control Council Concerning Study FTC-302
|
|
| 09:15 ET |
BioTransplant Initiates Phase I/II Trial of AlloMune(TM) Cancer System
|
|
| 08:29 ET |
Collgard Biopharmaceuticals' Receives Patent for New in Class Cancer Treatment
|
|
| 08:29 ET |
SafeScience and Universal Environmental Technologies To Market Chemical-Free Scale Reduction and Water Treatment Systems
|
|
| 07:31 ET |
Triangle Pharmaceuticals Clarifies Report Out of South Africa
|
|
Apr 05, 00
|
| 08:59 ET |
David K. Stevenson Elected to the ChiRex Board of Directors
|
|
Apr 04, 00
|
| 15:31 ET |
SafeScience, Inc. Receives IRB Approval For Phase II Studies of GBC-590 For Treatment of Pancreatic Cancer at Beth Israel Deaconess Medical Center
|
|
| 06:30 ET |
Triangle and Dynavax Enter Collaborative Agreement To Develop Immunotherapies For Hepatitis and HIV
|
|
Apr 03, 00
|
| 17:59 ET |
A. Gregory Sorensen, M.D., Joins Epix Medical, Inc.
|
|
| 15:16 ET |
AngioMARK Subject of Four Presentations at International MRI Conference
|
|
| 06:30 ET |
CuraGen and Gemini Enter Genome Wide Drug Target Discovery and Pharmacogenetics Collaboration
|
|
Mar 31, 00
|
| 11:05 ET |
SafeScience Reports 1999 Year End Financial Results
|
|
| 11:01 ET |
SafeScience, Inc. Completes $9 Million Private Placement With a Total Potential of $18 Million
|
|
Mar 30, 00
|
| 07:59 ET |
CuraGen and COR Therapeutics Expand Drug Discovery And Pharmacogenomics Collaboration
|
|
Mar 29, 00
|
| 07:59 ET |
RHeoGene to Report Key Progress in Gene-Switching Program at BIO 2000
|
|
Mar 28, 00
|
| 08:59 ET |
RTP Pharma Inc. Expands Business Development Team
|
|
| 07:59 ET |
- EPIX Medical, GE Medical Systems and Vital Images Discuss Innovations in the Diagnosis and Management of Vascular Disease -
|
|
Mar 27, 00
|
| 08:29 ET |
EPIX Agent Shows Promise in Mouse Model for Muscular Dystrophy
|
|
| 08:29 ET |
ICAgen and Yamanouchi Form Collaboration to Develop Novel Central Nervous System Therapeutics
|
|
| 08:29 ET |
Triangle Pharmaceuticals, Inc. Appoints Chris A. Rallis As President and Chief Operating Officer
|
|
| 07:31 ET |
Senator Kennedy and the Massachusetts Biotechnology Industry Promote Science Education at BIO 2000
|
|
Mar 24, 00
|
| 08:57 ET |
Aquila Closes Private Placement
|
|
Mar 22, 00
|
| 11:29 ET |
ICAgen and Children's Hospital Boston Collaborate to Identify And Develop Novel Pharmaceuticals
|
|
| 09:15 ET |
BioTransplant and The Massachusetts General Hospital Announce Award of U.S. Patent Covering a Novel Approach to Xenotransplantation Tolerance
|
|
Mar 21, 00
|
| 18:09 ET |
ArQule Appoints Two New Board Members
|
|
| 14:30 ET |
Dyax Signs Collaboration with Human Genome Sciences For Discovery of Human Therapeutics
|
|
| 09:01 ET |
Mosaic Appoints Vice President of Marketing
|
|
| 07:59 ET |
AutoImmune Inc. Signs Agreement
|
|
| 07:59 ET |
CuraGen to Apply Functional Genomic Technologies to Assemble Proteomic Map of Drosophila Genome
|
|
Mar 20, 00
|
| 10:20 ET |
equity4life: New Investment Company in the Healthcare Sector
|
|
| 08:29 ET |
EPIX MRI Contrast Agent Enables Highly Detailed Breast Cancer Images Using Cost Effective, Open MRI Scanners
|
|
| 07:29 ET |
Triangle Pharmaceuticals Announces a $15 Million Private Placement to Fund a New Health Information Technology Company, Intelligent Therapeutic Solutions, Inc.
|
|
Mar 17, 00
|
| 18:24 ET |
Rosetta Inpharmatics, Inc. Registers With SEC for Initial Public Offering
|
|
| 13:36 ET |
Rosetta Inpharmatics Inc. Names Gregory Sessler Chief Financial Officer
|
|
Mar 16, 00
|
| 08:29 ET |
ICAgen Appoints James Heyward Hull, Pharm.D., to Senior Vice President of Development and Regulatory Affairs
|
|
Mar 15, 00
|
| 08:31 ET |
Genomica Corporation Files for Initial Public Offering
|
|
Mar 14, 00
|
| 12:59 ET |
Genomica Appoints Kenneth S. Rubin Executive Vice President of Commercial Development
|
|
| 10:41 ET |
Genomica Corporation Raises $15 Million in Private Financing
|
|
| 10:40 ET |
Instrumentation Laboratory and InSource Health Services Solidify Partnership With Sole Source Agreement for Critical Care Systems
|
|
| 06:59 ET |
Genaissance Pharmaceuticals, Inc., Closes $60 Million Private Placement
|
|
Mar 13, 00
|
| 08:59 ET |
Patrick J. Sullivan, President and CEO of Cytyc Corporation, Joins Mosaic's Board of Directors
|
|
| 08:29 ET |
Coley Pharmaceutical Group Names Jerry A. Weisbach, Ph.D. and Manfred Karobath, M.D. to Board of Directors
|
|
Mar 10, 00
|
| 17:01 ET |
JSB Partners, LP Announces Its Advisory Role in Mitotix, Inc. Transaction
|
|
| 09:59 ET |
Collgard Biopharmaceuticals' Halofuginone Receives Orphan Drug Designation for Scleroderma from FDA
|
|
Mar 09, 00
|
| 07:59 ET |
Cardiac Science Announces Arizona Heart Hospital Is First Hospital To Purchase Powerheart(R)
|
|
Mar 08, 00
|
| 10:01 ET |
Scriptgen and 3DP Settle Patent Dispute
|
|
Mar 06, 00
|
| 09:46 ET |
Aquila Biopharmaceuticals' QS-21 Is Key Component in Several New Vaccines In the Clinic
|
|
| 07:29 ET |
Reprogenesis, Inc. Acquires Exclusive License to Children's Hospital/Harvard/MIT Organ Regeneration Technology and Product for Bladder Reconstruction
|
|
Mar 02, 00
|
| 08:29 ET |
Aastrom Biosciences Completes Private Equity Financing
|
|
| 07:59 ET |
CuraGen's Board of Directors Authorizes Two-for-One Stock Split
|
|
Feb 29, 00
|
| 12:02 ET |
Domain Pharma Corporation Announces Appointment of Graham Bunn as Global Vice President of Business Information Technology
|
|
| 12:02 ET |
Domain Pharma Corporation Announces Promotion Of Toby Bloom, Ph.D., To Chief Technology Officer
|
|
| 09:29 ET |
Bayer AG Selects Domain Pharma Corporation's Clintrace(TM) Release 2.8 For Adverse Event Tracking and Reporting
|
|
| 08:59 ET |
Genomica Corporation Unveils Latest Release of Its Discovery Manager(TM) Product at Genome Tri-Conference
|
|
Feb 28, 00
|
| 17:15 ET |
SafeScience, Inc. Receives IRB Approval For Phase II Studies of GBC-590 for Treatment of Pancreatic Cancer
|
|
| 10:24 ET |
ACT Group, Inc. Acquires Key Assets of Advanced Cell Technology, CIMA Biotechnology and Cyagra
|
|
| 08:59 ET |
ACT Group, Inc. Acquires Key Assets of Advanced Cell Technology, CIMA Biotechnology and Cyagra
|
|
Feb 25, 00
|
| 07:31 ET |
Triangle Pharmaceuticals, Inc. Reports Financial Results For Fourth Quarter And Year Ended December 31, 1999
|
|
Feb 24, 00
|
| 17:00 ET |
EPIX Medical Reports Fourth Quarter and Year-End Results For 1999
|
|
| 16:12 ET |
SCS Comments Relating to EPO Grant of 'Stem Cell Selection' Patent
|
|
| 10:21 ET |
TechEx Creates Internet Platform With Harvard and Its Affiliate Hospitals For Corporate Access to Biomedical Resources
|
|
| 08:29 ET |
AutoImmune Inc. Reports 1999 Fourth Quarter and Year End Financial Results
|
|
| 08:29 ET |
ImmunoGen Enters Research Collaboration With SUNY Stony Brook To Develop Taxane-Based Tumor-Activated Prodrugs
|
|
Feb 23, 00
|
| 08:46 ET |
Paradigm Genetics Reaches Bayer AG Collaboration Milestones
|
|
| 08:31 ET |
Kinetix Pharmaceuticals and Dana-Farber Cancer Institute
|
|
| 08:29 ET |
Lexicon Genetics Announces OmniBank(R) Internet Universal(TM) Agreement With Boehringer Ingelheim
|
|
Feb 22, 00
|
| 12:40 ET |
Paradigm Genetics Files Registration Statement for Proposed Initial Public Offering
|
|
| 09:05 ET |
Past CEO of Rhone-Poulenc Rorer Joins CuraGen's Board of Directors
|
|
| 08:41 ET |
ValiGene and Kimeragen In Merger to Create ValiGen, An Integrated Functional Genomics Company
|
|
| 08:29 ET |
Aquila Biopharmaceuticals Reports Financial Results for 1999
|
|
Feb 18, 00
|
| 13:15 ET |
Triangle Pharmaceuticals Announces Management Change
|
|
| 08:29 ET |
BioMarin Announces Fourth Quarter and 1999 Financial Results
|
|
Feb 17, 00
|
| 11:05 ET |
Aastrom Biosciences, Inc. Denies Fallacious Press Release
|
|
Feb 16, 00
|
| 10:51 ET |
Avant Immunotherapeutics Showcases Lead Product at Major Biotech Industry Conference
|
|
| 10:15 ET |
EPIX Medical Presents at BIO CEO & Investor Conference - AngioMARK, Lead Contrast Agent for MRI, in Late Stage Trials -
|
|
| 09:15 ET |
ImmunoGen, Inc. Provides Corporate and Clinical Update at 2nd Annual BIO CEO & Investor Conference
|
|
| 08:53 ET |
Coley Pharmaceutical Group Presenting at 2nd Annual BIO CEO & Investor Conference
|
|
| 08:29 ET |
BioMarin Pharmaceutical to Present at BIO CEO & Investor Conference
|
|
| 08:29 ET |
Lexicon Genetics Names James R. Piggott, Ph.D. Senior Vice President of Pharmaceutical Biology
|
|
| 08:29 ET |
XTL Biopharmaceuticals Reports First Human Data on Combination Monoclonal Antibody Therapeutic for Hepatitis B
|
|
| 08:01 ET |
StressGen to Present at 2nd Annual BIO CEO & Investor Conference
|
|
| 07:45 ET |
ArQule, Inc. Reports Financial Results for Fourth Quarter and Year Ended 1999
|
|
Feb 15, 00
|
| 08:29 ET |
Hyseq Awarded Patent Covering Use of Electrical Fields on Biochips
|
|
Feb 14, 00
|
| 16:01 ET |
MetaPhore to Exhibit Scientific Highlights at BIO CEO Conference
|
|
| 09:29 ET |
BioTransplant Incorporated Reports 1999 Fourth Quarter and Year End Results
|
|
| 09:15 ET |
BioTransplant Incorporated Completes $9.7 Million Private Placement
|
|
| 08:50 ET |
CuraGen Completes $150 Million Convertible Debentures Offering
|
|
| 08:29 ET |
Aquila Biopharmaceuticals Receives License Payments From Partners
|
|
| 08:29 ET |
Lexicon Genetics Names Julia P. Gregory Executive Vice President and Chief Financial Officer
|
|
| 08:29 ET |
Therion and National Cancer Institute Extend Collaborations
|
|
Feb 11, 00
|
| 08:00 ET |
UroGen Receives FDA Clearance to Enter Human Clinical Trial Of Gene Therapy for Hemophilia A
|
|
| 07:45 ET |
ArQule Appoints New Chief Financial Officer and Director of Business Development
|
|
Feb 10, 00
|
| 06:59 ET |
CuraGen Completes First Functional Genomics Map of Entire Genome
|
|
Feb 09, 00
|
| 15:06 ET |
Lexicon Genetics Incorporated Files Registration Statement for Proposed Initial Public Offering
|
|
Feb 08, 00
|
| 10:54 ET |
Biolink Raises $15.6 Million in Private Financing
|
|
| 08:29 ET |
Aastrom Biosciences, Inc. Reports Second Quarter Financial Results
|
|
| 06:31 ET |
ChiRex Reports Financial Results For Fourth-Quarter and Full-Year 1999
|
|
Feb 07, 00
|
| 13:34 ET |
Cambridge NeuroScience Reports Fourth Quarter and Year-End 1999 Financial Results
|
|
Feb 04, 00
|
| 08:00 ET |
Rosetta Inpharmatics Publishes Breakthrough Approach to Link Genomics To Protein Function in Science
|
|
Feb 03, 00
|
| 09:05 ET |
Hyseq Announces Financial Results for the Fourth Quarter and Year Ended December 31, 1999
|
|
| 08:31 ET |
Argonex and Wyeth-Lederle Enter Research Collaboration
|
|
| 08:30 ET |
Lexicon Genetics Announces Omnibank(R) Internet Universal(TM) Agreement With Organon
|
|
| 08:30 ET |
Phytera Completes $9.1 Million Financing
|
|
Feb 02, 00
|
| 14:52 ET |
Biolink Raises $15.6 Million in Private Financing
|
|
| 07:59 ET |
Dr. George B. Rathmann Joins Hyseq as Chairman
|
|
| 07:29 ET |
Triangle Pharmaceuticals Reports First Human Data From Phase I/II Study Of DAPD in HIV-Infected Patients
|
|
Feb 01, 00
|
| 07:29 ET |
Once-A-Day Haart Regimen Containing Coviracil(R) (Emtricitabine) Shows Potent Antiviral Activity In HIV-Infected Patients
|
|
Jan 31, 00
|
| 12:05 ET |
SafeScience Appoints John W. Burns as Chief Financial Officer
|
|
| 09:15 ET |
Massachusetts General Hospital and BioTransplant Incorporated Report Advances in Organ Transplantation and Immunocompetency
|
|
| 08:29 ET |
Phytera and Unilever Sign Joint Research and Development Agreement
|
|
Jan 28, 00
|
| 12:49 ET |
Biolink Names Donald H. Woods Senior Vice President
|
|
| 08:45 ET |
CuraGen Raises $125 Million from the Sale of Convertible Debentures
|
|
Jan 27, 00
|
| 08:29 ET |
Lexicon Genetics Announces OmniBank(R) Internet Universal(TM) Agreement With The R.W. Johnson Pharmaceutical Research Institute
|
|
Jan 26, 00
|
| 15:35 ET |
FDA Approves the Commercial Version of Cardiac Science's Powerheart(R) ECD(TM)
|
|
Jan 25, 00
|
| 08:29 ET |
Lexicon Genetics Announces OmniBank(R) Internet Universal(TM) Agreement With Searle
|
|
Jan 24, 00
|
| 09:02 ET |
Paradigm Genetics Enters Into Collaboration Agreement For Gene Function Research
|
|
| 08:29 ET |
The Medicines Company Acquires Innovative OB/GYN Product
|
|
Jan 20, 00
|
| 21:17 ET |
CuraGen Announces Proposed Sale of $100 Million of Convertible Notes
|
|
| 21:11 ET |
CuraGen Announces Fourth Quarter and Year End 1999 Financial Results
|
|
| 13:05 ET |
Lexicon Genetics Announces Launch of Lexgen.com(TM) Genomics Internet Exchange
|
|
Jan 19, 00
|
| 09:02 ET |
Afferon Corporation Advances U.S. Clinical Trial Program for Lead Product to Treat Urge Incontinence
|
|
| 08:29 ET |
ImmunoGen, Inc. Reports Second Quarter Results
|
|
| 08:29 ET |
MedLecture.com Debuts With User Base of 37,000+ Doctors; Pioneering e-Learning Tool Helps Time-Strapped Physicians
|
|
| 08:01 ET |
Coley Pharmaceutical Group and SmithKline Beecham Sign Collaboration
|
|
| 07:59 ET |
CuraGen Announces Change in Board of Directors
|
|
Jan 18, 00
|
| 08:59 ET |
Domain Pharma Announces Availability of Clintrial 4(TM) Release 4.2J for the Japanese Pharmaceutical Industry
|
|
| 08:29 ET |
Aquila Biopharmaceuticals Grants QS-21 License to Elan
|
|
| 08:29 ET |
Lexicon Genetics Grants Sublicense to Roche Bioscience Under Positive-Negative Selection and Isogenic DNA Technology
|
|
Jan 17, 00
|
| 11:44 ET |
FDA Grants Marketing Clearance for First New First-Line Monotherapy For Epilepsy (Seizure Disorder) in Six Years
|
|
| 11:43 ET |
FDA Grants Marketing Clearance for a New Treatment for Epilepsy (Seizure Disorder)
|
|
Jan 13, 00
|
| 11:59 ET |
AVANT Immunotherapeutics Is Leading a New Generation of Drugs In Cardiac Surgery
|
|
| 08:59 ET |
CpG ImmunoPharmaceuticals Changes Name to Coley Pharmaceutical Group
|
|
| 08:29 ET |
Lexicon Genetics Delivers 14 Lines of OmniBank(R) Mice to the Jackson Laboratory Under Contract With Merck Genome Research Institute
|
|
Jan 12, 00
|
| 11:32 ET |
CuraGen Receives Patents on Protein Interactions Implicated in Cancer
|
|
| 09:06 ET |
AltaRex In-Licenses Additional Antibody for AIT(R) Portfolio, Adds Leading Cancer Researchers to Scientific Advisory Board
|
|
| 07:45 ET |
Monsanto Extends and Expands Agreement with ArQule
|
|
Jan 11, 00
|
| 11:59 ET |
EPIX Medical, Inc. Speaks at Hambrecht & Quist 18th Annual Healthcare Conference
|
|
Jan 06, 00
|
| 11:43 ET |
Lexicon Genetics Announces Gene Function Collaboration With The Scripps Research Institute
|
|
Jan 05, 00
|
| 12:21 ET |
Aquila Initiates Third, Parallel Pivotal Product Licensing Study of Quilvax-M(TM)
|
|
| 10:31 ET |
WRPC Announces Glove Contract Will Not Be Renewed
|
|
| 08:31 ET |
Robert E. Petersen Returns to Publishing With Completion of Purchase of Sports Afield Magazine
|
|
| 08:31 ET |
license and development agreement with HeartSine Technologies, Inc. to utilize HeartSine's biphasic defibrillation waveform technology in Cardiac Science's in-hospital defibrillation products. In July 1999 Cardiac Science terminated its agreement in princ
|
|
Jan 04, 00
|
| 18:13 ET |
Cambridge NeuroScience and Algos Pharmaceutical Establish Licensing Agreement For Pain Products
|
|
| 09:00 ET |
AltaRex Announces Important Milestones for OvaRex(TM) MAb
|
|
| 08:29 ET |
Aquila Announces Issue of U.S. Patent Covering Isolation of Tick Borne Pathogen
|
|
| 08:29 ET |
CNA Announces Long-Term Care Industry's First 10-Year Rate Guarantee
|
|
Jan 03, 00
|
| 09:15 ET |
BioTransplant and The Massachusetts General Hospital Announce Award of U.S. Patent Covering a Unique Approach to Transplantation and Blood Cell Cancers
|
|
| 08:29 ET |
Cardiac Science Announces the First Commercial Shipment Of Powerheart(R) Hospital Defibrillator
|
|
Dec 29, 99
|
| 09:15 ET |
BioTransplant Incorporated Completes $7.7 Million Private Placement
|
|
Dec 23, 99
|
| 16:16 ET |
Genaissance Announces HAP(TM) Typing Facility For Processing of Clinical Trial Samples
|
|
Dec 21, 99
|
| 17:05 ET |
SafeScience Announces Issuance of Patent for Elexa Plant Defense Booster
|
|
| 09:01 ET |
International Isotopes Inc Announces Addition Of Bryce Drake and Scott Colpitts to Management Team
|
|
Dec 20, 99
|
| 10:42 ET |
Control Delivery Systems Announces Strengthened Management Team and Board of Directors
|
|
| 09:15 ET |
Domain Pharma Corporation Announces Availability Of Clintrace(TM) Release 2.8
|
|
| 08:29 ET |
Rosetta Inpharmatics Announces DuPont Pharmaceuticals as First Early Access Partner For Rosetta's Resolver(TM) Informatics System
|
|
Dec 16, 99
|
| 08:31 ET |
Genaissance Promotes Richard Judson, Ph.D. To Vice President Of Informatics And Appoints Martin Schultz, Ph.D. To Scientific Advisory Board
|
|
Dec 14, 99
|
| 08:29 ET |
Cambridge NeuroScience Receives Two U.S. Patents And Three U.S. Patent Allowances
|
|
Dec 10, 99
|
| 06:29 ET |
Triangle Pharmaceuticals Announces That Additional Phase III Studies for Coactinon(R) (Emivirine) Are Required
|
|
Dec 09, 99
|
| 12:45 ET |
huC242-DM1/SB-408075 Enters Phase I Human Clinical Studies
|
|
| 08:59 ET |
International Isotopes Inc Announces Additional Management Change
|
|
Dec 08, 99
|
| 07:59 ET |
TerraGen and Diversa Enter Into Patent Cross-Licensing Agreement
|
|
Dec 07, 99
|
| 14:24 ET |
AltaRex Publishes Early Prospective OvaRex(TM) MAb Data in the Journal Blood And Announces Updated Results
|
|
| 09:15 ET |
Massachusetts General Hospital and BioTransplant Present Advances In Transplantation Research at American Society of Hematology Conference
|
|
| 08:29 ET |
Aastrom Biosciences Receives Core Patent For Cell Therapy System
|
|
| 08:29 ET |
Argonex Completes $9.6 Million Financing to Expand Antigen Discovery Programs, Advance Clinical Programs
|
|
| 08:29 ET |
UroGenesys Researchers Discover New Target Antigen for Prostate Cancer
|
|
| 07:59 ET |
Published Study Concludes Unique Hospital Monitor Is Effective in Automatically Defibrillating Patients Within Seconds of Life-Threatening Heart Rhythms
|
|
Dec 06, 99
|
| 08:31 ET |
Cambridge Neuroscience Announces Extension of Allergan Collaboration
|
|
| 08:30 ET |
Therion Appoints Former Wyeth-Lederle Vaccines President, Ronald J. Saldarini, Ph.D., to Board of Directors
|
|
| 06:01 ET |
ChiRex Announces Shortfall in 2000 Demand From GlaxoWellcome Resulting In the Need to Rephase Supply Under the 1997 Agreement
|
|
Dec 03, 99
|
| 18:05 ET |
International Isotopes Inc Announces Management Changes
|
|
| 08:29 ET |
Lexicon Genetics Announces Agreement For Knockout Mice With BASF Bioresearch Corporation
|
|
Dec 02, 99
|
| 08:59 ET |
Maret Initiates Clinical Development Program With Lead Peptide for Chemotherapy Induced Neutropenia
|
|
Dec 01, 99
|
| 08:59 ET |
MetaPhore Receives Two SBIR Grants to Further Studies of Metal-Related Therapeutics
|
|
Nov 30, 99
|
| 15:45 ET |
International Isotopes Inc Obtains State Approval for Increased Production Of Medical Radioisotopes
|
|
| 08:31 ET |
ICAgen Raises $19 Million to Advance Ion Channel Drug Discovery and Development Programs
|
|
| 08:29 ET |
Aastrom Biosciences Announces Clinical Progress For The AastromReplicell(TM) System
|
|
| 07:59 ET |
Domain Pharma Corporation and Integrated Clinical Systems, Inc. Announce Availability of a Web Enabled Version of Integrated Review in December 1999
|
|
| 06:59 ET |
New Technique Tracks Female Sexual Response With Precision, EPIX Medical and Pfizer Data Show
|
|
Nov 29, 99
|
| 08:31 ET |
Cambridge NeuroScience Receives Two U.S. Patent Allowances For Key Growth Factor
|
|
| 08:29 ET |
AutoImmune Inc. Provides Update On Corporate Activities
|
|
| 08:29 ET |
Therion Awarded AIDS Vaccine Manufacturing Contracts from NIH
|
|
Nov 24, 99
|
| 12:22 ET |
SafeScience.com Internet Site Provides Communications Safety Net
|
|
Nov 23, 99
|
| 08:59 ET |
SafeScience Appoints Louis J. Riceberg, Ph.D. as Senior Vice President, Strategic Development and Kenneth J. Smaha as Chief Operating Officer
|
|
Nov 22, 99
|
| 12:26 ET |
MediSpectra Appoints Ross F. Flewelling, Ph.D., as Chief Technical Officer
|
|
| 09:01 ET |
New Data Demonstrate Activities of Daily Living Are Enhanced in Patients With Mild to Moderately Severe Alzheimer's Disease With Rivastigmine Tartrate
|
|
| 08:29 ET |
Cardiac Science Completes $8.7 Million Financing
|
|
Nov 19, 99
|
| 15:15 ET |
SafeScience Contracts Covance Inc. to Manage Phase II Trials of GBC-590 in Multiple Cancer Indications
|
|
Nov 18, 99
|
| 16:31 ET |
ImmunoGen Announces Data on Two New Tumor Types for huC242-DM1/SB-408075
|
|
| 08:31 ET |
AltaRex Announces Financial Results for the Third Quarter Ended September 30, 1999
|
|
| 08:31 ET |
Lexicon Genetics Grants Positive-Negative Selection Sublicense to Ligand Pharmaceuticals
|
|
Nov 17, 99
|
| 17:15 ET |
ImmunoGen Reports Anti-Tumor Activity and Minimal Toxicity for Small Cell Lung Cancer Compound
|
|
| 08:29 ET |
Aastrom Biosciences Awarded NIH Grant for Production Of T-Lymphocytes to Treat Viral Infections
|
|
| 08:29 ET |
Therion Appoints Richard Woodrich as Senior Vice President, Business Development
|
|
| 08:29 ET |
XTL Biopharmaceuticals and Roche Enter Agreement to Evaluate Therapeutics for Hepatitis C
|
|
Nov 15, 99
|
| 19:15 ET |
International Isotopes Inc Reports Third Quarter 1999 Financial Results
|
|
| 17:01 ET |
EPIX Medical, Inc. Exercises Loan Provision With Mallinckrodt, Inc.
|
|
| 11:41 ET |
Domain Pharma Corporation Receives ISO 9001 Certification
|
|
Nov 11, 99
|
| 13:03 ET |
MediSpectra Announces Key Advance in the Early Detection of Cervical Neoplasia
|
|
Nov 10, 99
|
| 08:59 ET |
ImmunoGen Options Antibody from Duke and Johns Hopkins Universities for Potential Development as Novel Cancer Therapeutic
|
|
Nov 09, 99
|
| 17:34 ET |
Pentose Demonstrates Utility of INACTINE(TM) For Viral Inactivation of Red Blood Cells and Plasma Transfusion Products
|
|
| 09:29 ET |
Children's Hospital, Boston and Boston Life Sciences Report Extensive Axonal Regeneration in Major Spinal Cord Pathway After Injury
|
|
| 09:15 ET |
BioTransplant Incorporated Reports Third Quarter 1999 Results
|
|
| 08:59 ET |
International Isotopes Inc Appoints Dr. David M. Camp As Chief Executive Officer
|
|
| 08:29 ET |
WRP Corporation Reports Third Quarter 1999 Results
|
|
Nov 08, 99
|
| 10:10 ET |
SafeScience Announces Global Strategy With Daymon Associates
|
|
| 08:59 ET |
-- Genaissance Awarded Broad Patent on Methods For Collecting Genes For Variation Analysis Across Populations --
|
|
Nov 05, 99
|
| 08:31 ET |
Cardiac Science Launches Unique Hospital Defibrillator At American Heart Association 72nd Scientific Sessions
|
|
| 08:30 ET |
LeukoSite Reports Third Quarter 1999 Financial Results
|
|
| 08:15 ET |
Inaugural Southeastern BIO Investor Forum to Highlight Over 20 Life Science Companies to Investors
|
|
Nov 04, 99
|
| 12:49 ET |
SafeScience Reports 1999 Third Quarter Financial Results
|
|
| 10:51 ET |
Domain Pharma Announces Launch Date For New Web-Based Remote Data Capture Solution For Internet Clinical Trials in Mid-2000
|
|
| 10:32 ET |
Mosaic Promotes Chris Boles, Ph.D. to Vice President of Research
|
|
Nov 02, 99
|
| 16:29 ET |
EPIX Medical Promotes Stephen C. Knight, M.D. to President and COO
|
|
| 08:59 ET |
XTL Biopharmaceuticals Establishes U.S. Operations
|
|
| 08:29 ET |
AutoImmune Inc. Reports Third Quarter 1999 Results
|
|
Nov 01, 99
|
| 17:37 ET |
Cardiac Science Announces Third Quarter Results
|
|
| 16:06 ET |
New EPIX Agent Provides High Resolution Images of Blood Clots
|
|
| 08:29 ET |
BioMarin Announces Third Quarter 1999 Financial Results
|
|
| 07:59 ET |
CuraGen Announces Second GeneCalling(TM) Gene Expression Patent
|
|
Oct 28, 99
|
| 12:00 ET |
Domain Pharma Corporation Expands Collaboration With Integrated Safety Systems, Inc.
|
|
| 08:29 ET |
Investigational Anticoagulant ANGIOMAX(TM) (formerly Hirulog(R) (bivalirudin)) To Be Made Available Through Expanded Access Study
|
|
| 07:59 ET |
CuraGen Announces Third Quarter 1999 Financial Results
|
|
Oct 27, 99
|
| 11:47 ET |
TechEx and Aurigin Systems Agree to Collaborate
|
|
| 08:29 ET |
Cambridge NeuroScience Reports Third Quarter 1999 Financial Results
|
|
| 08:29 ET |
Pentose Receives SBIR Grant for INACTINE(TM) Red Blood Cell Viral Inactivation Technology
|
|
Oct 26, 99
|
| 08:29 ET |
CpG ImmunoPharmaceuticals Appoints Aileen Ryan Vice President of Regulatory Affairs
|
|
| 07:01 ET |
Triangle Pharmaceuticals Presents Data From Pivotal Study Of Coactinon(R) (Emivirine) In Treatment-Naive, HIV-Infected Patients - Data Presented at 7th European Conference on Clinical Aspects And Treatments of HIV Infection in Lisbon -
|
|
| 06:59 ET |
Triangle Pharmaceuticals, Inc. Reports Financial Results For Third Quarter 1999
|
|
Oct 25, 99
|
| 10:21 ET |
ImmunoGen, Inc. Reports First Quarter Financial Results
|
|
| 10:14 ET |
Mitotix Announces Three U.S. Patents on p16 Tumor Suppressor Gene - Patented Technology Has Led to Preclinical Programs in Cancer, Cardiovascular Disease- CAMBRIDGE, Mass., Oct. 25 /PRNewswire/ -- Mitotix, Inc. announced today that the U.S. Patent and Tra
|
|
| 09:15 ET |
Massachusetts General Hospital and BioTransplant Report Research Advances for Cross-Species Transplantation
|
|
| 08:31 ET |
The Medicines Company's ANGIOMAX(TM) Brand of bivalirudin (formerly Hirulog(R)) Receives First Marketing Approval
|
|
| 08:29 ET |
Dyax Corp. and Pasteur Merieux Connaught Establish Collaboration
|
|
Oct 22, 99
|
| 15:23 ET |
Genaissance Announces Discovery of Extensive Gene Variation in Key Drug Targets
|
|
| 11:29 ET |
AltaRex Announces Operational Changes to Focus Support On Bringing OvaRex(TM) MAb to Market
|
|
| 09:00 ET |
International Isotopes Inc Announces Agreement With NeoRx Corporation
|
|
Oct 21, 99
|
| 18:25 ET |
Aquila Biopharmaceuticals Reports Financial Results For The Third Quarter 1999
|
|
| 16:55 ET |
EPIX Medical Reports Third Quarter 1999 Results
|
|
| 08:29 ET |
Aastrom Biosciences Reports Financial Results For its First Fiscal Quarter
|
|
Oct 19, 99
|
| 08:59 ET |
ICAgen Acquires Ion Channel Technology from Axys Pharmaceuticals
|
|
| 08:02 ET |
CuraGen Corporation Raises $26 Million from Biogen and Genentech
|
|
| 07:46 ET |
ChiRex Reports Financial Results for Third-Quarter and Nine-Months 1999; ChiRex Announces Agreement with Sepracor to Produce Three Products at Annan 3
|
|
| 06:38 ET |
/K I L L -- K I L L -- K I L L -- ChiRex Inc./
|
|
| 06:01 ET |
ChiRex Reports Financial Results For Third-Quarter and Nine-Months 1999
|
|
Oct 18, 99
|
| 09:50 ET |
European Patent Office Affirms Validity of Claims in Aquila's European Patent Covering Stimulon(R) Technology
|
|
| 08:29 ET |
Aquila Initiates Second, Parallel Pivotal Product Licensing Study of Quilvax-M(TM)
|
|
| 08:01 ET |
ArQule, Inc. Reports Financial Results For Third Quarter and Nine Months Ended September 30, 1999
|
|
| 07:59 ET |
Therion Biologics and National Cancer Institute Initiate Phase II Trial of Novel Melanoma Vaccines
|
|
Oct 15, 99
|
| 11:14 ET |
Market Value of New England-Based Biotechnology Industry More Than Doubles in Past 12 Months
|
|
Oct 14, 99
|
| 18:03 ET |
AltaRex Announces New Partnering Plans for OvaRex(TM) MAb : Purdue Foregoes Option
|
|
| 10:22 ET |
ImmunoGen Reports Favorable Pharmacokinetics for huC242-DM1/SB-408075
|
|
| 08:32 ET |
Instrumentation Laboratory Announces Agreement With Health Services Corporation of America
|
|
Oct 13, 99
|
| 08:59 ET |
Research Facilities Select Domain Pharma's Clintrial 4(TM) to Manage Clinical Trial Data
|
|
| 08:59 ET |
Rhone-Poulenc Agro and ICAgen Initiate Chemistry and Screening Agreement
|
|
Oct 12, 99
|
| 17:17 ET |
Reprogenesis, Inc. Awarded $2 Million Federal Grant For Cardiovascular Biology Program
|
|
| 10:20 ET |
International Isotopes Inc Initiates Dual Production of Heart Diagnostic
|
|
| 07:59 ET |
CuraGen Appoints Christopher K. McLeod as Executive Vice President
|
|
Oct 07, 99
|
| 17:20 ET |
Triangle Pharmaceuticals Announces Modification of its Clinical Study MKC-303
|
|
| 13:59 ET |
MetaPhore Reports on Stable SuperOxide Dismutase Mimetic with Activity Against Inflammation and Reperfusion Injury
|
|
| 07:59 ET |
CuraGen Appoints Peter T. Lomedico, Ph.D. as Vice President of Discovery Research
|
|
Oct 06, 99
|
| 08:29 ET |
Gemin X Presents Discovery of Novel Bcl-2 Inhibitor as Anticancer Agent At Conference on Differentiation Therapy
|
|
Oct 05, 99
|
| 16:01 ET |
Lexicon Genetics Announces Database Agreement With Millennium Pharmaceuticals
|
|
| 08:29 ET |
Aastrom Biosciences Retains Salomon Smith Barney For Merger and Acquisition Services
|
|
| 08:29 ET |
Dyax Signs 40th Licensee for Broad Phage Display Licensing Program
|
|
Oct 04, 99
|
| 08:02 ET |
CuraGen and Glaxo Wellcome Collaborate in Alzheimer's Disease Research
|
|
Oct 01, 99
|
| 07:29 ET |
ArQule and Bayer Announce Collaboration in Combinatorial Chemistry
|
|
Sep 30, 99
|
| 11:08 ET |
Domain Pharma Announces Appointment of Jennifer Cotteleer as Vice President, Consulting and Educational Services for North America
|
|
Sep 29, 99
|
| 15:30 ET |
ChiRex Appoints Professor Andrew G. Myers to Its Scientific Advisory Board
|
|
| 14:42 ET |
Inaugural Mass Opportunities Conference to Highlight 58 Biotechnology Companies to Investors
|
|
| 08:29 ET |
Aronex Pharmaceuticals Reports Phase II Data on NYOTRAN(R) in Patients With Systemic Fungal Disease at ICAAC
|
|
Sep 28, 99
|
| 08:31 ET |
Dyax Names Stephen Galliker, C.P.A. as Executive Vice President, Finance and Administration and Chief Financial Officer
|
|
| 08:31 ET |
XTL Biopharmaceuticals' Human Monoclonal Antibody Therapeutic For Chronic Hepatitis B Enters Phase I Clinical Trials
|
|
Sep 27, 99
|
| 13:00 ET |
ImmunoGen, Inc. Elects to Exercise $2.5 Million Put Option Under SmithKline Beecham Agreement
|
|
| 09:42 ET |
Novartis Receives FDA Approvable Letter For a New Therapy to Treat Epilepsy (Seizure Disorder)
|
|
| 09:25 ET |
Triangle Pharmaceuticals Reports Coactinon(R) (Emivirine) Phase II Study Demonstrates Potency and Tolerability in HIV-Infected Patients
|
|
| 09:25 ET |
Triangle Pharmaceuticals Reports Preliminary Resistance Profile Data On Coactinon(R) (Emivirine) in HIV Coactive Therapy
|
|
| 09:15 ET |
BioTransplant Achieves Milestone in Novartis Collaboration on Xenotransplantation
|
|
| 08:25 ET |
Aronex Pharmaceuticals Reports Phase III Data on Nyotran(R) in Patients With Systemic Fungal Disease at ICAAC
|
|
| 07:29 ET |
Triangle Pharmaceuticals Reports DAPD Preclinical Safety And Antiviral Activity Against Drug-Resistant HIV Strains
|
|
| 07:29 ET |
Triangle Pharmaceuticals Reports Data on Pharmacokinetics and Tolerability of Coactinon(R) (Emivirine) in HIV-1 Infected Pregnant Women and Their Offspring
|
|
Sep 24, 99
|
| 18:15 ET |
Aronex Pharmaceuticals Receives FDA Letter Concerning ATRAGEN
|
|
Sep 23, 99
|
| 13:11 ET |
MediSpectra Completes $10 Million Private Placement
|
|
Sep 21, 99
|
| 15:39 ET |
Inaugural Mass Opportunities Conference to Highlight 58 Biotechnology Companies to Investors
|
|
| 10:09 ET |
CuraGen Expands Database of Novel Human Genes to Over 70,000 Assemblies
|
|
| 09:05 ET |
ImmunoGen, Inc. Investigational New Drug Application for huC242-DM1/SB-408075 Accepted by FDA
|
|
| 08:29 ET |
Siemens Medical Systems, EPIX Medical, Mallinckrodt Collaborate on Magnetic Resonance Imaging Technology
|
|
Sep 20, 99
|
| 15:03 ET |
Novartis Launches New Alzheimer's Disease Website
|
|
| 08:29 ET |
Genaissance Appoints Dr. Jurgen Drews, Former President of Roche Global Research, as Board Chairman
|
|
Sep 17, 99
|
| 08:35 ET |
Aronex Pharmaceuticals Announces NYOTRAN(R) Phase III Data Accepted as Late Breaker Abstract at ICAAC
|
|
Sep 16, 99
|
| 09:31 ET |
Biolink Corporation Reports on Commercialization Advances In Europe for the Dialock(R) Hemodialysis System
|
|
Sep 15, 99
|
| 10:59 ET |
Reprogenesis, Inc. Closes $10.5 Million Financing
|
|
| 10:11 ET |
New Chemical Entities, Inc. and Thetagen, Inc. Merge
|
|
| 09:48 ET |
Instrumentation Laboratory Announces Agreement With InSource Health
|
|
Sep 14, 99
|
| 08:29 ET |
BioMarin and Genzyme Report Positive One Year Summary Data for MPS-1 Patients Receiving Enzyme Replacement Therapy
|
|
Sep 13, 99
|
| 17:41 ET |
Instrumentation Laboratory Announces Fiscal 1999 First Quarter Results
|
|
| 11:01 ET |
Shaw's, Safescience in Exclusive Co-Branding Agreement; Own Label Program Expanded With Tested Cleaning Products
|
|
| 08:31 ET |
XTL Biopharmaceuticals and Eli Lilly & Company Enter Agreement To Evaluate Therapeutics For Hepatitis C
|
|
| 07:59 ET |
WRP Corporation Named 'Top 100 Supplier' by Sysco Corporation For Fourth Consecutive Year
|
|
Sep 10, 99
|
| 10:08 ET |
NitroMed Acquires BiDil(TM) New Drug Application for Treatment Of Congestive Heart Failure
|
|
| 08:29 ET |
Dyax Promotes Pamela Hay to Senior Vice President of Corporate Development
|
|
Sep 08, 99
|
| 15:29 ET |
EPIX Medical Awarded U.S. Patent For Manufacturing Process
|
|
| 08:59 ET |
International Isotopes Obtains Regulatory Approvals From the State of Texas
|
|
| 08:29 ET |
CuraGen Completes $15 Million Private Financial Placement
|
|
Sep 07, 99
|
| 13:00 ET |
SafeScience, Inc. Clarifies Misinformation
|
|
Sep 03, 99
|
| 11:00 ET |
AltaRex and Biomira Announce Settlement of Lawsuits
|
|
Sep 02, 99
|
| 08:59 ET |
Cardiac Science Announces Distributors Ready for Global Launch of Unique Hospital Defibrillator
|
|
| 08:31 ET |
Lexicon Genetics Grants Sublicense to Avatar BioSci, Inc. For Infectious Disease and Cancer Applications
|
|
Sep 01, 99
|
| 07:30 ET |
AutoImmune Announces Phase III Trial Results for Colloral(R)
|
|
Aug 31, 99
|
| 12:14 ET |
TechEx Continues Rapid Growth and Expansion
|
|
| 08:29 ET |
Advanced Cell Technology Receives Broad U.S. Patent Covering Method of Nuclear Transfer for Non-Human Mammalian Cloning
|
|
| 08:29 ET |
BioMarin Announces Exercise of Underwriters' Over-allotment Option in Its Initial Public Offering
|
|
Aug 26, 99
|
| 10:37 ET |
Cardiac Science Announces Second Quarter Results
|
|
| 07:59 ET |
Amersham Pharmacia Biotech and Dyax Corp. Agree to Develop and Market Innovative Separations Technology
|
|
Aug 25, 99
|
| 08:09 ET |
Asthma Study Reveals Treatment Concerns Patients Skip Medication to Avoid Side Effects
|
|
Aug 24, 99
|
| 18:17 ET |
Double Transplant Frees Patient From Need for Immunosuppressive Drugs Patient Treated Successfully for Both Kidney Failure and Multiple Myeloma
|
|
| 08:59 ET |
Afferon Corporation Announces Two Appointments to its Board of Directors
|
|
Aug 19, 99
|
| 17:26 ET |
International Isotopes Inc Announces Second Quarter Financial Results
|
|
| 08:29 ET |
Aastrom Biosciences, Inc. Reports Fourth Quarter and Fiscal Year 1999 Financial Results
|
|
Aug 18, 99
|
| 10:10 ET |
Stem Cell Sciences Announces Collaboration with Rhone-Poulenc Rorer
|
|
Aug 17, 99
|
| 16:29 ET |
BioMarin Announces Second Quarter 1999 Financial Results
|
|
| 08:29 ET |
Lexicon Genetics Announces Agreement for Knockout Mice With Rockefeller University
|
|
Aug 16, 99
|
| 08:31 ET |
Pentose Files Investigational New Drug Application for Red Blood Cell Viral Inactivation Technology
|
|
| 08:01 ET |
CuraGen Discovery Expands Database to Over 120,000 cSNPs
|
|
Aug 13, 99
|
| 08:59 ET |
WRP Corporation Reports Second Quarter 1999 Results
|
|
| 08:45 ET |
SafeScience Reports 1999 Second Quarter Financial Results
|
|
| 07:30 ET |
Triangle Pharmaceuticals, Inc. Reports Financial Results for Second Quarter 1999
|
|
Aug 12, 99
|
| 17:55 ET |
LeukoSite Reports Second Quarter 1999 Financial Results
|
|
| 08:59 ET |
OXiGENE Exercises Option and Signs a Licensing Agreement For the Ombretastatin Technology From Arizona State University
|
|
| 08:32 ET |
AltaRex Announces Financial Results for the Second Quarter Ended June 30, 1999
|
|
| 08:29 ET |
-- Solvay's Worldwide Head of R&D to Join ArQule's Board of Directors --
|
|
Aug 10, 99
|
| 17:39 ET |
Aquila Biopharmaceuticals Receives Phase II SBIR Grant to Develop Tuberculosis Vaccine Using CD1 Technology
|
|
Aug 09, 99
|
| 10:22 ET |
Biolink Corporation Appoints Robert Mercier President and CEO and Expands Management Team
|
|
| 08:59 ET |
Argonex and Rohm and Haas Form Joint Venture
|
|
| 08:30 ET |
BioTransplant Incorporated Reports Second Quarter 1999 Results
|
|
Aug 06, 99
|
| 08:52 ET |
WRP Majority Shareholder Withdraws Verbal Merger Proposal at This Time
|
|
Aug 04, 99
|
| 09:18 ET |
SafeScience and Prince Agri Products Announce Product Development and Marketing Partnership
|
|
| 08:31 ET |
BioMarin Announces the Appointment of John L. Jost, Ph.D. as Vice President Manufacturing
|
|
| 08:29 ET |
Dyax Corp. Acquires Target Quest
|
|
Aug 03, 99
|
| 09:01 ET |
ICAgen and Bristol-Myers Squibb Extend Drug Discovery and Development Collaboration
|
|
| 08:32 ET |
Canadian Researchers Discover Gene Responsible For Regulation of HDL Cholesterol Levels
|
|
| 08:31 ET |
CpG ImmunoPharmaceuticals Completes $12.9 Million Financing
|
|
| 08:15 ET |
AutoImmune Inc. Reports Second Quarter 1999 Results
|
|
Aug 02, 99
|
| 08:29 ET |
- ArQule Appoints Dr. Philippe Bey, Formerly of Hoechst Marion Roussel (HMR), as New Chief Scientific Officer, Senior VP Research -
|
|
| 08:29 ET |
UCB Pharma Appoints Thomas Beck, M.D. as President and Director of Global Research
|
|
| 08:29 ET |
VARIAGENICS, INC. Closes $19.0 Million Financing, Taylor J. Crouch Appointed as President and CEO
|
|
Jul 29, 99
|
| 08:30 ET |
Instrumentation Laboratory and Beckman Coulter Announce New Strategic Alliance and Cross Distribution Agreement
|
|
| 08:15 ET |
CuraGen Announces Second Quarter 1999 Financial Results
|
|
Jul 28, 99
|
| 17:12 ET |
V.I. Technologies to Merge with Pentose Pharmaceuticals
|
|
| 08:30 ET |
International Isotopes Develops Pre-Production High Quality I-123
|
|
| 08:30 ET |
Lexicon Genetics Announces Agreement With Millennium Pharmaceuticals
|
|
| 08:29 ET |
Aastrom Biosciences Enters Distribution Agreements With Gambro A/S And Micromin AG for AastromReplicell(TM) System
|
|
| 07:59 ET |
OXiGENE Reports Second Quarter 1999 Financial Results
|
|
Jul 27, 99
|
| 10:58 ET |
Cardiac Science Establishes Middle Eastern Distribution Channels For Powerheart(R) Fully Automatic Defibrillator Monitor
|
|
Jul 26, 99
|
| 16:31 ET |
Aquila Biopharmaceuticals Reports Financial Results For the Second Quarter of 1999
|
|
| 08:29 ET |
New GBC-590 Phase I Data Confirm Earlier Studies
|
|
Jul 23, 99
|
| 09:15 ET |
Cambridge NeuroScience Reports Second Quarter 1999 Financial Results
|
|
| 08:06 ET |
BioMarin Pharmaceutical Inc. Makes Initial Public Offering of Common Stock
|
|
Jul 22, 99
|
| 17:00 ET |
EPIX Medical Reports Second Quarter 1999 Results
|
|
Jul 21, 99
|
| 19:09 ET |
LeukoSite Completes Acquisition of ProScript, Inc.; Raises $14.4 Million in Private Placement
|
|
| 16:31 ET |
Aquila Closes Direct Limited Placement
|
|
| 07:00 ET |
ArQule Announces Combinatorial Chemistry Partnership with Pfizer - Collaboration Worth Up to $117 Million -
|
|
| 06:59 ET |
ArQule, Inc. Reports Financial Results for Second Quarter Ended June 30, 1999
|
|
Jul 20, 99
|
| 09:41 ET |
Cardiac Science Provides Update on HeartSine Technologies Inc. Acquisition
|
|
Jul 19, 99
|
| 12:41 ET |
International Isotopes Inc Obtains Exclusive License For Palladium-103 Brachytherapy Seeds
|
|
| 08:29 ET |
Aquila and University of Wisconsin Initiate Pivotal Product Licensing Studies of Quilvax-M(TM)
|
|
| 07:59 ET |
OXiGENE Reports Data on Cellular Mechanism of Action for CA4P at British Scientific Meetings
|
|
Jul 15, 99
|
| 10:29 ET |
SafeScience, Inc. Hosts First World Brand Conference
|
|
| 06:59 ET |
International Isotopes Updates Investors On 1999 Financial Expectations and Corporate Strategy
|
|
Jul 14, 99
|
| 08:29 ET |
Aastrom Biosciences Awarded NIH Grant for Expanding Hematopoietic Cells to Accelerate Platelet Recovery
|
|
| 06:59 ET |
ChiRex Reports Financial Results for Second-Quarter and First-Half 1999
|
|
Jul 13, 99
|
| 10:44 ET |
Hepatitis C Patients and Health Care Providers Now Able to Access Customized Information
|
|
| 08:31 ET |
SafeScience, Inc. Added to the Russell 3000 Index
|
|
| 08:30 ET |
AltaRex Announces OvaRex(TM) MAb Clinical Progress
|
|
Jul 12, 99
|
| 08:31 ET |
ChiRex Appoints Former Schering Plough Vice President of Chemical Development, Bruce P. Shutts As Vice President, Development Operations
|
|
Jul 08, 99
|
| 08:39 ET |
Aastrom Biosciences Highlights Stem Cell Expansion Study In Proceedings of the National Academy of Sciences
|
|
| 08:29 ET |
Pentose Pharmaceuticals Appoints John R. Chapman, Ph.D., as Vice President of Blood Products Research
|
|
Jul 07, 99
|
| 08:59 ET |
Afferon to Extend European Phase II Clinical Trials of RTX(TM) With Approvals in UK and France
|
|
Jul 06, 99
|
| 08:31 ET |
Dyax Appoints Scott Chappel, Ph.D., as Senior Vice President, Research
|
|
Jun 29, 99
|
| 09:01 ET |
Domain Pharma Corporation Adding Web Capabilities to its Clintrial(TM) 4 Clinical Data Management Solutions
|
|
Jun 28, 99
|
| 08:30 ET |
Therion Completes $10.5 Million Financing to Accelerate Cancer Vaccine Development
|
|
| 08:29 ET |
Cardiac Science and Medtronic Physio-Control Sign European Distribution Agreement for Powerheart(R) ECD(TM)
|
|
Jun 24, 99
|
| 08:59 ET |
SafeScience's Lectin Inhibitor Stabilizes PSA in Advanced Stage Cancer Patients
|
|
| 08:33 ET |
ICAgen Obtains Exclusive Rights to Ion Channel Disease Targets From the Research Foundation of State University of New York's Stony Brook Campus
|
|
| 08:29 ET |
Apoptogen Discovers Novel Cellular Pathway for Anti-Apoptosis Protein Production
|
|
| 08:29 ET |
Lexicon Genetics Announces Rapid New Method for Accelerating Drug Discovery
|
|
Jun 23, 99
|
| 06:59 ET |
LeukoSite to Acquire ProScript and Raise $14.4 Million in Private Placement
|
|
Jun 22, 99
|
| 11:11 ET |
Domain Pharma Announces Appointment of Webb Stacy, Ph.D., as Vice President of Development
|
|
Jun 21, 99
|
| 16:15 ET |
EPIX Medical and Mallinckrodt Initiate Phase III Clinical Trial of AngioMARK
|
|
Jun 16, 99
|
| 03:00 ET |
OXiGENE and Active Biotech Enter Research Collaboration to Develop Anti-Inflammatory Therapeutics
|
|
Jun 14, 99
|
| 06:29 ET |
Eurona Medical AB Presents Research Results for ACE Responder Assay
|
|
Jun 10, 99
|
| 08:29 ET |
Lexicon Genetics Announces Agreement for Knockout Mice With Academic Institutions
|
|
Jun 09, 99
|
| 08:29 ET |
CpG ImmunoPharmaceuticals Appoints Ralph Venhaus, M.D., Vice President of Medical Affairs
|
|
| 07:29 ET |
LeukoSite, Inc. and ILEX Oncology, Inc. to Present CAMPATH(R) Pivotal Phase II Data at European Haematology Meeting
|
|
| 03:00 ET |
OXiGENE Reports Mechanism Underlying Specificity of Tumor Vascular Targeting of Combretastatin A-4 Prodrug (CA4P)
|
|
Jun 08, 99
|
| 15:40 ET |
WRP Corporation Announces Verbal Receipt of Merger Proposal and Appointment of Special Committee
|
|
| 08:59 ET |
Domain Pharma Announces Clintrace(TM) Upgrade
|
|
| 08:29 ET |
Cardiac Science Establishes South American Distribution Channels for Powerheart(R) Fully Automatic Defibrillator Monitor
|
|
Jun 07, 99
|
| 09:10 ET |
SafeScience Partners with Southern Africa's Leading Agrochemical Distributor to Enter Growing Continental Agbio Market
|
|
Jun 04, 99
|
| 18:47 ET |
Aquila Biopharmaceuticals Files for Registration of Common Stock
|
|
Jun 03, 99
|
| 09:59 ET |
AutoImmune Inc. Board of Directors Elects President and CEO Robert C. Bishop as Chairman
|
|
| 08:59 ET |
International Isotopes Inc Closes Private Equity Financing < Product Sales Expected to Increase Throughout 1999 >
|
|
| 08:29 ET |
Aastrom Initiates Plans for Capital and Operational Expansion
|
|
Jun 02, 99
|
| 10:00 ET |
AltaRex Appoints Marlene R. Booth as Vice President, Regulatory Affairs and Project Management
|
|
| 09:01 ET |
TerraGen Announces Second Collaboration with Schering-Plough Research Institute to Discover Novel Anti-Infective Drugs
|
|
| 07:59 ET |
Lexicon Genetics Launches Internet-Based Genomics Database
|
|
Jun 01, 99
|
| 15:45 ET |
Instrumentation Laboratory Announces Fiscal 1998 Results
|
|
| 14:12 ET |
AltaRex Announces Closing of Additional C$5.3 Million Under Its Equity Financing
|
|
| 08:31 ET |
ImmunoGen, Inc. Receives Second Milestone Payment from SmithKline Beecham as Part of Colorectal Cancer Treatment Agreement
|
|
May 27, 99
|
| 16:31 ET |
International Isotopes Inc Announces First Quarter Financial Results and Equity Financing
|
|
| 08:10 ET |
Perstorp AB Makes Offer to Acquire Endogen, Inc.
|
|
May 26, 99
|
| 10:00 ET |
Less Toxic Bone Marrow Transplant Technique May Have More Powerful Anti-Cancer Effect
|
|
| 08:29 ET |
AltaRex Announces Financial Results for the First Quarter Ended March 31, 1999
|
|
May 25, 99
|
| 12:12 ET |
ImmunoGen, Inc. Appoints Senior Director of Business Development to Pursue Additional Collaborations
|
|
May 24, 99
|
| 09:59 ET |
Lexicon Genetics Announces Agreement for Knockout Mice With Cephalon
|
|
| 09:02 ET |
Highly Potent Naturally-Occuring Fungus Provides First Non-Toxic Insecticide for Household and Fire Ants, Cockroaches, and Termites
|
|
| 08:29 ET |
Phytera Appoints Nancy Wetherbee as Vice President of Business Development
|
|
| 08:28 ET |
EPIX and Mallinckrodt Sponsored Research Reported in 9 Presentations at International MRI Conference
|
|
May 20, 99
|
| 17:50 ET |
SunPharm Corporation Announces First Quarter 1999 Financial Results
|
|
| 14:21 ET |
Domain Pharma Reports Robust Industry Participation in MedDRA Seminars Across the U.S.
|
|
| 07:29 ET |
Sandra Palleja, M.D., of Triangle Pharmaceuticals Receives Award From Latino Commission on AIDS
|
|
| 04:00 ET |
OXiGENE Reports Progress of Declopramide
|
|
May 19, 99
|
| 15:23 ET |
CuraGen Announces Completion of High Resolution Rat Genome Maps
|
|
| 09:04 ET |
Cardiac Science's Powerheart(R) ECD(TM) Debuts at AACN Meeting in New Orleans
|
|
| 08:29 ET |
Massachusetts General Hospital and BioTransplant Announce Progress in Transplantation Research
|
|
May 18, 99
|
| 12:08 ET |
SafeScience Appoints Richard A. Daoust, M.S., Ph.D. as Vice President of Agricultural Products
|
|
| 11:59 ET |
AltaRex Researchers Present Positive OvaRex(TM) MAb Results in Ovarian Cancer Patients at ASCO Conference
|
|
| 08:59 ET |
SafeScience Reports Significant Anti-Tumor Response in Preclinical Study on GBC-590 for Prostate Cancer
|
|
| 07:30 ET |
Triangle Pharmaceuticals Reports Data From Expanded Study of Anti-HBV Activity of Coviracil(TM) (Emtricitabine)
|
|
| 06:59 ET |
ChiRex Announces Acquisition of Cauldron Process Chemistry
|
|
May 17, 99
|
| 12:45 ET |
SafeScience Appoints Clark F. Springgate, M.D., Ph.D. as Chief Medical Officer
|
|
| 08:29 ET |
Warner-Lambert Expands Clinical Trial of SunPharm's Cancer Drug Following Positive Results in Renal Cell Patients
|
|
| 07:59 ET |
Cardiac Science Announces First Quarter Results
|
|
May 14, 99
|
| 14:00 ET |
International Isotopes Achieves Major Milestone In Commercial Operation of LINAC
|
|
May 13, 99
|
| 15:15 ET |
SafeScience Receives Key Patent on CAN-296 for the Treatment of Fungal Infections
|
|
| 13:01 ET |
Novartis Receives FDA Approvable Letter For New Therapy to Treat Alzheimer's Disease
|
|
| 09:05 ET |
AltaRex Grants Purdue Pharma L.P. an Option to License Two Products in a Potential
|
|
| 07:29 ET |
Triangle Pharmaceuticals, Inc. Reports Financial Results for First Quarter 1999
|
|
May 12, 99
|
| 11:52 ET |
Cardiac Science Signs Distribution Agreements in China and Korea for Life- Saving Fully Automatic Powerheart(R) ECD(TM)
|
|
| 08:30 ET |
LeukoSite Reports First Quarter 1999 Financial Results
|
|
May 11, 99
|
| 07:30 ET |
WRP Corporation Reports Strong Growth For First Quarter 1999
|
|
| 03:30 ET |
OXiGENE Secures Patent Protection for the Anti-Inflammatory Properties of Its Benzamide Technology
|
|
May 10, 99
|
| 16:30 ET |
Aquila Biopharmaceuticals Reports Financial Results For The First Quarter of 1999
|
|
| 16:23 ET |
Epic Therapeutics Completes $12.5M Financing
|
|
| 11:15 ET |
Forsyth Expands Biomedical Research Activities; New Research Complex Opens
|
|
| 07:59 ET |
Ventana Genetics Completes $8 Million Financing; Changes Name to Arcaris Inc.
|
|
May 07, 99
|
| 10:42 ET |
AltaRex Closes C$14.3 Million Financing
|
|
| 08:29 ET |
Glaxo Wellcome, Emory University and Triangle Pharmaceuticals Announce Agreements Resolving Their Dispute Relating to Coviracil(TM) (Emtricitabine, Formerly Known as FTC)
|
|
| 07:59 ET |
EPIX Medical and Mallinckrodt Magnetic Resonance Imaging Agent Subject of Presentation at Radiology Conference
|
|
May 06, 99
|
| 15:40 ET |
CuraGen Announces Industry's First Internet-Based Genomics Portal
|
|
| 08:30 ET |
BioTransplant Incorporated Reports First Quarter 1999 Results
|
|
| 08:28 ET |
EPIX Medical and Mallinckrodt Magnetic Resonance (MR) Imaging Agent Subject of Presentation at International Cardiac MR Conference
|
|
May 05, 99
|
| 17:41 ET |
ArQule Compound Reaches Pre-IND Stage with Roche Bioscience
|
|
| 15:30 ET |
Cardiac Science Establishes Distribution Channels in Three Major European Markets for its Powerheart(R) Fully Automatic, External Cardioverter Defibrillator-Monitor
|
|
| 14:20 ET |
EPIX Medical and Mallinckrodt Magnetic Resonance Imaging Agent Subject of Presentation at Thromboembolic Disease Conference
|
|
| 09:01 ET |
International Isotopes Inc Expands Radioisotope Programs
|
|
May 04, 99
|
| 08:29 ET |
AutoImmune Inc. Reports First Quarter 1999 Results
|
|
| 07:59 ET |
CuraGen and COR Therapeutics Enter Product Discovery and Pharmacogenomics Collaboration
|
|
| 02:30 ET |
Glyko, Inc. Acquires Biochemical Reagent Business from Oxford GlycoSciences Plc
|
|
May 03, 99
|
| 12:23 ET |
/C O R R E C T I O N -- ImmunoGen, Inc./
|
|
| 12:10 ET |
ImmunoGen, Inc. Reports Third Quarter Financial Results
|
|
| 08:59 ET |
Afferon Corporation Enters Exclusive European Development and License Agreement with Mundipharma, an Associate of The Purdue Frederick Company
|
|
Apr 29, 99
|
| 17:40 ET |
EPIX Medical Reports First Quarter 1999 Results
|
|
| 08:29 ET |
Dyax Promotes Shirish Hirani, Ph.D., to Senior Vice President of Product Development
|
|
| 07:59 ET |
CuraGen Corporation Announces First Quarter 1999 Financial Results
|
|
Apr 28, 99
|
| 16:48 ET |
OXiGENE Reports Earnings for First Quarter 1999
|
|
| 09:05 ET |
SafeScience Partners With Daymon Associates to Market and Sell SafeScience(R) Consumer Products Worldwide
|
|
| 08:31 ET |
Aastrom Biosciences Reports Third Quarter and Nine Months Ended March 31, 1999 Financial Results
|
|
| 07:59 ET |
BioImage A/S Raises $17 million in Initial Financing
|
|
| 07:00 ET |
ChiRex Reports Financial Results For First-Quarter 1999
|
|
Apr 27, 99
|
| 15:14 ET |
AltaRex Files Final Prospectus for Financing of Up to C$17 Million
|
|
| 08:29 ET |
Cambridge NeuroScience Reports First Quarter 1999 Financial Results
|
|
Apr 26, 99
|
| 07:59 ET |
Domain Pharma Corporation's Clintrial 4 Release 4.2 Facilitates Global Clinical Data Management
|
|
Apr 21, 99
|
| 17:15 ET |
ArQule, Inc. Reports Financial Results for First Quarter Ended March 31, 1999
|
|
| 15:15 ET |
AmeriNet Choice, WRP Corporation Announce Exclusive Private Label Glove Contract
|
|
| 10:40 ET |
Joseph Grimm Joins NitroMed as Senior Vice President Business Development and Chief Financial Officer
|
|
| 08:58 ET |
SafeScience Becomes Sponsor of New "Healthy Home" Area of America Online's Interest Channel
|
|
Apr 20, 99
|
| 08:59 ET |
Cognetix Receives $800,000 in SBIR Funding to Enhance Functional Assay Capabilities
|
|
Apr 19, 99
|
| 08:59 ET |
International Isotopes Inc Successfully Ships First Commercial Products From Denton Facility
|
|
| 08:29 ET |
Pentose Pharmaceuticals and Cangene Corporation Sign Development, Manufacture and License Agreement
|
|
| 07:59 ET |
TerraGen Raises Cdn$8 Million in Financing - Company Also Changes Name to TerraGen Discovery Inc. -
|
|
Apr 16, 99
|
| 08:45 ET |
Phytera, Inc. Withdraws Its Initial Public Offering
|
|
| 08:29 ET |
RTP Pharma Inc. Licenses Drug Delivery Technology to IDEXX Laboratories Subsidiary for Veterinary Applications
|
|
Apr 15, 99
|
| 08:31 ET |
Aastrom Biosciences Announces European Launch of the Aastromreplicell(TM) System
|
|
| 08:29 ET |
Kinetix Pharmaceuticals Completes $8.8 Million Financing to Accelerate Drug Discovery Programs
|
|
| 07:59 ET |
CpG ImmunoPharmaceuticals Initiates Phase I Clinical Trial of CpG DNA(TM) for Hepatitis B
|
|
Apr 14, 99
|
| 11:01 ET |
AltaRex Update - Legal Proceedings With Biomira
|
|
| 08:46 ET |
BioMarin Completes $26 Million Private Placement
|
|
| 08:29 ET |
Endogen, Inc. Announces Third Quarter Financial Results for Fiscal 1999
|
|
Apr 13, 99
|
| 04:00 ET |
Preclinical Studies With OXiGENE'S Combretastatin Enhances Radiation Effects By Reducing Blood Flow in Tumors
|
|
Apr 07, 99
|
| 08:29 ET |
Phytera Awarded SBIR Grant to Develop New Tools for Antibacterial Drug Discovery
|
|
Apr 06, 99
|
| 08:31 ET |
NitroMed Receives Broad Patent Covering Novel Treatments for Male Erectile Dysfunction
|
|
Apr 05, 99
|
| 16:25 ET |
SunPharm Reports 1998 Financial Results
|
|
| 08:15 ET |
AutoImmune Inc. and Eli Lilly To Restructure Relationship For Diabetes Product
|
|
| 07:58 ET |
ProScript Receives SBIR Grant for Novel Stroke Treatment
|
|
| 06:59 ET |
LeukoSite and ILEX Oncology Provide Update on CAMPATH(R) Clinical Development Program
|
|
Apr 01, 99
|
| 15:43 ET |
AltaRex Update - OvaRex(TM) MAb and BrevaRex(TM) MAb Clinical Trials
|
|
| 08:31 ET |
FDA Commissioner Henney and Senator Kennedy Meet with MBC and Local Biotechnology Companies to Discuss Industry Concerns
|
|
| 08:30 ET |
Variagenics, Inc. Obtains Exclusive License to MTHFR Gene; Pharmacogenomic Marker Linked to Cardiovascular Disease
|
|
Mar 31, 99
|
| 07:59 ET |
CuraGen Initiates Search for CEO to Continue Momentum
|
|
| 01:30 ET |
TerraGen Agrees to Acquire Xenova Discovery from Xenova Group plc
|
|
Mar 30, 99
|
| 18:32 ET |
International Isotopes Inc Announces Financial Results For Year End 1998
|
|
| 07:59 ET |
Cambridge Antibody Technology & Wyeth-Ayerst Laboratories Form Major Alliance
|
|
| 07:59 ET |
Copernicus Receives Broad Patents for DNA Delivery Technology
|
|
Mar 29, 99
|
| 08:31 ET |
Advanced Cell Technology Appoints Robert Lanza, M.D. to Lead Tissue Engineering and Transplant Research
|
|
| 08:29 ET |
Aquila Initiates Phase IIb Clinical Trial of Quilimmune-P(TM)
|
|
Mar 25, 99
|
| 14:05 ET |
Arthur F. Staubitz Joins Aastrom Biosciences' Board of Directors
|
|
Mar 24, 99
|
| 08:29 ET |
LeukoSite Reports Year-End 1998 Financial Results
|
|
| 08:29 ET |
Pentose Pharmaceuticals and V.I. Technologies Sign Development, Manufacture and License Agreement
|
|
| 07:59 ET |
Richard A. Flavell, Ph.D., Innovator in Drug Development, Joins CuraGen's Scientific Advisory Board
|
|
Mar 22, 99
|
| 15:53 ET |
ChiRex Appoints Thomas I. H. Dubin Vice President, General Counsel and Secretary
|
|
| 08:29 ET |
Dyax Appoints David Patteson President of Biotage(TM), Separations Division
|
|
| 07:59 ET |
CuraGen and Roche Sign Product Discovery and Pharmacogenomics Agreement
|
|
Mar 19, 99
|
| 07:59 ET |
AltaRex Updates Clinical Progress for OvaRex(TM) MAb and BrevaRex(TM) MAb
|
|
Mar 18, 99
|
| 09:01 ET |
Scriptgen Elects New Member to its Scientific Advisory Board
|
|
Mar 17, 99
|
| 09:00 ET |
SafeScience Inc. Adds South Korea to Its Rapidly Expanding International Distribution Network
|
|
| 08:01 ET |
Copernicus Therapeutics Receives Grant from National Cancer Institute
|
|
| 07:59 ET |
AltaRex Files Lawsuit Against Biomira Inc.
|
|
Mar 15, 99
|
| 16:45 ET |
ChiRex Obtains Exclusive License For Amino Acid Technology From Harvard University
|
|
| 08:29 ET |
Governor Cellucci Joins With Massachusetts Biotechnology Industry to Promote Science Education
|
|
| 08:29 ET |
TerraGen Diversity Agrees to Acquire ChromaXome from Trega Biosciences
|
|
Mar 11, 99
|
| 09:28 ET |
PLIVA and The Althexis Company Announce a Collaboration on the Structure-Based Drug Design of Novel Broad Spectrum Antibiotics
|
|
Mar 10, 99
|
| 12:45 ET |
AltaRex Announces Financial Results for the Fourth Quarter and Year Ended December 31, 1998
|
|
Mar 09, 99
|
| 08:45 ET |
SafeScience Inc. Signs Distribution Agreement With Australia's Leading Agrochemical Distributor
|
|
Mar 08, 99
|
| 11:54 ET |
International Isotopes Inc and GammaPlus, LLC Enter into Joint Venture
|
|
| 09:02 ET |
SafeScience Secures Radio Celebrity to Promote E-Commerce Web Site Launch and SafeScience Products
|
|
| 08:29 ET |
Aastrom Biosciences Awarded NIH Grant to Support Cord Blood Transplant Program
|
|
Mar 05, 99
|
| 19:01 ET |
New Medication for Alzheimer's Disease Demonstrates Significant Effect on Patients' Abilities in Key Measures
|
|
Mar 03, 99
|
| 08:29 ET |
ImmunoGen, Inc. Receives U.S. Patent Covering Cytotoxic Agent for Use With Tumor Activated Prodrug Technology
|
|
Mar 02, 99
|
| 13:44 ET |
AltaRex Announces Commencement of Legal Action By Biomira
|
|
| 08:29 ET |
BioTransplant Announces U.S. Patent, Affording Broad Coverage of Core Technology
|
|
| 08:29 ET |
WRP Corporation Announces Fourth Quarter and 1998 Year End Results
|
|
Mar 01, 99
|
| 14:38 ET |
Variagenics Announces Senior Management Appointments in Marketing and Finance
|
|
| 05:00 ET |
Zeneca Agrochemicals to Use Rosetta Inpharmatics' Chemical Profiling Technology
|
|
Feb 25, 99
|
| 16:32 ET |
ArQule, Inc. Reports Financial Results for Fourth Quarter and Year Ended 1998
|
|
| 16:15 ET |
ImmunoGen, Inc. CEO Provides Background on Recent Corporate Achievements at BIO CEO & Investor Conference
|
|
Feb 24, 99
|
| 17:20 ET |
ChiRex Announces Public Offering of 2.5 Million Shares
|
|
| 13:36 ET |
Rosetta Inpharmatics Completes Merger With Acacia Biosciences
|
|
| 10:27 ET |
AltaRex Announces Potential Legal Action
|
|
Feb 23, 99
|
| 08:31 ET |
CuraGen Corporation Announces Fourth Quarter And Year End 1998 Financial Results
|
|
| 08:15 ET |
AutoImmune Inc. and Teva Pharmaceuticals Sign Exclusive Agreement
|
|
Feb 22, 99
|
| 08:59 ET |
Massachusetts Biotechnology Council Appoints Stephen Mulloney as Manager, Government Relations and External Communications
|
|
Feb 18, 99
|
| 10:58 ET |
Aquila Biopharmaceuticals Reports Financial Results for 1998
|
|
| 08:59 ET |
BIOSTAR Raises $3.2 Million CAD to Advance Prostate Cancer Product Development
|
|
| 08:29 ET |
Michael S. Perry Joins BioTransplant's Board of Directors
|
|
| 08:15 ET |
AutoImmune Inc. Completes Phase III Enrollment for Colloral(R)
|
|
Feb 17, 99
|
| 08:31 ET |
BioTransplant Incorporated Reports 1998 Fourth Quarter and Year End Results
|
|
| 08:31 ET |
CuraGen Awarded U.S. Patent Covering Open System of Gene Expression Technology
|
|
Feb 16, 99
|
| 14:29 ET |
Domain Pharma Names Four Vice Presidents
|
|
| 08:59 ET |
TerraGen Diversity Appoints Richard Baltz, Ph.D., to Scientific Advisory Board
|
|
| 08:29 ET |
BIOSTAR Announces Creation of STAR BIOTECH
|
|
| 05:59 ET |
OXiGENE Discontinues Neu-Sensamide(TM) Project; Focusing Resources on Three Other Products in Development
|
|
Feb 12, 99
|
| 13:02 ET |
Phytera, Inc. Delays Its Initial Public Offering
|
|
| 08:30 ET |
LeukoSite Completes Acquisition of CytoMed, Inc.
|
|
Feb 11, 99
|
| 12:45 ET |
WRP Corporation Appoints Robert J. Simmons, Jr. as Vice President for National Accounts
|
|
| 07:59 ET |
ProScript Initiates Second Phase I Trial For PS-341, Novel Chemotherapeutic Agent
|
|
Feb 10, 99
|
| 08:29 ET |
Incyte and ICAgen Announce Collaborative Agreement in Ion Channel Research
|
|
| 06:59 ET |
ChiRex Reports Financial Results for Fourth-Quarter and Full-Year 1998
|
|
Feb 09, 99
|
| 07:59 ET |
ImmunoGen, Inc. Reports Second Quarter Financial Results
|
|
Feb 08, 99
|
| 10:30 ET |
Women's Health Issues Explored at BIO CEO & Investor Conference
|
|
| 08:01 ET |
Variagenics, Inc. Acquires Exclusive Rights to Leading Pharmacogenomic Technologies For Neurological Disorders
|
|
Feb 05, 99
|
| 08:29 ET |
Cambridge NeuroScience Reports Fourth Quarter and Year-End 1998 Financial Results
|
|
| 08:29 ET |
Triangle Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year Ended December 31, 1998
|
|
Feb 03, 99
|
| 08:59 ET |
MediSpectra Vice President Receives Federal Hammer Award from Vice President Al Gore's National Partnership for Reinventing Government
|
|
| 08:02 ET |
ImmunoGen, Inc. and SmithKline Beecham Sign $45 Million Agreement
|
|
Feb 02, 99
|
| 08:30 ET |
Copernicus Therapeutics Appoints Maureen A. Costello, Ph.D., to Director, Pharmaceutical Development -- Mark J. Cooper, M.D., Promoted To Senior Vice President--
|
|
| 08:29 ET |
Aastrom Biosciences Announces CE Mark Approval For Cord Blood Therapy Kit
|
|
| 07:59 ET |
XTL and Collaborators at Hadassah University Hospital and Weizmann Institute Develop Trimera Disease Model for Hepatitis B
|
|
Feb 01, 99
|
| 13:00 ET |
ChiRex Names Stuart E. Needleman Vice President, Business Development Of ChiRex Technology Center
|
|
| 08:31 ET |
Triangle Pharmaceuticals Adopts Stockholder Rights Plan
|
|
Jan 28, 99
|
| 18:00 ET |
Alpha-Beta Technology Enters Into Assignment for the Benefit of Creditors to Liquidate Assets
|
|
| 09:01 ET |
OXiGENE Reports Fourth Quarter and Fiscal 1998 Results
|
|
| 08:30 ET |
Copernicus Awarded $1.5 Million Grant from Cystic Fibrosis Foundation; Grant to Support Innovative Gene Delivery Approach to Treat Cystic Fibrosis
|
|
Jan 27, 99
|
| 11:30 ET |
SafeScience Receives Patent For New Fungicide For Control of Plant Disease
|
|
| 09:01 ET |
RTP Pharma Inc. Announces Collaboration with Phasex Corporation to Expand Insoluble Drug Delivery (IDD(TM)) Technology
|
|
Jan 26, 99
|
| 18:44 ET |
Biotechnology Industry Organization to Host Unique Investor Conference Highlighting Biotechnology's Prospects for Improving Health Care
|
|
| 08:59 ET |
Cognetix Appoints Brian Anderson to Chief Executive Officer
|
|
| 08:31 ET |
Aastrom Biosciences Reports Second Quarter And Six Months Ended December 31, 1998 Financial Results
|
|
| 08:30 ET |
Triangle Pharmaceuticals Presents Results of a Phase I/II Clinical Study With Coviracil(TM) (emitricitabine), Formerly Known as FTC in HIV-Infected Patients
|
|
| 08:29 ET |
Instrumentation Laboratory Completes Purchase of Hemoliance
|
|
Jan 22, 99
|
| 13:27 ET |
Flanders Foreign Investment Office Celebrates One Year Anniversary in Boston Office
|
|
| 09:31 ET |
Alpha-Beta Technology Discontinues Phase III Trial of Betafectin(R) PGG-glucan in Upper G-I Surgery Patients
|
|
Jan 21, 99
|
| 17:55 ET |
Cambridge NeuroScience Announces Nasdaq Delisting
|
|
| 13:55 ET |
International Isotopes Inc Receives Approval From the State of Texas For Production of Radioisotopes Used in the Diagnosis of Heart Disease
|
|
| 08:59 ET |
TerraGen Diversity Receives U.S. Patent for Combinatorial Biosynthesis Technology
|
|
Jan 20, 99
|
| 15:45 ET |
Instrumentation Laboratory Announces Multi-Year Critical Care Contract with Shared Services Healthcare Inc.
|
|
Jan 19, 99
|
| 10:30 ET |
SafeScience Inc. Signs Distribution Agreement For Europe With Intrachem Bio International
|
|
| 08:29 ET |
ChiRex Names Michael J. Nicholds Vice President Sales and Marketing
|
|
Jan 14, 99
|
| 15:30 ET |
XTL Biopharmaceuticals, Ltd. to Present at Hambrecht & Quist's 17th Annual Healthcare Conference
|
|
| 08:15 ET |
Endogen, Inc. Announces Second Quarter Financial Results for Fiscal 1999
|
|
Jan 13, 99
|
| 10:30 ET |
AVANT Immunotherapeutics, Inc. Presents at The Hambrecht & Quist 17th Annual Healthcare Conference
|
|
Jan 12, 99
|
| 08:29 ET |
ICAgen Obtains Exclusive Rights to Novel Ion Channel Drug Discovery Technology from Rockefeller University
|
|
| 08:29 ET |
WRP Corporation Announces Placement of Common Stock
|
|
Jan 11, 99
|
| 23:45 ET |
BioMarin Pharmaceutical Inc. Addresses Hambrecht & Quist 17th Annual Healthcare Conference
|
|
| 16:01 ET |
LeukoSite and Warner-Lambert Sign Discovery and Development Collaboration
|
|
| 15:29 ET |
LeukoSite, Inc. Addresses Hambrecht & Quist's 17th Annual Health Care Conference
|
|
| 14:27 ET |
NitroMed to Present at the Hambrecht & Quist 17th Annual Healthcare Conference
|
|
| 08:59 ET |
SafeScience Signs Distribution Agreement For SafeScience Products in Mexico and Central America
|
|
| 08:29 ET |
Instrumentation Laboratory Announces Fiscal 1998 Third Quarter Results
|
|
Jan 07, 99
|
| 10:52 ET |
ProScript and NCI Collaborate on Anticancer Therapeutic
|
|
| 10:08 ET |
Scriptgen and DuPont Collaborate to Discover New Antibacterial Drugs
|
|
| 08:29 ET |
Gamera Bioscience Expands Headquarters and R&D Facility
|
|
Jan 06, 99
|
| 11:20 ET |
AltaRex Appoints Christopher F. Nicodemus, M.D. as Senior Vice President, Medical and Regulatory Affairs
|
|
Jan 05, 99
|
| 08:59 ET |
International Isotopes Inc and University of Texas Southwestern Medical Center Initiate Advanced Imaging Program
|
|
Jan 04, 99
|
| 18:24 ET |
LeukoSite Signs Agreement to Acquire CytoMed; Purchase Expected to Add $15 Million in Cash and Two Clinical Compounds
|
|
Dec 31, 98
|
| 13:35 ET |
International Isotopes Inc Begins Shipment of Improved I-125 Brachytherapy Seeds
|
|
Dec 29, 98
|
| 08:29 ET |
Lloyd M. Smith, Ph.D., Pioneer in Automated DNA Sequencing, Joins CuraGen's Scientific Advisory Board
|
|
Dec 28, 98
|
| 08:29 ET |
Triangle Pharmaceuticals Announces Sale of Preferred Stock
|
|
Dec 23, 98
|
| 11:18 ET |
CuraGen Corporation Announces Departure of Gregory T. Went, Ph.D.
|
|
Dec 21, 98
|
| 15:04 ET |
AltaRex Announces FDA Fast Track Designation for its Lead Product OvaRex(TM) MAb
|
|
| 08:29 ET |
Quintiles and Variagenics Establish Partnership for Pharmacogenomic Applications in Clinical Development
|
|
| 07:55 ET |
Cambridge NeuroScience and Bayer to Collaborate in the Development of GGF2 For Neurodegenerative Diseases
|
|
Dec 18, 98
|
| 06:59 ET |
Alpha-Beta Technology, Inc. Shareholders Approve Resolutions
|
|
Dec 17, 98
|
| 08:29 ET |
Aastrom Biosciences Announces CE Mark Approval For Stem Cell Therapy Kit
|
|
| 06:59 ET |
ChiRex Names Frank J. Wright Executive Vice President, Corporate Development
|
|
Dec 16, 98
|
| 09:20 ET |
ArQule, Inc. Executes a Four Year Collaboration with R.W. Johnson Pharmaceutical Research Institute for the Discovery of Novel Pharmaceuticals
|
|
| 08:30 ET |
The Medicines Company Appoints Armin M. Kessler to Board of Directors
|
|
Dec 15, 98
|
| 16:30 ET |
International Isotopes Raises Over $10 Million From Private Placement
|
|
| 15:47 ET |
Scriptgen Completes $12 Million Private Placement
|
|
| 08:58 ET |
Epic Therapeutics Initiates Pivotal Trial of ProMaxx(TM) 100
|
|
| 08:30 ET |
Triangle Pharmaceuticals Announces $48 Million Private Placement
|
|
Dec 14, 98
|
| 10:45 ET |
WRP Corporation Announces New Bank Credit Facility
|
|
| 09:01 ET |
TerraGen and Schering-Plough Research Institute Establish Collaboration To Discover Novel Anti-Infective Drugs
|
|
| 08:00 ET |
SafeScience Cleaning Products Show Superior Results in Head to Head Tests Against Leading Brands
|
|
Dec 11, 98
|
| 08:59 ET |
Researchers Report on the Mechanism of Action for OXiGENE'S Declopramide
|
|
Dec 09, 98
|
| 08:59 ET |
MediSpectra Appoints David Lipson, Ph.D. as Vice President, Product Development
|
|
Dec 08, 98
|
| 08:31 ET |
Massachusetts General Hospital and BioTransplant Report Advances in the Treatment of Blood Cell Cancers
|
|
Dec 07, 98
|
| 12:30 ET |
Scientific Advisory Board Commends International Isotopes on Progress
|
|
| 10:15 ET |
Aastrom Biosciences Presents Clinical Results at The American Society of Hematology Meeting
|
|
| 09:50 ET |
ZymeTx Reveals New Flu Surveillance Network at International Symposium on Influenza And Respiratory Viruses
|
|
| 08:31 ET |
The Medicines Company Begins Phase III Clinical Trial of Hirulog(R) Anticoagulant in Heart Attack Patients
|
|
Dec 04, 98
|
| 12:15 ET |
ZymeTx, Inc. Announces Filing of Registration Statement For 2,400,000 Shares of Existing Common Stock with Expiring Lock-Up Agreements
|
|
| 08:29 ET |
Pentose Pharmaceuticals Appoints Two Executives to Management Team
|
|
Dec 03, 98
|
| 16:13 ET |
Instrumentation Laboratory Announces Senior Executive Resigns Posts
|
|
| 11:17 ET |
Grupo CH-Werfen SA Announces The Agreement To Acquire Hemoliance
|
|
| 08:29 ET |
Gamera Bioscience Appoints George Church, Ph.D. and Howard Goodman, Ph.D. to Scientific Advisory Board
|
|
Dec 02, 98
|
| 08:29 ET |
Aastrom Biosciences Initiates Pivotal Trial of The AastromReplicell(TM) System in Breast Cancer Patients
|
|
Dec 01, 98
|
| 12:35 ET |
SafeScience Expands Product Portfolio With Acquisition Of PhytoPharmaceuticals, Inc.
|
|
| 09:00 ET |
MediSpectra Names Richard J. Thomas and Kim D. Blickenstaff to Board of Directors
|
|
| 08:15 ET |
Dyax and Genzyme Form Partnership to Develop and Commercialize New Anti-Inflammatory Treatments
|
|
Nov 23, 98
|
| 09:58 ET |
CytoMed Appoints Grace Yeh, Ph.D. As Chief Scientific Officer
|
|
| 08:29 ET |
University of Florida Reports Preclinical Studies That Show Enhanced Anti-Tumor Activity When OXiGENE's Combretastatin is Combined With Radiation
|
|
Nov 20, 98
|
| 07:00 ET |
CuraGen and Glaxo Wellcome Initiate Pharmacogenomics-Based Drug Discovery Collaboration
|
|
Nov 19, 98
|
| 07:59 ET |
Dyax Corp. Issued Fourth U.S. Patent for Phage Display
|
|
| 07:59 ET |
Joseph A. Taylor Joins Aastrom Biosciences' Board of Directors
|
|
| 07:30 ET |
Endogen Names Christine Burns, Ph.D. as Vice President of Product Development and Technology
|
|
| 07:29 ET |
Pentose Pharmaceuticals Awarded SBIR Grant to Apply INACTINE(TM) Viral Inactivation for Treatment of Plasma-Derived Therapeutic Proteins
|
|
Nov 18, 98
|
| 14:21 ET |
CuraGen Announces Discovery of over 60,000 cSNPs
|
|
| 09:18 ET |
Christopher M. Salyer Elected to ZymeTx's Board of Directors
|
|
| 09:01 ET |
International Isotopes Reports Financial Results For the Third Quarter Ended September 30, 1998
|
|
Nov 17, 98
|
| 12:18 ET |
AltaRex Announces Financial Results for the Third Quarter Ended September 30, 1998
|
|
| 08:29 ET |
AltaRex Announces Financial Results for the Third Quarter Ended September 30, 1998
|
|
Nov 16, 98
|
| 16:00 ET |
Alpha-Beta Technology, Inc. Reports Third Quarter 1998 Results
|
|
| 15:29 ET |
SunPharm Reports Third Quarter 1998 Financial Results
|
|
| 14:21 ET |
Dyax Corp. Completes $31 Million Private Financing Led By HealthCare Ventures L.L.P. and Alta Partners
|
|
| 08:29 ET |
Cobe BCT And Aastrom Biosciences To End Field-Specific Distribution Agreement
|
|
Nov 13, 98
|
| 10:45 ET |
International Isotopes Inc Successfully Tests Initial Stage of Modified SSC LINAC
|
|
| 08:45 ET |
Triangle Pharmaceuticals Reports Preliminary Data on the Activity of FTC in Hepatitis B-infected Patients
|
|
Nov 12, 98
|
| 10:54 ET |
GelTex Announces Five Senior Management Appointments
|
|
| 07:29 ET |
Advanced Cell Technology Announces Use of Nuclear Transfer Technology for Successful Generation of Human Embryonic Stem Cells
|
|
Nov 11, 98
|
| 07:29 ET |
LeukoSite Reports Third Quarter 1998 Financial Results
|
|
| 04:00 ET |
OXiGENE Initiates Phase I Studies of Combretastatin
|
|
Nov 10, 98
|
| 12:34 ET |
Significant Advance In Cardiovascular Risk Assessment
|
|
| 08:59 ET |
MediSpectra, Inc. Appoints Pamela J. Weagraff as Vice President, Regulatory and Quality
|
|
| 08:30 ET |
Gamera Bioscience Expands Scientific Advisory Board
|
|
Nov 09, 98
|
| 08:59 ET |
Cognetix Names Scott Hagen Chief Financial Officer
|
|
| 08:30 ET |
BioTransplant Incorporated Reports Third Quarter 1998 Results
|
|
Nov 05, 98
|
| 14:14 ET |
/C O R R E C T I O N -- Massachusetts Biotechnology Council/
|
|
| 13:33 ET |
AltaRex Submits IND Amendment To Initiate Phase II Trial of OvaRex(TM) MAb For Ovarian Cancer
|
|
| 10:45 ET |
Aastrom Biosciences Announces Operational Changes to Focus Support On European Product Launch and U.S. Trials
|
|
| 09:47 ET |
Massachusetts Biotechnology Council Receives Federal Hammer Award for Collaborative Work with Local FDA
|
|
| 08:30 ET |
SafeScience Presents Promising New Data With GBC-590 On Human Pancreatic Cancer
|
|
| 08:30 ET |
Triangle Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 1998
|
|
| 07:59 ET |
Massachusetts Biotechnology Council Receives Federal Hammer Award for Collaborative Work with Local FDA
|
|
Nov 04, 98
|
| 08:30 ET |
AltaRex Submits IND Amendment to Initiate Second Phase IIb Trial Of OvaRex(TM) MAb for Ovarian Cancer
|
|
| 08:30 ET |
Cambridge NeuroScience Reports Third Quarter 1998 Financial Results
|
|
| 07:59 ET |
Acacia Biosciences Awarded $1 Million Grant From U.S. Department of Energy
|
|
Nov 03, 98
|
| 08:59 ET |
MediSpectra, Inc. Announces the Appointment of Robert J. Nordstrom, Ph.D., Vice President, Research
|
|
| 08:30 ET |
Aastrom Biosciences Receives U.S. Patents For High-Efficiency Gene Transfer Using the Aastrom(TM) Gene Loader
|
|
| 08:15 ET |
AutoImmune Inc. Reports Third Quarter 1998 Results
|
|
| 07:15 ET |
ChiRex Reports Financial Results for Third-Quarter and First Nine Months of 1998
|
|
Nov 02, 98
|
| 13:50 ET |
AltaRex Receives International Preliminary Examination Report for Key Patent Application
|
|
| 09:27 ET |
Eurona Medical AB Receives ISO 9001 Certification
|
|
| 09:02 ET |
International Isotopes Inc Achieves Beam in CP-42 MeV Accelerator
|
|
| 08:30 ET |
Aquila Biopharmaceuticals' Key Patent Upheld in Europe
|
|
| 08:30 ET |
Instrumentation Laboratory Announces Multi-Year Supply Contract With Novation
|
|
| 08:29 ET |
Pentose Reports New Preclinical Data on INACTINE(TM) for Ex Vivo Viral Inactivation of Red Blood Cells for Transfusion
|
|
| 07:30 ET |
GelTex, Genzyme Announce FDA Marketing Approval for Renagel(R) Capsules
|
|
Oct 29, 98
|
| 13:41 ET |
ZymeTx Reports Financial Results for the First Quarter Ended September 30, 1998
|
|
| 09:52 ET |
ImmunoGen, Inc. Reports First Quarter Financial Results
|
|
| 07:59 ET |
Neose Technologies Reports Third Quarter Financial Results
|
|
| 07:05 ET |
CuraGen Reports Third Quarter 1998 Results
|
|
Oct 28, 98
|
| 17:01 ET |
IBEX to Resume Phase III Testing of Neutralase(TM)
|
|
| 09:02 ET |
OXiGENE Reports Earnings For Third Quarter 1998
|
|
| 08:28 ET |
CpG ImmunoPharmaceuticals Reports on Enhanced Method for Inducing Mucosal Immune Responses in J. Immunology
|
|
| 07:58 ET |
SEQUUS Pharmaceuticals, Inc. Reports Third Quarter Operating Results
|
|
Oct 27, 98
|
| 08:29 ET |
Aastrom Biosciences, Inc. Reports First Quarter Financial Results - Company Looks Toward European Product Launch -
|
|
Oct 26, 98
|
| 16:30 ET |
SafeScience Nominates Brian Hughes to Board of Directors
|
|
| 13:30 ET |
WRP Corporation Subsidiary American Health Products Named 'Top 100 Supplier' by Sysco Corporation
|
|
| 12:26 ET |
UCB Pharma Expands Scientific Presence in the U.S.
|
|
| 12:00 ET |
CytoMed Enters Into Agreement with UCB Pharma
|
|
| 11:40 ET |
SunPharm to Provide Additional Data 0n Anti-Diarrhea Compound
|
|
| 08:30 ET |
WRP Corporation Reports Record Third Quarter 1998 Results
|
|
| 08:04 ET |
FDA Advisory Committee Declines to Approve The Medicines Company's Hirulog(R) (Bivalirudin) in Close Vote
|
|
| 06:59 ET |
GelTex Pharmaceuticals Reports Third Quarter 1998 Results
|
|
Oct 22, 98
|
| 16:46 ET |
Alpha-Beta Technology, Inc. Completes Private Financing
|
|
| 12:31 ET |
Aquila Biopharmaceuticals Reports Financial Results For The Third Quarter 1998
|
|
| 08:31 ET |
Aastrom Biosciences Announces CE Mark Approval In Preparation of Initial Product Launch in Europe
|
|
| 08:31 ET |
Alpha-Beta Technology and IDEXX Laboratories to Enter into Commercial Alliance; Products to Target Veterinary, Environmental and Food Markets
|
|
Oct 21, 98
|
| 08:29 ET |
Endogen Awarded $230,000 Phase II SBIR Grant
|
|
| 08:02 ET |
Clinical Utility of Matritech's NMP22 Test for Early Detection of Bladder Cancer Demonstrated by Cleveland Clinic Researchers
|
|
| 07:59 ET |
ArQule Amends Agreement with Roche Bioscience
|
|
Oct 20, 98
|
| 08:59 ET |
MediSpectra Appoints James F. Myrtle, Ph.D., as Vice President, Clinical Affairs
|
|
| 08:29 ET |
Aastrom Biosciences Awarded Phase II SBIR Grant to Support Umbilical Cord Blood Transplant Program
|
|
| 08:29 ET |
ProScript Promotes Peter Elliott, Ph.D., to Vice President Pharmacology and Drug Development
|
|
| 07:20 ET |
CuraGen Launches SeqCalling(TM) Process for the Discovery and Development of Pharmaceutical and Life Science-based Products
|
|
Oct 16, 98
|
| 12:45 ET |
International Isotopes Inc Closes on Refinancing on Facilities
|
|
| 08:29 ET |
Cambridge NeuroScience Stays Delisting By Requesting Nasdaq Hearing
|
|
Oct 15, 98
|
| 17:15 ET |
ArQule, Inc. Reports Financial Results for Third Quarter and Nine Months 1998 Ended September 30, 1998
|
|
| 10:06 ET |
NitroMed Presents Preclinical Results Demonstrating Potential of NO-enhanced Compounds to Treat Male Erectile Dysfunction
|
|
| 09:13 ET |
The Medicines Company Announces Senior Management Appointments
|
|
Oct 14, 98
|
| 08:30 ET |
Argonex Appoints Ramila Philip, Ph.D., as Vice President, Immunology and Clinical Affairs
|
|
| 08:30 ET |
ProScript Initiates Phase I Trial For a New Class of Cancer Therapeutics
|
|
| 08:13 ET |
Aquila Announces Initial Results Of Phase II Clinical Trial Of Quilimmune-P(TM) To Prevent Pneumococcal Infections
|
|
Oct 13, 98
|
| 16:30 ET |
Scriptgen Pharmaceuticals, Inc. Files Patent Infringement Suit Against 3-Dimensional Pharmaceuticals, Inc.
|
|
| 08:32 ET |
Dyax Corp. Appoints Gregory Phelps as Vice Chairman, Board of Directors
|
|
| 08:29 ET |
Argonex Appoints J. Mark Braughler, Ph.D., as President
|
|
| 06:59 ET |
AltaRex Submits IND for Second Antibody-Based Product For the Treatment of Cancer
|
|
Oct 08, 98
|
| 09:15 ET |
Stephen K. Reidy, General Partner for Euclid Partners, Joins MediSpectra's Board of Directors
|
|
| 08:59 ET |
MediSpectra, Inc. Raises $9 Million in Private Placement
|
|
| 08:45 ET |
BioTransplant and MedImmune Announce Issuance of Second U.S. Patent Covering MEDI-507 and BTI-322 Antibodies
|
|
| 08:30 ET |
BioMarin Pharmaceutical Acquires Glyko, Inc., Gains Access to Complementary Carbohydrate Technology and Expertise
|
|
Oct 07, 98
|
| 08:29 ET |
Dyax Corp. Receives $1.7 Million Grant from NIST
|
|
Oct 06, 98
|
| 15:27 ET |
IBEX Announces Results For Its Fourth Quarter and Year Ended July 31, 1998
|
|
| 07:59 ET |
Johns Hopkins Medical Institutions Uses Matritech's NMP22(R) Bladder Cancer Test
|
|
Oct 05, 98
|
| 15:19 ET |
Flanders Foreign Investment Office to Present at EuropaBio '98
|
|
| 08:29 ET |
Aastrom Biosciences Announces Positive Multi-Center Clinical Trial Results In Breast Cancer Patients
|
|
| 08:29 ET |
Triangle Pharmaceuticals Announces the Issuance of a Patent For FTC to Emory University
|
|
Oct 01, 98
|
| 08:29 ET |
Alpha-Beta Researchers Identify Promising New Approach to Treat Serious Fungal Disease
|
|
Sep 29, 98
|
| 12:15 ET |
Endogen, Inc. Announces First Quarter Financial Results for Fiscal 1999
|
|
Sep 28, 98
|
| 08:29 ET |
Alpha-Beta Presents Fungal Disease Program Data at The Interscience Conference on Antimicrobial Agents and Chemotherapy (Icaac)
|
|
Sep 25, 98
|
| 08:30 ET |
SafeScience Inc. Gains Strong Marketing Experience With New Board Member
|
|
Sep 24, 98
|
| 08:29 ET |
BioTransplant Receives Orphan Drug Designation For a Key Component of the AlloMune(TM) Transplantation System
|
|
Sep 23, 98
|
| 10:00 ET |
Researchers Demonstrate Direct Anti-Tumor Effect of Combretastatin and Show Advances in Development of a New Gene Therapy Model
|
|
Sep 22, 98
|
| 16:01 ET |
AltaRex Appoints Edward M. Fitzgerald As Chief Financial Officer
|
|
Sep 21, 98
|
| 10:00 ET |
OXiGENE Provides Clinical Development Update On Neu-Sensamide(TM)
|
|
| 09:10 ET |
Aquila Relocates Corporate Facilities and Offices
|
|
Sep 18, 98
|
| 08:28 ET |
BioTransplant Collaborators at MGH Report Advances Toward Establishing Long-term Xenograft Acceptance; Research Article Published in Science
|
|
Sep 16, 98
|
| 15:54 ET |
IBEX Announces Preclinical Study of Neutralase(TM) Shows Beneficial Anti-thrombotic Effects Following Heparin Reversal
|
|
| 09:56 ET |
IPNI Communications Corporation Receives $5 Million in Financing: Funds to Support Expansion of Physician/Pharmaceutical Videoconferencing Network
|
|
| 08:59 ET |
Afferon Corporation Announces Positive Preliminary Results of Phase I/II European Clinical Trials of RTX for Urge Incontinence
|
|
| 08:29 ET |
SEQUUS Pharmaceuticals Names Elizabeth M. Greetham to Board of Directors
|
|
Sep 10, 98
|
| 11:38 ET |
Texas State Bank to Fund International Isotopes Inc Facilities and Expansions
|
|
| 08:30 ET |
Gamera Bioscience Names Dr. Peter Wilding to Scientific Advisory Board
|
|
| 08:29 ET |
Vanderbilt Researchers Report Alpha-Beta's Betafectin(R) and Antibiotics are Synergistic in Ability to Prevent Antibiotic Resistant Staph. Infections
|
|
Sep 09, 98
|
| 08:30 ET |
SunPharm Appoints Michael T. Cullen, M.D., M.B.A. as Vice President and Medical Director
|
|
| 08:29 ET |
ZymeTx Announces FDA Clearance for Next Generation ZstatFlu
|
|
| 07:59 ET |
Massachusetts Biotechnology Council Rates Candidates in 8th Congressional District Race
|
|
| 07:59 ET |
Matritech and Laboratory Corporation of America(R) Holdings to Offer Matritech's NMP22(R) Bladder Cancer Test
|
|
Sep 08, 98
|
| 16:05 ET |
ChiRex Accelerates Technology Development by Establishing Full-Service Process Development Center in Boston
|
|
| 08:29 ET |
BioTransplant Announces Departure of Robert Kauffman, M.D., Ph.D., Vice President of Clinical Affairs
|
|
Sep 04, 98
|
| 16:30 ET |
International Isotopes Issues a Correction for September 1 Release
|
|
Sep 01, 98
|
| 11:35 ET |
International Isotopes Inc Accepts Completion of Radiopharmaceutical Production Facility From MSS
|
|
| 10:12 ET |
/K I L L K I L L K I L L -- International Isotopes Inc/
|
|
| 10:01 ET |
International Isotopes Inc Accepts Completion of Radiopharmaceutical Production Facility From MSS
|
|
| 08:01 ET |
ChiRex Names Michael A. Griffith Chairman and Chief Executive Officer
|
|
Aug 31, 98
|
| 09:15 ET |
Instrumentation Laboratory Announces Fiscal 1998 Second Quarter Results
|
|
| 08:29 ET |
The Medicines Company Completes $36 Million Private Placement With Morgan Stanley Venture As Lead Investor
|
|
Aug 26, 98
|
| 17:22 ET |
BioMarin Expands Management Team with Experienced Leadership from Academia and the Biotechnology Industry
|
|
| 11:33 ET |
Alpha-Beta Technology Awarded Three NIH Grants in Support of Antifungal Drug Discovery Program
|
|
| 11:33 ET |
ZymeTx Reports Financial Results for the Year and Fourth Quarter Ended June 30, 1998
|
|
| 08:29 ET |
Aastrom Biosciences Appoints William Odell as Senior Vice President Product Operations
|
|
| 07:59 ET |
Cambridge Neuroscience Reports Important Advances in GGF2 Multiple Sclerosis Program
|
|
Aug 25, 98
|
| 08:59 ET |
Scriptgen Bolsters Key Management Team
|
|
Aug 24, 98
|
| 10:00 ET |
ArQule Presents Combinatorial Chemistry Advances at American Chemical Society
|
|
| 09:00 ET |
Scriptgen Announces Management Promotions
|
|
Aug 20, 98
|
| 12:43 ET |
Endogen Announces Launch of mRNA Detection Kits
|
|
| 10:29 ET |
MorphoSys and LeukoSite Sign Collaboration Agreement
|
|
| 08:30 ET |
BioMarin Establishes Genetics Division, Appoints Emil D. Kakkis, M.D., Ph.D. as President
|
|
Aug 19, 98
|
| 09:36 ET |
AltaRex Announces Financial Results for the Second Quarter Ended June 30, 1998
|
|
| 08:59 ET |
ArQule Announces Collaboration to Develop and Commercialize Integrated Bioseparations Products
|
|
| 08:29 ET |
CpG ImmunoPharmaceuticals Appoints Robert Bratzler, Ph.D., as President and Chief Executive Officer
|
|
| 07:29 ET |
International Isotopes Reports Second Quarter 1998 Financial Results
|
|
Aug 18, 98
|
| 17:56 ET |
Aastrom Biosciences, Inc. Reports Fourth Quarter and Fiscal 1998 Financial Results
|
|
Aug 17, 98
|
| 16:05 ET |
ChiRex Obtains Exclusive License for Buchwald ABT Technologies From M.I.T.
|
|
| 15:34 ET |
Alpha-Beta Technology, Inc. Second Quarter 1998 Results
|
|
| 07:01 ET |
ArQule Updates Investors on Corporate Strategy, Adjusts 1998 Financial Expectations
|
|
| 06:36 ET |
SEQUUS Pharmaceuticals, Inc. Responds To Recent Shareholder Inquiries
|
|
| 04:37 ET |
Novartis and Acacia Biosciences Enter into Profiling Agreement
|
|
| 04:36 ET |
VARIAGENICS, INC. Appoints Gregory Verdine, Ph.D., as Principal Scientific Advisor
|
|
Aug 14, 98
|
| 08:31 ET |
SafeScience Bolsters Sales and Marketing Program
|
|
Aug 13, 98
|
| 12:49 ET |
Virus Research Institute Reports Positive Results of Rotavirus Vaccine Phase II Efficacy Study
|
|
| 09:58 ET |
SunPharm Reports Second Quarter 1998 Financial Results
|
|
| 08:29 ET |
LeukoSite Reports Second Quarter Results
|
|
| 08:29 ET |
The Medicines Company Acquires Novel Treatment for Acute Migraine Headache from Immunotech
|
|
Aug 12, 98
|
| 12:05 ET |
ZymeTx Signs Contract With Managed Care Company to Use ZstatFlu(TM)
|
|
| 09:00 ET |
Cognetix Names Brian Anderson Executive Vice President, Corporate Development
|
|
Aug 11, 98
|
| 08:29 ET |
Dr. Charles Burke Joins Endogen's Board of Directors
|
|
| 08:09 ET |
Matritech Reports Second Quarter Financial Results
|
|
Aug 10, 98
|
| 12:22 ET |
International Isotopes Inc Receives 510(k) Clearance For Imagyn I-125 Brachytherapy Seed
|
|
Aug 07, 98
|
| 08:29 ET |
Triangle Pharmaceuticals, Inc. Reports Financial Results For Second Quarter 1998
|
|
Aug 06, 98
|
| 10:59 ET |
RTP Pharma Inc. Announces US$3.5 Million Investment by EGS Partners and Credit Agricole
|
|
| 09:17 ET |
Virus Research Institute, Inc. Reports 1998 Second Quarter Results
|
|
Aug 04, 98
|
| 08:29 ET |
BioTransplant Incorporated Reports Second Quarter 1998 Results
|
|
| 08:29 ET |
Gamera Bioscience Unveils First LabCD(TM) Prototype
|
|
| 08:29 ET |
Phytera Extends and Expands Research, Development and Marketing Alliance With Tsumura to Discover Novel Drugs for Arthritis and Allergies
|
|
| 08:15 ET |
AutoImmune Inc. Reports Second Quarter 1998 Results
|
|
Aug 03, 98
|
| 16:29 ET |
Instrumentation Laboratory S.p.A. Announces Results of Rights Offering
|
|
| 08:29 ET |
Acacia Biosciences Receives Three SBIR Grants To Enhance Company's Proprietary Technology Platform
|
|
Jul 31, 98
|
| 10:15 ET |
BioChem Pharma and Briana Bio-Tech Finalize Agreement To Develop Breast Cancer Detection System
|
|
Jul 30, 98
|
| 07:59 ET |
Cambridge NeuroScience Reports Second Quarter 1998 Financial Results
|
|
| 07:59 ET |
Neose Technologies Reports Second Quarter Financial Results
|
|
| 07:15 ET |
WRP Corporation Reports Record Second Quarter Results Consecutive Four Quarters Show Increase in Profits & Revenues
|
|
| 06:59 ET |
SEQUUS Pharmaceuticals, Inc. Reports Second Quarter Operating Results
|
|
Jul 29, 98
|
| 13:32 ET |
Instrumentation Laboratory Announces Multi-Year Sole Source Supply Contract With Joint Purchasing Corporation (JPC)
|
|
| 08:29 ET |
SEQUUS Pharmaceuticals Names Top Executives to Round-Out Senior Management Team
|
|
Jul 28, 98
|
| 08:45 ET |
International Isotopes Inc Receives State Regulatory Approval to Operate The Company's LINAC and Cyclotron
|
|
| 08:30 ET |
SEQUUS Pharmaceuticals Signs Marketing Agreement for AMPHOTEC(R) in Portugal With FARMA-APS Limited
|
|
| 08:29 ET |
Phytera and Lilly Sign Research Collaboration Agreement to Discover and Develop Infectious Disease Products
|
|
Jul 27, 98
|
| 16:00 ET |
ArQule, Inc. Plans Senior Management Succession; Initiates Search for CEO with Drug Discovery Expertise
|
|
| 12:59 ET |
WRP Corporation Names Daniel W. Colcord Vice President, Sales
|
|
| 10:29 ET |
New Drug For Alzheimer's Disease Demonstrates Robust Effect on Cognitive Function
|
|
| 08:28 ET |
Pentose Pharmaceuticals Awarded SBIR Grant to Develop Novel Method of Viral Inactivation in Laboratory Blood Collection Tubes
|
|
| 08:27 ET |
SafeScience Brand Expands Into Cleaning Products That Offer High Performance, Product Safety and 50% Cost Savings
|
|
| 06:58 ET |
GelTex Pharmaceuticals Reports Second Quarter 1998 Results
|
|
Jul 24, 98
|
| 08:59 ET |
OXiGENE, Inc. Registration Statement Filed with SEC to Extend Expiration Date of Warrants Declared Effective
|
|
Jul 23, 98
|
| 16:28 ET |
ArQule Breaks Ground for a 130,000 s.f. Headquarters and R&D Facility
|
|
Jul 22, 98
|
| 15:27 ET |
Endogen Reports 1998 Year End and Fourth Quarter Results
|
|
| 09:02 ET |
OXiGENE Reports Earnings For Second Quarter 1998
|
|
| 08:27 ET |
Aastrom Receives Phase II SBIR Grant For Novel Ex Vivo Stem Cell Expansion Process
|
|
Jul 21, 98
|
| 16:31 ET |
Aronex Pharmaceuticals, Inc. Reports Second Quarter 1998 Results
|
|
| 16:19 ET |
Aronex Pharmaceuticals Announces Expanded Clinical Development Program For ATRAGEN(R)
|
|
| 08:59 ET |
ArQule and Monsanto Reach First Milestone in Development Collaboration
|
|
| 08:29 ET |
Gamera Bioscience Expands And Strengthens Management Team
|
|
Jul 20, 98
|
| 08:29 ET |
Variagenics Receives Four U.S. Pharmacogenomics Patents Covering Methods For High Throughput Genetic Variance Discovery
|
|
Jul 17, 98
|
| 08:59 ET |
Cognetix Acquires Viatech Imaging to Expand Drug Discovery Capabilities
|
|
Jul 16, 98
|
| 19:09 ET |
ChiRex Reports Financial Results for Second-Quarter and First-Half 1998
|
|
Jul 15, 98
|
| 16:49 ET |
ArQule, Inc. Reports Financial Results for Second Quarter 1998 Ended June 30, 1998
|
|
| 11:00 ET |
BioTransplant and MedImmune Report Phase II Results of BTI-322 to Treat Graft-versus-host Disease in Transplant Patients
|
|
| 08:00 ET |
BioMarin Raises $11 Million in Private Placements
|
|
| 07:57 ET |
SafeScience Adds Breakthrough Technology From Earthgreen Products, Inc. to Its Greenleaf(R) Plant Nutrition Product Line
|
|
Jul 14, 98
|
| 11:38 ET |
Colin Dykes, Ph.D., Joins Variagenics as Vice President, Genomics
|
|
| 08:29 ET |
MGH and BioTransplant Announce Advances in Achieving Tolerance in Transplantation Models
|
|
Jul 13, 98
|
| 11:15 ET |
FDA Clears BioTransplant IND for Initial Testing of AlloMune Transplantation System in Humans
|
|
| 08:30 ET |
Cambridge NeuroScience and Boehringer Ingelheim to End Collaboration
|
|
| 08:29 ET |
Acacia Biosciences Issued Fundamental U.S. Patent Covering Gene Expression Interpretation
|
|
| 07:59 ET |
ZymeTx, Inc. Signs Licensing Agreement on Potential HIV Antiviral
|
|
Jul 09, 98
|
| 16:11 ET |
AltaRex Initiates Second Phase II Study of OvaRex(TM) for Treatment of Ovarian Cancer
|
|
| 08:59 ET |
OXiGENE, Inc. Files with SEC to Extend Expiration Date of Warrants
|
|
Jul 08, 98
|
| 08:00 ET |
International Isotopes Inc Receives State Regulatory Approval to Initiate Manufacturing Operations
|
|
Jul 07, 98
|
| 08:30 ET |
Zymetx, Inc. Reports on Positive Developments for ZStatFlu(TM): Growing Awareness of Benefits of Influenza Diagnostic Test
|
|
| 07:30 ET |
ChiRex Announces Restructuring to Implement Product Management Strategy; Management Changes Underway
|
|
Jul 06, 98
|
| 08:29 ET |
Aastrom Biosciences Completes $5 Million Financing
|
|
| 07:00 ET |
LeukoSite Raises $11.8 Million In Private Placement
|
|
Jul 01, 98
|
| 08:31 ET |
TO BUSINESS EDITOR AND MEDICAL EDITOR:
|
|
Jun 30, 98
|
| 16:02 ET |
AltaRex Establishes Clinical Advisory Board
|
|
| 10:00 ET |
RTP Pharma Inc. Announces C$14.6 Million Private Placement
|
|
| 08:30 ET |
Phytera Completes $7.6 Million Financing
|
|
Jun 29, 98
|
| 15:03 ET |
GelTex Pharmaceuticals and Genzyme Report Positive Preliminary Results of Extended Use Clinical Trial of RenaGel(R) Non-Absorbed Phosphate Binder
|
|
| 09:18 ET |
International Isotopes Inc Announces Completion of Administration, Manufacturing and Service Facilities
|
|
Jun 25, 98
|
| 08:59 ET |
SafeScience Signs Agreement With Thermo Fibergen to Market and Distribute a New Consumer Product
|
|
Jun 23, 98
|
| 08:35 ET |
Ventana Efficiently Identifies Molecules Involved in Key Physiological Functions
|
|
Jun 22, 98
|
| 08:59 ET |
Cognetix Raises $6 Million in Venture Financing
|
|
Jun 18, 98
|
| 08:30 ET |
SunPharm's Lead Cancer Drug Featured at NCI-EORTC Symposium
|
|
Jun 17, 98
|
| 08:29 ET |
OXiGENE's Combretastatin Combined With Chemotherapy or Radiation in Mice Shows Enhanced Tumor Response
|
|
| 07:59 ET |
International Isotopes Inc Initiates Installation of Linear Accelerator into New Facility
|
|
Jun 16, 98
|
| 13:32 ET |
Drug Discovery Summit Points to Dramatic Shifts in Pharmaceutical Discovery Paradigm
|
|
| 12:46 ET |
BioChem Pharma and Briana Bio-Tech to Develop Breast Cancer Detection System
|
|
Jun 15, 98
|
| 16:30 ET |
Aronex Pharmaceuticals Presents at BIO'98 Investor & Partnering Conference
|
|
| 15:56 ET |
DuPont Agricultural Enterprise and Acacia Biosciences Enter Into Profiling Agreement
|
|
| 12:00 ET |
StressGen Biotechnologies Presents at BIO '98 Investor & Partnering Conference
|
|
| 08:39 ET |
ChiRex Experiences Production Difficulty with a Contract Product
|
|
Jun 12, 98
|
| 15:29 ET |
Wyeth-Ayerst Invests $2.0 Million in ArQule, Inc. In Accord with Five Year Drug Discovery Collaboration
|
|
| 10:43 ET |
Neose Technologies to Produce Complex Carbohydrates For Bristol-Myers Squibb Oncologic Vaccines
|
|
| 10:17 ET |
Aquila Biopharmaceuticals to Present at BIO '98 Investor & Partnering Conference
|
|
Jun 10, 98
|
| 07:59 ET |
International Isotopes Inc Increases Production of Sr-89 for Bone Cancer Pain Palliation
|
|
Jun 08, 98
|
| 09:02 ET |
SafeScience Reports First Quarter 1998 Financial Results
|
|
| 08:41 ET |
Phytera and Chiron Sign Research Collaboration Agreement
|
|
| 08:39 ET |
Alpha-Beta Awarded Two SBIR Grants for AntiFungal Drug Discovery Program
|
|
Jun 04, 98
|
| 08:29 ET |
Scriptgen and Lilly Expand Drug Discovery Collaboration
|
|
Jun 03, 98
|
| 09:09 ET |
SunPharm Receives U.S. Patent Allowance For Lead Cancer Drug
|
|
| 08:32 ET |
Reprogenesis, Inc. Initiates Pivotal Trial for Urinary Reflux Product
|
|
| 08:30 ET |
ProScript and Hoechst Marion Roussel Extend Research Collaboration to Develop Therapeutics for Inflammatory Disease
|
|
Jun 02, 98
|
| 10:00 ET |
International Isotopes Inc Acquires Exclusive U.S. Patent License and 510k on I-125 Brachytherapy Seeds
|
|
| 08:44 ET |
ArQule, Inc. and Genome Therapeutics Corporation to Collaborate in Genomics-Based Antibacterial and Antifungal Drug Discovery
|
|
| 08:30 ET |
Argonex Raises $7.5 Million to Accelerate Cancer Vaccine Programs
|
|
| 08:27 ET |
Aastrom Biosciences Receives SBIR Grant For Dendritic Cell Expansion For Cancer Immunotherapy
|
|
Jun 01, 98
|
| 09:59 ET |
SafeScience Expands Distribution of Products to Europe and South America
|
|
May 28, 98
|
| 14:50 ET |
Instrumentation Laboratory S.p.A. Announces Change In American Depositary Share Ex-Rights Date
|
|
May 27, 98
|
| 18:14 ET |
Instrumentation Laboratory S.p.A. Announces Change in American Depositary Share Ex-Rights Date
|
|
| 08:29 ET |
Matritech Announces Approval in Japan of the NMP22(R) Test Kit for Both Monitoring and Screening of Bladder Cancer Patients
|
|
| 08:28 ET |
Mary Lincoln Campbell Joins Aastrom Biosciences' Board of Directors
|
|
May 20, 98
|
| 16:17 ET |
International Isotopes Inc Reports to Shareholders First Quarter 1998 Results
|
|
| 10:15 ET |
SafeScience Bolsters Scientific Advisory Board
|
|
| 09:04 ET |
Matritech NuMA(TM) Test Kit FDA 510(k) Decision Has No Affect on Product Approvability; Development On-Track
|
|
| 08:30 ET |
Researchers Present Preclinical Feasibility Study for Matritech's NMP179 as a Cervical Cancer Tumor Marker at American Society of Clinical Oncology (ASCO)
|
|
May 19, 98
|
| 16:30 ET |
Matritech Receives 510(k) Response from FDA
|
|
| 11:41 ET |
Eurona Medical AB Appoints Thomas Pollare, M.D., Ph.D., Vice President, Business Development
|
|
| 08:29 ET |
Clinical Results of New Cancer Drug Presented at ASCO
|
|
May 18, 98
|
| 08:30 ET |
Triangle Pharmaceuticals Announces New Appointments to Board of Directors
|
|
| 08:29 ET |
NitroMed Announces Key Advances in Developing Safer Anti-inflammatory Drugs
|
|
| 08:29 ET |
Phase II Clinical Results Presented at American Gastroenterology Association on SunPharm Compound to Treat Refractory AIDS-Related Diarrhea
|
|
May 15, 98
|
| 17:30 ET |
Alpha-Beta Technology, Inc. Reports First Quarter 1998 Results
|
|
| 10:28 ET |
SunPharm Reports First Quarter Financial Results
|
|
| 07:59 ET |
Pentose Pharmaceuticals Presents Novel Method of Viral Inactivation to Improve Safety of Blood Products at 8th International Congress on Infectious Diseases
|
|
May 14, 98
|
| 09:30 ET |
BioTransplant and MedImmune Announce Initial Clinical Safety and Pharmacokinetics Data for MEDI-507
|
|
| 08:29 ET |
Phytera and NeuroSearch Sign Research, Development and Marketing Agreement
|
|
May 13, 98
|
| 19:34 ET |
LeukoSite Reports First Quarter Results and Progress on Three Clinical Programs
|
|
| 19:33 ET |
LeukoSite Reports First Quarter Results and Progress on Three Clinical Programs
|
|
| 08:30 ET |
Aastrom Biosciences Announces Initial Clinical Results and Expansion Of Trial for Cord Blood Transplants
|
|
| 08:30 ET |
MGH and BioTransplant Announce Key Advances in Transplantation Research
|
|
May 12, 98
|
| 10:54 ET |
Briana Announces Management Appointments
|
|
| 09:00 ET |
Scriptgen and Boston University Researchers Synthesize Novel Broad-Spectrum Antibiotic
|
|
| 08:30 ET |
CytoMed Begins Clinical Trials of CMI-977 Asthma Therapeutic
|
|
| 08:30 ET |
Gamera Bioscience Raises Additonal $2.5 Million for Total $7 Million Private Placement
|
|
| 08:30 ET |
Gamera Bioscience Raises Additonal $2.5 Million for Total $7 Million Private Placement
|
|
May 11, 98
|
| 08:59 ET |
International Isotopes Inc Receives Regulatory Approval to Initiate Operation of Accelerator
|
|
| 08:31 ET |
Biolink Corporation Initiates Dialock(TM) Pivotal Trial
|
|
| 08:29 ET |
Phytera and Galileo Sign Research, Development and Marketing Agreement
|
|
May 08, 98
|
| 08:30 ET |
BioTransplant Reports First Quarter 1998 Results
|
|
| 08:30 ET |
BioTransplant Reports First Quarter 1998 Results
|
|
| 08:29 ET |
Triangle Pharmaceuticals, Inc. Reports Financial Results for First Quarter 1998
|
|
| 08:29 ET |
Triangle Pharmaceuticals, Inc. Reports Financial Results for First Quarter 1998
|
|
May 07, 98
|
| 08:29 ET |
SEQUUS Pharmaceuticals Signs Marketing Agreement for AMPHOTEC(R) in Southeast Asia and Australia with Faulding Pharmaceuticals
|
|
| 08:29 ET |
SEQUUS Pharmaceuticals Signs Marketing Agreement for AMPHOTEC(R) in Southeast Asia and Australia with Faulding Pharmaceuticals
|
|
| 08:29 ET |
Virus Research Institute, Inc. Reports First Quarter Results
|
|
| 08:00 ET |
Cubist and Merck Expand Drug Discovery and Development Collaboration
|
|
May 06, 98
|
| 08:29 ET |
Cubist Pharmaceuticals Reports First Quarter 1998 Results
|
|
| 08:29 ET |
Cubist Pharmaceuticals Reports First Quarter 1998 Results
|
|
| 08:27 ET |
Cambridge NeuroScience Appoints Harry W. Wilcox President and CEO; Company Focuses Resources on Three Programs
|
|
| 08:27 ET |
Cambridge NeuroScience Appoints Harry W. Wilcox President and CEO; Company Focuses Resources on Three Programs
|
|
May 05, 98
|
| 00:00 ET |
AutoImmune Inc. Initiates Colloral Phase III Trial and Reports First Quarter 1998 Results
|
|
May 04, 98
|
| 14:35 ET |
SafeScience To Begin Trading On Nasdaq
|
|
May 01, 98
|
| 09:10 ET |
MIGAL Will Be The First SafeScience Institute
|
|
Apr 30, 98
|
| 16:30 ET |
Matritech Reports First Quarter Results
|
|
| 13:00 ET |
Triangle Pharmaceuticals' James A. Klein, Jr. Named 1998 Financial Executive of the Year
|
|
| 08:30 ET |
Neose Technologies Reports First Quarter Financial Results
|
|
Apr 29, 98
|
| 08:59 ET |
Genetics Institute Launches New Order Online Product Ordering Site
|
|
Apr 28, 98
|
| 08:29 ET |
Aastrom Biosciences, Inc. Reports Third Quarter and Nine Months Ended March 31, 1998 Financial Results
|
|
| 08:29 ET |
Aastrom Biosciences, Inc. Reports Third Quarter and Nine Months Ended March 31, 1998 Financial Results
|
|
| 08:29 ET |
Animal Cloning Technology Applied to Parkinson's Disease
|
|
| 08:29 ET |
Animal Cloning Technology Applied to Parkinson's Disease
|
|
| 08:29 ET |
Mayo Licenses Pioneering Clinical Application of Pharmacogenomics to Variagenics, Inc.
|
|
| 08:29 ET |
Mayo Licenses Pioneering Clinical Application of Pharmacogenomics to Variagenics, Inc.
|
|
| 07:59 ET |
ImmunoGen Reports Third Quarter Financial Results
|
|
| 06:59 ET |
SEQUUS Pharmaceuticals, Inc. Reports First Quarter Operating Results
|
|
| 06:59 ET |
SEQUUS Pharmaceuticals, Inc. Reports First Quarter Operating Results
|
|
Apr 27, 98
|
| 15:55 ET |
International Isotopes Inc Expands Products For Cancer Therapy
|
|
| 15:55 ET |
International Isotopes Inc Expands Products For Cancer Therapy
|
|
| 09:45 ET |
Study Led By National Jewish Suggests Enhanced Therapeutic Index of Levalbuterol vs. Racemic Albuterol in Asthma Patients
|
|
| 08:29 ET |
Scriptgen Pharmaceuticals Relocates Corporate Headquarters to 85,000 Square Foot Facility in Waltham, Massachusetts
|
|
| 08:29 ET |
Scriptgen Pharmaceuticals Relocates Corporate Headquarters to 85,000 Square Foot Facility in Waltham, Massachusetts
|
|
| 06:45 ET |
GelTex Pharmaceuticals Reports First Quarter 1998 Results
|
|
Apr 24, 98
|
| 08:41 ET |
SafeScience and Dominion BioSciences Partner to Develop and Market Environmentally-Safe Pesticides
|
|
Apr 23, 98
|
| 17:33 ET |
ChiRex Reports Financial Results for First Quarter 1998
|
|
| 16:30 ET |
ChiRex Reports Financial Results for First Quarter 1998
|
|
| 08:35 ET |
Aastrom Biosciences, Inc. Announces Manufacturing Supply Agreement With SeaMED
|
|
Apr 22, 98
|
| 14:42 ET |
/C O R R E C T I O N -- Cambridge NeuroScience, Inc./
|
|
| 14:36 ET |
Cambridge NeuroScience Reports First Quarter 1998 Financial Results
|
|
| 09:24 ET |
Cambridge NeuroScience Reports First Quarter 1998 Financial Results
|
|
| 05:16 ET |
Evolution of a Texas Biomedical Company
|
|
Apr 21, 98
|
| 15:26 ET |
Alpha-Beta Technology Completes Interim Analysis for Phase II Trial of Betafectin(R) PGG-glucan in Inflammatory Bowel Disease Surgery
|
|
| 11:21 ET |
ArQule, Inc. and ACADIA Pharmaceuticals Announce Collaboration for Discovery and Development of Novel Drug Candidates
|
|
| 08:55 ET |
Cubist and Neurogen Announce Collaboration to Discover Antiinfectives Against Drug Resistant Microorganisms
|
|
| 08:30 ET |
Aksys, Ltd. Reports 1998 First Quarter Results
|
|
| 08:29 ET |
ProScript Appoints Dan R. Burns as President and CEO
|
|
| 08:29 ET |
Scriptgen Bolsters Management Team With Experienced Leadership From Big Pharma
|
|
Apr 20, 98
|
| 08:29 ET |
Matritech Reaches Agreement with Organon Teknika for Marketing NMP22(R) in Spain and Portugal
|
|
Apr 17, 98
|
| 15:08 ET |
VARIAGENICS Announces Appointment of Directors in Pharmacogenomics
|
|
| 12:44 ET |
Endogen and Third Wave Technologies Announce Product Data at Experimental Biology '98 Meeting
|
|
| 09:15 ET |
Charles A. LeMaistre, M.D. Joins Board of Directors of International Isotopes Inc.
|
|
Apr 16, 98
|
| 08:29 ET |
Triangle Pharmaceuticals, Inc. Raises Additional $7,875,000 Through Exercise of Over-Allotment Option
|
|
Apr 15, 98
|
| 17:08 ET |
Michael Rosenblatt, M.D., Harvard Medical School Professor and Former Senior VP for Research at Merck, Joins ArQule's Board of Directors
|
|
| 16:44 ET |
ArQule, Inc. Reports Financial Results for First Quarter 1998 Ended March 31, 1998
|
|
| 13:05 ET |
Neose Selects Recipients For Second Annual Glycoscience Research Award
|
|
Apr 14, 98
|
| 16:10 ET |
Aquila Biopharmaceuticals Acquires VacTex, Inc.
|
|
Apr 13, 98
|
| 08:44 ET |
Instrumentation Laboratory Launches GEM SensiCath and GEM OpticalCAM
|
|
Apr 09, 98
|
| 14:27 ET |
ArQule, Inc. Granted Two U.S. Patents
|
|
| 08:29 ET |
Triangle Pharmaceuticals, Inc. Announces a Public Offering of 3,500,000 Shares of Common Stock at $15.00 Per Share
|
|
Apr 08, 98
|
| 17:29 ET |
International Isotopes Inc. Convenes Science & Technology Advisory Board
|
|
Apr 07, 98
|
| 13:15 ET |
Endogen Enters into Product Supply and Licensing Agreements with Becton, Dickinson and Company
|
|
| 08:29 ET |
SEQUUS Names Michael W. Ramsay Vice President for Manufacturing Operations
|
|
Apr 06, 98
|
| 08:38 ET |
Chemicus Receives $250,000 in SBIR Funding to Enhance Scale-up Technology for Drug Discovery
|
|
Mar 26, 98
|
| 08:58 ET |
International Isotopes Inc. Purchases Additional Assets to Expand Production Capabilities
|
|
| 08:29 ET |
NetGenics Completes $17.7 Million Private Placement
|
|
Mar 24, 98
|
| 16:29 ET |
Instrumentation Laboratory Announces Fiscal 1997 Results
|
|
| 10:45 ET |
Briana Announces Appointment of New Board Member
|
|
| 08:59 ET |
John LaLonde Joins Aksys, Ltd. as Vice President of Research and Development
|
|
| 08:29 ET |
Endogen, Inc. Announces Third Quarter Financial Results for Fiscal 1998
|
|
Mar 23, 98
|
| 15:06 ET |
Cambridge NeuroScience Clarifies Dividend
|
|
| 10:59 ET |
CytoMed Enters Collaborative Research Agreement with UCB Pharma to Develop Anti-Inflammatory Therapeutics
|
|
Mar 20, 98
|
| 08:59 ET |
M. Scott Salka Appointed Chief Executive Officer of Ventana Genetics
|
|
Mar 19, 98
|
| 09:59 ET |
Massachusetts Biotechnology Council Elects New President and Expands Board of Directors
|
|
| 08:30 ET |
Matritech and Curtin Matheson Scientific/Fisher HealthCare Sign Distribution Agreement for Bladder Cancer Test
|
|
| 06:59 ET |
GelTex Pharmaceuticals Announces Public Offering of 3,000,000 Shares of Common Stock at $27.00 Per Share
|
|
Mar 17, 98
|
| 08:29 ET |
Peptimmune and Peptide Therapeutics Group Enter Collaborative Agreement to Develop Cathepsin S inhibitors to Treat Asthma, Autoimmune Diseases
|
|
Mar 16, 98
|
| 08:59 ET |
SunPharm Reports 1997 Financial Results
|
|
Mar 13, 98
|
| 17:02 ET |
ChiRex Reports Financial Results for Fourth-Quarter and Year-End 1997
|
|
Mar 12, 98
|
| 08:30 ET |
Dyax Corp. and SangStat Medical Corp. Sign a Research and License Agreement
|
|
Mar 11, 98
|
| 07:45 ET |
GelTex Appoints Senior Vice President of Research & Development and Vice President of Regulatory Affairs
|
|
Mar 10, 98
|
| 09:47 ET |
Eurona Medical AB Appoints Tommy Lewander, Ph.D., Vice President, Research and Development
|
|
| 09:01 ET |
Triangle Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year Ended December 31, 1997
|
|
| 08:59 ET |
Triangle Pharmaceuticals Files Registration Statement for Public Offering of Common Stock
|
|
Mar 09, 98
|
| 17:15 ET |
Cambridge NeuroScience Reports Preliminary Analysis of CERESTAT(R) Phase III Data; Potential Benefit in Stroke Sub-Population to be Assessed
|
|
| 08:30 ET |
Cubist Anti-infective Daptomycin Shows Activity Against Emerging Strains of Drug Resistant Staphylococcus Aureus
|
|
Mar 06, 98
|
| 13:32 ET |
Scriptgen Expands Research Facilities
|
|
| 06:00 ET |
Alpha-Beta Technology, Inc. Reports 1997 Fourth Quarter and Year End Results
|
|
Mar 05, 98
|
| 08:59 ET |
IL Subsidiary Chromogenix AB Enters Discussions to Transfer Business Operations
|
|
Mar 04, 98
|
| 10:21 ET |
BioChem Pharma Executive Vice President, R&D, Elected Chairman of the Board of Briana Bio-Tech Inc.
|
|
| 10:17 ET |
International Isotopes Inc. Expands Facility for Contract Manufacturing of Finished Radiopharmaceuticals
|
|
Mar 03, 98
|
| 09:08 ET |
Instrumentation Laboratory Board of Directors Sets Annual Shareholder Meeting to Approve Rights Offering
|
|
| 05:00 ET |
LeukoSite Names Dr. Timothy Springer and Dr. Yasunori Kaneko to Board of Directors
|
|
Mar 02, 98
|
| 08:30 ET |
ArQule, Inc. and Sepracor Inc. Advance Drug Discovery Collaboration to Optimize Lead Compounds for Anti-Virals
|
|
Feb 27, 98
|
| 21:03 ET |
Triangle Pharmaceuticals Issues Clarification
|
|
| 11:15 ET |
Scriptgen Withdraws Initial Public Offering
|
|
| 09:00 ET |
Triangle Pharmaceuticals Signs Agreement to License L-FMAU From Bukwang Pharmaceuticals
|
|
Feb 26, 98
|
| 15:03 ET |
Physiometrix's Equinox EEG System Featured in Conjunction With Cabletron's RoamAbout LAN Technology at HIMSS
|
|
| 08:29 ET |
K. Shan Padda Joins Aksys' Board of Directors
|
|
Feb 25, 98
|
| 14:41 ET |
Matritech Researchers Present Comparative Data on NuMA Colon Cancer Test at the Joint American Association of Cancer Research, Japan Cancer Association
|
|
| 08:31 ET |
Cambridge NeuroScience Reports Fourth Quarter and Year-End 1997 Financial Results
|
|
| 05:00 ET |
LeukoSite Reports Year-End 1997 Financial Results; Strategic Alliances and Financing Accelerate Drug Development Efforts
|
|
Feb 24, 98
|
| 08:29 ET |
AutoImmune Inc. To Conduct Colloral(R) Pivotal Trial
|
|
| 07:59 ET |
Neose Reports Fourth Quarter and 1997 Year End Financial Results
|
|
Feb 18, 98
|
| 17:10 ET |
Matritech Reports Fourth Quarter and Year End Results
|
|
| 16:30 ET |
ArQule, Inc. Reports Financial Results for Fourth Quarter and Year Ended December 31, 1997
|
|
| 08:59 ET |
CytoMed, Inc. Completes $17.1 Million in Private Financing
|
|
| 08:45 ET |
Cubist Signs Phase III Clinical Supply Contract for Daptomycin
|
|
| 08:31 ET |
The Medicines Company's NDA for Hirulog(R) Anticoagulant in Angioplasty Accepted as 'Filable' by FDA
|
|
| 08:29 ET |
Virus Research Institute, Inc. Reports Year End Results
|
|
Feb 17, 98
|
| 09:01 ET |
EcoScience Announces Record Revenues for the Second Quarter of Fiscal 1998
|
|
Feb 13, 98
|
| 08:29 ET |
BioTransplant Reports 1997 Fourth Quarter and Year End Results
|
|
Feb 12, 98
|
| 08:59 ET |
SEQUUS Pharmaceuticals, Inc. Appoints Robin D. Campbell, Ph.D. to Board of Directors
|
|
Feb 11, 98
|
| 09:15 ET |
New SafeScience Carbohydrate Compound Shows Strong Antibacterial Activity in Crops
|
|
| 09:00 ET |
Physiometrix Hires Daniel W. Muehl as Vice President and Chief Financial Officer
|
|
| 08:59 ET |
GelTex Pharmaceuticals Reports 1997 Fourth Quarter and Year End Results
|
|
| 08:59 ET |
SEQUUS Pharmaceuticals and Gensia Sicor Announce Marketing Agreement for Amphocil(TM) In Mexico
|
|
| 08:29 ET |
Aksys, Ltd. is Issued Ten New Patents on PHD(TM) Personal Hemodialysis System
|
|
Feb 10, 98
|
| 09:15 ET |
International Isotopes Expands Brachytherapy Program Through Collaboration With M.D. Anderson Cancer Institute
|
|
| 08:59 ET |
Acacia Biosciences Names Stewart Scherer, Ph.D. Vice President of Bioinformatics
|
|
| 08:59 ET |
L. Patrick Gage, Ph.D., President of Genetics Institute, Inc., Joins ArQule's Board of Directors
|
|
Feb 09, 98
|
| 08:59 ET |
Dyax Corp. Appoints Keith S. Ehrlich, C.P.A. as Senior Vice President, Finance and Administration and Chief Financial Officer
|
|
| 08:29 ET |
Virus Research Institute to Collaborate with Heska to Develop Vaccines for Animal Health
|
|
Feb 05, 98
|
| 08:40 ET |
Variagenics, Inc. Receives U.S. Patent Covering Variagenic Targeting(TM), a Pharmacogenomic Method for Discovery of Novel Anti-Cancer Drugs
|
|
Feb 04, 98
|
| 18:28 ET |
ImmunoGen Reports Second Quarter Financial Results
|
|
Feb 03, 98
|
| 09:09 ET |
Cubist Pharmaceuticals Reports 1997 Results
|
|
| 08:37 ET |
Instrumentation Laboratory Announces Multi-Year Supply Contract With Premier
|
|
| 07:59 ET |
Cubist Pharmaceuticals Reports 1997 Results
|
|
| 07:59 ET |
Leading Urology Centers Report Advantages of Matritech NMP22(R) Bladder Cancer Test
|
|
Feb 02, 98
|
| 14:35 ET |
Pharmadigm, Inc. Names Andrew T. Chiu as Director of Pharmacology
|
|
| 08:59 ET |
Pharmadigm, Inc. Names Andrew T. Chiu as Director of Pharmacology
|
|
| 07:00 ET |
ArQule, Inc. Granted U.S. Patent for Fundamental Approach to Designing and Manufacturing Arrays of Chemical Compounds
|
|
Jan 29, 98
|
| 16:29 ET |
GelTex Pharmaceuticals Files Registration Statement with SEC for Public Offering of 2,500,000 Shares of Common Stock
|
|
Jan 28, 98
|
| 10:15 ET |
Eurona Medical AB Raises $8.0 Million in Private Financing to Advance Pharmacogenomic Programs
|
|
| 08:29 ET |
Dyax Corp. Establishes Research Collaboration with Genetics Institute to Discover Novel Purification Tools
|
|
Jan 27, 98
|
| 08:59 ET |
ArQule, Inc. and CuraGen Corporation Enter Drug Discovery Collaboration
|
|
| 08:59 ET |
BioMarin Raises $10 Million in Private Financings
|
|
| 08:27 ET |
Aastrom Biosciences, Inc. Reports Second Quarter and Six Months Ended December 31, 1997 Financial Results
|
|
Jan 26, 98
|
| 10:58 ET |
Afferon Begins Phase II Trial of Resiniferatoxin (RTX) for the Treatment of Urge Incontinence
|
|
| 08:59 ET |
International Isotopes Signs Contract To Supply Brachytherapy Radioisotope Seeds For Cancer Therapy
|
|
| 08:29 ET |
Triangle Pharmaceuticals Reports Data on Initial Results of FTC Phase I/II Trial
|
|
| 07:59 ET |
Matritech Receives U.S. Patent Allowance For Nuclear Matrix Protein Based Testing For Breast Cancer
|
|
Jan 22, 98
|
| 16:35 ET |
Instrumentation Laboratory Announces Rights Offering of $22 Million; Senior Notes to be Repaid
|
|
| 09:59 ET |
Michael Morse Named Director, Finance and Administration of Peptimmune, Inc.
|
|
| 08:29 ET |
Aksys, Ltd. Reports Financial Results for the Year and Fourth Quarter Ended December 31, 1997
|
|
Jan 21, 98
|
| 13:38 ET |
International Isotopes Elects Science and Technology Advisory Board
|
|
| 08:17 ET |
Aquila Hires James L. Warren as CFO
|
|
Jan 20, 98
|
| 15:36 ET |
ChiRex Appoints Beth Hecht As General Counsel
|
|
| 13:45 ET |
Cleveland Clinic Studies Drug That May Reduce Inflammation and Improve Healing After Post-Mastectomy Reconstructive Surgery
|
|
| 11:59 ET |
University of Massachusetts Researchers Announce Birth of Genetically Modified Cloned Calves
|
|
| 11:24 ET |
Myriad Genetics, Inc. Files Suit Against OncorMed, Inc.
|
|
| 08:44 ET |
Aquila Initiates Phase II Clinical Trial of Quilimmune-P(TM), Company's Lead Human Product
|
|
| 08:29 ET |
American Cyanamid and Acacia Biosciences Enter Into Profiling Agreement
|
|
| 08:29 ET |
BioMarin Initiates Definitive Trials of Lead Enzyme Replacement Product for Crippling, Fatal Genetic Disease
|
|
| 08:29 ET |
Matritech Awarded SBIR Grant for Development of Cancer Tests
|
|
| 08:14 ET |
Matritech Awarded SBIR Grant for Development of Cancer Tests
|
|
| 08:10 ET |
Myriad Genetics Launches CardiaRisk(TM) Test for Risk of Cardiovascular Disease in Hypertensive Patients
|
|
| 08:05 ET |
Myriad Genetics Awarded Two Additional BRCA1 Patents
|
|
| 07:59 ET |
Myriad Genetics Announces Three New Gene Discoveries
|
|
Jan 16, 98
|
| 08:59 ET |
IGG International Changes Corporate Name to SafeScience, Inc.
|
|
Jan 15, 98
|
| 09:59 ET |
Reprogenesis Presents Novel Tissue Augmentation Technology at Hambrecht & Quist Annual Health Care Conference
|
|
| 08:29 ET |
Pentose Pharmaceuticals Appoints Martin D. Williams as Vice President, Business Development, Sales & Marketing
|
|
Jan 14, 98
|
| 12:00 ET |
AutoImmune Inc. Presents at Hambrecht & Quist 17th Annual Healthcare Conference
|
|
| 08:02 ET |
New Agreement to Find Cancer Vaccines
|
|
Jan 13, 98
|
| 08:30 ET |
LeukoSite and Warner-Lambert Extend Drug Discovery Collaboration
|
|
Jan 12, 98
|
| 19:02 ET |
ChiRex Reports Preliminary Unaudited Financial Results For Fourth Quarter and Year End 1997
|
|
| 10:59 ET |
Virus Research Institute Licenses Therapore(TM) for Delivery of Immunotherapeutics for Chronic Viral Infections and Cancers
|
|
| 10:25 ET |
ArQule, Inc. Names Former F. Hoffmann-La Roche Head of Global Drug Development as New CEO
|
|
| 09:22 ET |
ArQule, Inc. Names Former F. Hoffmann-La Roche Head of Global Drug Development as New CEO
|
|
| 07:40 ET |
Abbott Laboratories Extends Drug Discovery Agreement with ArQule, Inc.
|
|
| 07:29 ET |
ArQule Advances Product Discovery Collaborations With Major Corporate Collaborators
|
|
Jan 09, 98
|
| 07:59 ET |
Cubist Awarded Two Grants From The National Institutes of Health
|
|
Jan 08, 98
|
| 17:50 ET |
Joseph Grimm Joins Alpha-Beta Technology as CFO
|
|
| 08:29 ET |
NetGenics and Gene Codes Sign Agreement to Add Sequencher(TM) to SYNERGY(TM) Framework
|
|
Jan 07, 98
|
| 17:13 ET |
Alpha-Beta's MycoTox Subsidiary Achieves First Milestone for Anti-Fungal Program
|
|
| 08:59 ET |
IGG International, Inc. Secures Foreign Distribution Agreements for SafeScience(TM) Agricultural Products
|
|
| 07:59 ET |
Aksys, Ltd. Announces Strategic Alliance
|
|
Jan 06, 98
|
| 11:18 ET |
ArQule, Inc. Granted U.S. Patent for Aminimide Biological Mimetic
|
|
| 08:59 ET |
Physiometrix Names Tibor L. Foldvari, Ph.D. Senior Vice President of Research, Development and Clinical Affairs
|
|
| 08:29 ET |
Pentose Pharmaceuticals Closes $7 Million Private Financing
|
|
| 08:00 ET |
Cambridge NeuroScience Reports Positive Results From Pain Study
|
|
Jan 05, 98
|
| 16:23 ET |
GelTex Pharmaceuticals' NDA for RenaGel(R) Non-Absorbed Phosphate Binder Accepted as 'Filable' by FDA
|
|
| 14:40 ET |
Endogen, Inc. Announces Second Quarter Financial Results for Fiscal 1998
|
|
Jan 04, 98
|
| 15:40 ET |
Instrumentation Laboratory Secures Primary Supplier Agreement with MAGNET
|
|
Dec 23, 97
|
| 08:29 ET |
Peptimmune Collaborators at Harvard Demonstrate Linked Peptide Antigens Can 'Superactivate' Immune Response; PNAS Reports
|
|
Dec 22, 97
|
| 08:29 ET |
Triangle Pharmaceuticals Announces the Re-Initiation of Trials with DMP-450
|
|
Dec 18, 97
|
| 12:09 ET |
International Isotopes Enters into Contract for Early Development of I-125 Brachytherapy Seeds
|
|
| 10:59 ET |
RTP Pharma Inc. Postpones Initial Public Offering in Canada
|
|
| 08:30 ET |
GelTex Pharmaceuticals Begins Phase III Clinical Program for CholestaGel(R) Non-absorbed Cholesterol Reducer
|
|
| 07:30 ET |
LeukoSite And Genentech Enter Collaboration For Inflammatory Bowel Disease Therapy
|
|
Dec 17, 97
|
| 16:29 ET |
ArQule, Inc. and Ontogeny, Inc. Announce Collaboration for Discovery of Novel Therapeutics
|
|
| 11:02 ET |
Nabi Appoints Tanina Frouge as Director, Investor Relations
|
|
| 08:29 ET |
Cubist Hires Frederick B. Oleson as Vice President, Drug Development
|
|
Dec 16, 97
|
| 07:59 ET |
Cambridge NeuroScience Will Not Restart Accrual in Stroke Trial
|
|
Dec 15, 97
|
| 08:29 ET |
ArQule Gains License for the Synthesis of alpha-Amino Acids from the University of Southern California
|
|
| 08:04 ET |
Pentose Pharmaceuticals to Receive First U.S. and European Patents for PAPIRINE(TM) Technology to Treat Viral Infections
|
|
Dec 12, 97
|
| 15:34 ET |
BioSym '97 Highlights Expanding Role of Hollow Fiber Bioreactor Technology in Cell Culture
|
|
Dec 11, 97
|
| 08:29 ET |
ImmunoGen Announces Completion of Private Placement
|
|
| 08:29 ET |
Virus Research Institute Announces Rotavirus Vaccine Collaboration with SmithKline Beecham
|
|
Dec 09, 97
|
| 07:29 ET |
Myriad Genetics Announces Patent on Gene Finding Technology
|
|
Dec 05, 97
|
| 08:29 ET |
ImmunoGen's C242-DM1 Tumor-Activated Prodrug Demonstrates Safety in Preclinical Studies
|
|
Dec 04, 97
|
| 09:01 ET |
Aastrom Biosciences' Stem Cell Production Process Reduces Breast Tumor Contamination
|
|
| 08:29 ET |
Abbott Laboratories Chooses NetGenics' SYNERGY to Manage Genomics Data for Drug Discovery
|
|
Dec 03, 97
|
| 08:29 ET |
Neose Technologies Initiates Phase I Study of NE-1530 for Pediatric Ear Infections
|
|
| 08:00 ET |
Ventana Genetics Raises $6 Million in Private Financing From Warburg, Pincus Ventures, L.P.
|
|
| 07:59 ET |
Matritech Announces Completion of Preclinical Trial for New Cervical Cancer Test
|
|
Dec 02, 97
|
| 11:39 ET |
International Isotopes Appoints Wes Dunn as Director of Environmental Health and Safety and Chief Radiation Officer
|
|
| 09:15 ET |
Myriad Genetics, Inc. Files Suit Against OncorMed, Inc.
|
|
| 08:59 ET |
Myriad Genetics Awarded U.S. Patent on BRCA1 Gene Mutations
|
|
| 08:29 ET |
Peptimmune Acquires Option to HIV Therapeutic Vaccine Technology From Massachusetts General Hospital
|
|
Dec 01, 97
|
| 13:15 ET |
Instrumentation Laboratory Announces Fiscal 1997 Third Quarter Results
|
|
| 08:59 ET |
Acacia Biosciences Receives SBIR Grant to Develop Response Profiles of Human Therapeutics
|
|
Nov 26, 97
|
| 08:59 ET |
Aastrom Biosciences, Inc. Announces Public Offering of Preferred Stock
|
|
Nov 24, 97
|
| 09:09 ET |
International Isotopes Signs Letter of Intent to Supply Radioisotope Seeds to Imagyn Medical Technologies
|
|
| 08:59 ET |
Aastrom Biosciences Appoints Bruce W. Husel as Vice President Quality Systems
|
|
| 08:30 ET |
Dr. David W. Barry Elected as Chairman of the Inter-Company Collaboration for AIDS Drug Development
|
|
| 07:59 ET |
Neose Technologies and Johnson & Johnson Subsidiary Collaborate to Develop Complex Carbohydrates
|
|
Nov 20, 97
|
| 13:15 ET |
EcoScience Announces Intent to Merge with Agro Power Development
|
|
| 08:59 ET |
Aastrom Biosciences Receives U.S. Patent Covering Culture Chamber for Producing Human Cells
|
|
| 07:59 ET |
Myriad Genetics, Inc. and Bayer Corporation Expand Alliance to Develop Dementia and Depression Therapies with New ProNet(TM) Technology
|
|
Nov 19, 97
|
| 08:30 ET |
ImmunoGen Reports First Quarter Financial Results
|
|
| 08:29 ET |
ArQule Elects Four New Members to its Scientific Advisory Board
|
|
Nov 18, 97
|
| 16:29 ET |
Alpha-Beta Technology, Inc. Reports Third Quarter 1997 Results
|
|
Nov 17, 97
|
| 15:01 ET |
/C O R R E C T I O N -- Myriad Ultrasound Systems Ltd./
|
|
| 14:56 ET |
FDA Panel Recommends Approval of Myriad Ultrasound Systems' Clinical Bone Sonometer
|
|
| 14:52 ET |
FDA Panel Recommends Approval of Myriad Ultrasound Systems' Clinical Bone Sonometer
|
|
| 14:29 ET |
FDA Panel Recommends Approval of Myriad Ultrasound Systems' Clinical Bone Sonometer
|
|
| 08:29 ET |
Sankyo Company, Ltd. and ArQule, Inc. Execute a Broad Three Year Collaboration for the Discovery of Novel Pharmaceuticals
|
|
Nov 14, 97
|
| 11:00 ET |
EcoScience Announces Results for the First Quarter of Fiscal 1998
|
|
| 08:29 ET |
International Isotopes Purchases 92,000 Sq. Ft. Facility for Contract Manufacturing and Reports Results for Third Quarter 1997
|
|
| 08:29 ET |
LeukoSite Reports Third Quarter 1997 Financial Results
|
|
| 08:29 ET |
Virus Research Institute, Inc. Reports 1997 Third Quarter Results
|
|
Nov 13, 97
|
| 10:54 ET |
Myriad to Launch First Genetic Test for High Blood Pressure
|
|
| 08:29 ET |
Cambridge NeuroScience Reports Third Quarter 1997 Financial Results
|
|
| 08:29 ET |
Triangle Pharmaceuticals Provides Product Update and Reports Third Quarter 1997 Results
|
|
Nov 12, 97
|
| 16:23 ET |
Virus Research Institute Announces Preliminary Phase II Adjumer(TM) Flu Vaccine Results
|
|
Nov 11, 97
|
| 08:29 ET |
Dyax Corp. Names Shirish Hirani Vice President of Program Management, Research Division
|
|
| 08:29 ET |
MetaMorphix Collaborators at Johns Hopkins Demonstrate GDF-8's Potent Role in Regulating Muscle Growth in Cattle
|
|
Nov 10, 97
|
| 12:30 ET |
Massachusetts Biotechnology Council Applauds Congressional Passage of Prescription Drug User Fee Act
|
|
| 08:29 ET |
LeukoSite, Warner-Lambert, and Kyowa Hakko Form Chemokine Drug Discovery Alliance
|
|
| 08:25 ET |
Matritech Reports Third Quarter Results
|
|
| 05:59 ET |
Cubist Acquires Worldwide Rights to Develop Daptomycin To Treat Bacterial Infections
|
|
Nov 07, 97
|
| 11:15 ET |
BioTransplant Reports Financial Results for the Third Quarter 1997
|
|
| 08:29 ET |
Richard B. Egen Joins Aksys' Board of Directors
|
|
Nov 06, 97
|
| 14:12 ET |
Instrumentation Laboratory Announces Partnership With International Technidyne
|
|
| 08:53 ET |
IGG International is Granted EPA Approval to Market ELEXA as a Plant Defense Booster
|
|
| 08:29 ET |
ArQule, Inc. and ViroPharma Incorporated Announce Collaboration for Discovery and Development of Novel Therapeutics
|
|
| 08:29 ET |
Zola P. Horovitz Joins NitroMed Board of Directors
|
|
| 07:54 ET |
Myriad Genetics, Inc. Reports Results for First Quarter of Fiscal 1998
|
|
Nov 05, 97
|
| 09:01 ET |
Dyax Corp. to Receive Fourth U.S. Patent for Phage Display
|
|
| 08:59 ET |
RTP Pharma Inc. Files Preliminary Prospectus for Initial Public Offering in Canada
|
|
Nov 04, 97
|
| 08:35 ET |
Alpha-Beta Agrees with FDA on Confirmatory Phase III Trial of Betafectin(R) PGG-glucan in Non-Colorectal G-I Surgery Patients
|
|
| 08:29 ET |
Cambridge NeuroScience Receives Drug Delivery Device Patent for Sustained, Controlled Release of Large Molecules
|
|
| 08:14 ET |
AutoImmune Inc. Provides Product Update And Reports Third Quarter 1997 Results
|
|
| 07:29 ET |
Myriad Genetics Forms Collaboration with Valley Mental Health on Central Nervous System Disorders
|
|
Nov 03, 97
|
| 15:59 ET |
GelTex Pharmaceuticals Submits NDA for RenaGel(R) Non-Absorbed Phosphate Binder
|
|
| 07:29 ET |
Cubist Pharmaceuticals Reports Third-Quarter Results
|
|
Oct 31, 97
|
| 08:29 ET |
ChiRex Completes Purchase of Glaxo Wellcome Manufacturing Facility at Annan, Scotland
|
|
Oct 30, 97
|
| 08:29 ET |
Nabi Reports Third Quarter 1997 Financial Results
|
|
Oct 28, 97
|
| 09:29 ET |
National 'Foot Care Aware' Program Screening Thousands to Reduce Rate of Lower Limb Amputations
|
|
| 08:59 ET |
RTP Pharma Inc. Receives Broad Patent for use of a Novel Peptide in Gastrointestinal Medical Procedures
|
|
Oct 27, 97
|
| 11:10 ET |
GelTex Pharmaceuticals Reports Third Quarter 1997 Results
|
|
Oct 23, 97
|
| 16:08 ET |
Nabi Signs Manufacturing Agreement with Cangene Corporation for New Formulation of H-BIG
|
|
| 16:04 ET |
Dyax Corp. Signs Collaborative Study Agreement with Merck & Co.
|
|
| 11:09 ET |
Neose Technologies Reports Third Quarter Financial Results
|
|
Oct 22, 97
|
| 11:43 ET |
IGG International Acquires Portfolio of Agricultural Products from Leket-Bar Ltd.
|
|
| 09:29 ET |
Dyax Corp. Establishes New Drug Discovery Collaboration
|
|
| 08:29 ET |
Keith T. Coleman Joins NetGenics as Chief Financial Officer
|
|
Oct 21, 97
|
| 08:29 ET |
Cambridge NeuroScience Initiates Second Phase I Study of CNS 5161 and Announces Successful Completion of First Phase I Trial
|
|
| 08:03 ET |
Physiometrix Reports Third Quarter and Nine Month Financial Results for Fiscal 1997
|
|
| 06:59 ET |
Aksys, Ltd. Reports Financial Results for the Third Quarter Ended September 30, 1997
|
|
Oct 20, 97
|
| 06:59 ET |
Cubist Hires Vice President, Drug Discovery From Hoffman-LaRoche; Elects Dr. David Martin, Jr. to Board of Directors and Promotes Dr. Francis Tally
|
|
Oct 17, 97
|
| 10:59 ET |
Sano Provides Update on Clinical Trial Programs for its Lead Products
|
|
| 07:59 ET |
Physiometrix Awarded Supply Agreement With Joint Purchasing Corporation Of New York
|
|
Oct 16, 97
|
| 16:29 ET |
RTP Pharma Inc. to Form an Alliance with Elan Corporation to Develop Improved Cyclosporine Products
|
|
| 13:00 ET |
New Topical Antifungal Combination Therapy Provides Cure of Tinea Pedis With Only One Week of Treatment
|
|
| 07:59 ET |
Matritech Submits 510(K) Premarket Notification To FDA For Clearance of Blood Based Colon Cancer Test
|
|
Oct 15, 97
|
| 17:43 ET |
ArQule, Inc. Reports Financial Results for the Third Quarter and Nine Month Period Ended September 30, 1997
|
|
| 16:01 ET |
Chirex Reports $0.14 EPS and 28% Increase in Core Sales for Third Quarter 1997
|
|
| 11:10 ET |
International Isotopes' Expertise Complemented by Several Strategic Alliances
|
|
Oct 14, 97
|
| 14:49 ET |
Myriad Genetics Publishes Breast Cancer Gene Test Criteria
|
|
| 08:58 ET |
Point Therapeutics Raises $2.8 Million in Initial Financing
|
|
Oct 10, 97
|
| 17:42 ET |
Briana Bio-Tech Share Consolidation Effective October 15, 1997
|
|
| 09:24 ET |
Myriad Arranges Undervalued Share Transaction
|
|
Oct 09, 97
|
| 09:44 ET |
Briana Licenses Multiple Sclerosis Technology
|
|
| 08:33 ET |
Physiometrix Announces Positive Results from Retrospective Study and Provides Product Development Update for Patient State Analyzer
|
|
| 08:29 ET |
ArQule, Inc. and RiboGene, Inc. Announce Collaboration for Discovery and Development of Novel Drug Candidates
|
|
Oct 08, 97
|
| 17:51 ET |
Aastrom Biosciences Announces Filing for Offering of Common Stock
|
|
| 16:15 ET |
Alpha-Beta's MycoTox Subsidiary Awarded Four SBIR Grants to Fund Anti-Fungal Drug Discovery Program
|
|
| 09:59 ET |
Dyax Corp. and CropTech Receive $4.3 Million Grant From NIST
|
|
| 08:34 ET |
Cubist and Merck Expand Collaboration in Novel Antibiotic Drug Discovery and Development
|
|
| 08:29 ET |
Cambridge NeuroScience Awarded Phase I SBIR Grant for Development of Novel Agents to Reverse Nerve Damage
|
|
| 07:58 ET |
Cubist and Merck Expand Collaboration in Novel Antibiotic Drug Discovery and Development
|
|
Oct 07, 97
|
| 11:14 ET |
Hirulog Restores Heart Vessel Blood Flow More Effectively Than Heparin in Heart Attack Patients -- Report Published in Circulation
|
|
| 08:40 ET |
Aastrom Biosciences Awarded Two NIH Grants for Umbilical Cord Blood Transplants and AIDS Gene Therapy
|
|
| 08:29 ET |
BioTransplant and Novartis Sign Agreement to Expand Xenotransplantation Collaboration
|
|
Oct 06, 97
|
| 07:31 ET |
Scientists at Myriad Genetics Advance Research on MMAC1 Cancer Gene Toward Drug Development
|
|
Oct 03, 97
|
| 14:29 ET |
Briana Bio-Tech Announces Share Consolidation
|
|
| 11:56 ET |
/C O R R E C T I O N -- International Isotopes Inc./
|
|
Oct 02, 97
|
| 12:30 ET |
International Isotopes Reports Financial Results for Second Quarter and Six Months Ended June 30, 1997
|
|
Oct 01, 97
|
| 13:12 ET |
Briana Closes Third Portion of Special Warrants Financing
|
|
| 09:29 ET |
FHS' Fourth Generation Medical Management System to Include Purkinje's Computerized Patient Records
|
|
| 09:14 ET |
Endogen, Inc. Announces First Quarter Financial Results for Fiscal 1998
|
|
| 07:59 ET |
Cubist and Novalon Extend Research Collaboration for Antiinfective Drug Discovery
|
|
| 06:59 ET |
Myriad Genetics Discovers Tumor Suppressor Role of Gene in Colon, Breast and Other Major Cancers
|
|
Sep 30, 97
|
| 11:59 ET |
International Isotopes Raises Additional Funds Through Exercise of Over-Allotment Option
|
|
Sep 29, 97
|
| 08:29 ET |
Triangle Pharmaceuticals Reports Data on Increased Dosages of MKC-442 in HIV-Infected Patients
|
|
Sep 26, 97
|
| 08:59 ET |
Mitotix, Inc. Appoints Arthur F. Kluge, Ph.D. Vice President, Drug Discovery And Muzammil M. Mansuri, Ph.D. To Executive Vice President, Research
|
|
| 08:29 ET |
Aksys, Ltd. Is Issued Six New Patents On PHD(TM) Personal Hemodialysis System
|
|
Sep 25, 97
|
| 11:59 ET |
ArQule, Inc. Receives U.S. Patent for Methods for Polymer Design
|
|
| 09:29 ET |
Dyax Corp. Issued U.S. Patent Covering Novel Elastase Inhibitors
|
|
Sep 24, 97
|
| 16:15 ET |
CholestaGel(R) and Lovastatin in Low Dose Combination Provide Enhanced Cholesterol-Lowering Activity, GelTex Phase II Study Finds
|
|
| 07:55 ET |
Aastrom To Initiate Clinical Trials Of Umbilical Cord Blood Transplants In Adult And Pediatric Cancer Patients
|
|
Sep 22, 97
|
| 11:51 ET |
Variagenics, Inc. Secures Fundamental Genetic Variance Screening Technologies for Pharmacogenetics through Acquisition of Avitech Diagnostics, Inc.
|
|
Sep 19, 97
|
| 16:59 ET |
Neose Technologies, Inc. Adopts Shareholder Rights Plan
|
|
| 09:35 ET |
Alpha-Beta Technology, Inc. Cuts Work Force to Reduce Expenses and Focus on Betafectin(R) PGG-glucan Clinical Development
|
|
Sep 18, 97
|
| 12:59 ET |
ArQule Appoints Robert F. Tilton, Jr., Ph.D. as Vice President for Chemical Design, Informatics and Discovery Technologies
|
|
| 10:29 ET |
Nabi Launches New WinRho SDF
|
|
Sep 17, 97
|
| 08:29 ET |
Blair M. Flicker to Join NitroMed Board of Directors
|
|
Sep 16, 97
|
| 09:59 ET |
Inflazyme and Aquasearch Enter Into 10 Year Drug Discovery And Manufacturing Agreement
|
|
| 08:29 ET |
EcoScience Announces First Annual Profit For Fiscal 1997
|
|
| 08:28 ET |
Cambridge NeuroScience Discontinues Traumatic Brain Injury Trial
|
|
Sep 12, 97
|
| 08:58 ET |
International Isotopes Receives Commendation From State of Texas and City of Denton
|
|
Sep 11, 97
|
| 11:49 ET |
MGH and BioTransplant Announce Key Advances in Xenotransplantation Research
|
|
Sep 10, 97
|
| 12:02 ET |
Linda Jenckes, Formerly of U.S. Department of Health and Human Services, Joins Nabi's Board of Directors
|
|
| 09:02 ET |
Dyax Corp. Licenses Fundamental Discovery Technology from MIT
|
|
| 08:58 ET |
Massachusetts Biotechnology Council Appoints Michael J. Malinowski as Manager, Government Relations and External Communications
|
|
| 08:29 ET |
Apoptogen Inc. Raises C$8 Million in Private Financing
|
|
Sep 08, 97
|
| 09:09 ET |
Briana Closes Second Portion Of Special Warrants Financing
|
|
Sep 05, 97
|
| 08:44 ET |
Aastrom Biosciences, Inc. Reports Fourth Quarter and Fiscal 1997 Financial Results
|
|
Sep 04, 97
|
| 15:59 ET |
Cambridge NeuroScience Initiates Phase I Study of CNS 5161 In Healthy Volunteers
|
|
| 15:59 ET |
Endogen Enters into Product Development and Marketing Agreement with Third Wave Technologies
|
|
| 10:44 ET |
Inflazyme Signs Agreement With Inveresk Research (North America) To Manage Pre-IND and IND Programs for its Lead Anti-Asthma Drug, Apanol(TM)
|
|
Sep 03, 97
|
| 08:59 ET |
RTP Pharma Inc. Licenses Improved Formulation of Propofol Anesthetic to AMRAD
|
|
| 08:14 ET |
AutoImmune Inc. Announces Future Direction of Company
|
|
Sep 02, 97
|
| 08:31 ET |
Novel Cell Survival Protein Provides Neuroprotection in Model of Stroke; Report Published in Nature Medicine
|
|
Aug 29, 97
|
| 08:29 ET |
Triangle Pharmaceuticals Completes Acquisition of Avid Corp.
|
|
Aug 28, 97
|
| 08:59 ET |
ArQule, Inc. and GenQuest, Inc. Announce Collaboration for Discovery and Development of Novel Drug Candidates
|
|
Aug 27, 97
|
| 08:29 ET |
GelTex Announces Four Senior Management Appointments
|
|
Aug 26, 97
|
| 11:50 ET |
ChiRex Appoints Eric Jacobsen, Ph.D., to Board of Directors
|
|
Aug 20, 97
|
| 08:29 ET |
Michael D. Loberg Named CEO of NitroMed, Inc.
|
|
Aug 18, 97
|
| 15:22 ET |
Instrumentation Laboratory Announces Fiscal 1997 Second Quarter Results
|
|
| 15:15 ET |
Instrumentation Laboratory Announces Fiscal 1997 Second Quarter Results
|
|
| 15:06 ET |
Instrumentation Laboratory Announces Fiscal 1997 Second Quarter Results
|
|
Aug 15, 97
|
| 08:31 ET |
International Isotopes Inc. Prices Its Initial Public Offering of 2,200,000 Shares of Common Stock at $9.00 per Share
|
|
| 07:02 ET |
Myriad Genetics, Inc. Reports Year End Results
|
|
Aug 14, 97
|
| 16:14 ET |
Alpha-Beta Technology, Inc. Reports Second Quarter 1997 Results
|
|
Aug 12, 97
|
| 08:29 ET |
Triangle Pharmaceuticals, Inc. Reports Financial Results for Second Quarter 1997
|
|
Aug 11, 97
|
| 13:21 ET |
Briana Acquires New Breast Cancer Detection System First Major Step in Developing Oncology Product Portfolio
|
|
| 08:29 ET |
Eli Lilly & Co. and Acacia Biosciences Enter Into Research Collaboration
|
|
Aug 06, 97
|
| 16:29 ET |
Nabi Reports Second Quarter 1997 Financial Results
|
|
| 08:29 ET |
BioTransplant Incorporated Reports Financial Results for the Second Fiscal Quarter Ended June 30, 1997
|
|
Aug 05, 97
|
| 11:05 ET |
Nabi Begins Phase II Clinical Trials of H-BIG(R) 5% I.V. Formulation in Liver Transplant Patients
|
|
Aug 04, 97
|
| 14:32 ET |
Nabi Adopts Preferred Stock Purchase Rights Plan
|
|
| 08:30 ET |
AutoImmune Inc. Reports Additional Clinical Data and Second Quarter 1997 Results
|
|
| 07:59 ET |
Virus Research Institute, Inc. Reports 1997 Second Quarter Results
|
|
| 07:32 ET |
Alpha-Beta Announces Preliminary Analysis of Betafectin(R) Phase III Clinical Trial
|
|
Jul 31, 97
|
| 08:59 ET |
Dyax Appoints Two Executives to its Separations Division
|
|
| 08:58 ET |
Francis P. Tally, M.D., Appointed to Therion Biologics Board of Directors
|
|
| 08:29 ET |
Endogen Reports 1997 Year End and Fourth Quarter Results
|
|
| 07:59 ET |
Cambridge NeuroScience Reports Second Quarter 1997 Financial Results
|
|
Jul 30, 97
|
| 08:29 ET |
Robert S. Cohen Joins NitroMed Board of Directors
|
|
Jul 29, 97
|
| 06:59 ET |
NeoTherapeutics Reports Memory Improvement of Alzheimer's Patients in Clinical Trial
|
|
Jul 28, 97
|
| 16:10 ET |
GelTex Pharmaceuticals Reports Second Quarter 1997 Results
|
|
| 08:59 ET |
Apex Bioscience Appoints Julius Krevans and John Zabriskie to Board of Directors
|
|
Jul 24, 97
|
| 15:43 ET |
Aronex Pharmaceuticals, Inc. Reports Second Quarter 1997 Results
|
|
| 08:59 ET |
Dyax Corp. Names Peter Sprague Vice President of Drug Discovery, Research Division
|
|
| 08:12 ET |
IGG International Reports Positive Results with Elexa(TM) SafeScience(TM) Fungicide in Two U.S. Field Studies on Grapes
|
|
| 08:11 ET |
Neose Technologies Reports Second Quarter Financial Results
|
|
Jul 23, 97
|
| 08:00 ET |
Aksys, Ltd. Reports Financial Results For The Second Quarter Ended June 30, 1997
|
|
Jul 22, 97
|
| 07:45 ET |
Cambridge NeuroScience Awarded Phase I SBIR Grant for Development of Novel Cancer Treatments
|
|
Jul 21, 97
|
| 08:59 ET |
Variagenics Raises $12.1 Million in Private Financing
|
|
| 08:29 ET |
Pharmacia Biotech AB Extends Joint Research Program with ArQule, Inc.
|
|
Jul 16, 97
|
| 10:57 ET |
NeoTherapeutics Promotes Michelle S. Glasky, PH.D. to Vice President, Scientific Affairs
|
|
Jul 15, 97
|
| 07:41 ET |
ChiRex Reports Financial Results for Second Quarter 1997
|
|
Jul 14, 97
|
| 12:47 ET |
First Patients Dosed In Phase I Study On New Class Of Drugs For Alzheimer's Disease
|
|
| 08:59 ET |
Therion Biologics Issued Broad U.S. Patents Covering Fundamental AIDS Vaccine Technology
|
|
Jul 10, 97
|
| 07:01 ET |
Wyeth-Ayerst and ArQule, Inc. Execute a Broad Five Year Collaboration for Discovery and Development of Novel Pharmaceuticals
|
|
Jul 08, 97
|
| 07:59 ET |
Virus Research Institute Moves Rotavirus Vaccine Ahead to Phase II Clinical Trials
|
|
Jul 07, 97
|
| 09:00 ET |
Dyax Creates Strategic Advisory Committee
|
|
| 08:07 ET |
ChiRex to Buy Glaxo Wellcome Pharmaceutical Facility at Annan, Scotland
|
|
| 07:05 ET |
Broad Scope Patents Give Aastrom Biosciences Unique Position For Stem Cell and Ex Vivo Gene Therapy Industries Worldwide
|
|
Jul 03, 97
|
| 08:04 ET |
Transcend Therapeutics, Inc. Announces Initial Public Offering of 1,800,000 Shares of Common Stock at $10 Per Share
|
|
Jul 02, 97
|
| 12:10 ET |
ArQule, Inc. Announces Collaboration with the University of California San Francisco for Discovery and Development of Viral Protease Inhibitors
|
|
Jul 01, 97
|
| 07:49 ET |
Triangle Pharmaceuticals Agrees to Acquire Avid Corp.
|
|
Jun 25, 97
|
| 11:29 ET |
Inflazyme Announces Positive Preclinical Results For Bispan(TM)
|
|
| 08:59 ET |
NIAID Commences Clinical Trial with Therion Biologics' Recombinant Multi-antigen AIDS Vaccine, TBC-3B
|
|
Jun 24, 97
|
| 08:17 ET |
Cambridge NeuroScience Temporarily Suspends Accrual In Stroke Trial
|
|
Jun 23, 97
|
| 08:59 ET |
RTP Pharma Inc. Receives U.S. Patent for Improved Formulation of Propofol Anesthetic Agent
|
|
| 08:29 ET |
NetGenics and Incyte to Link Software Platforms For Pharmaceutical Bioinformatics
|
|
Jun 20, 97
|
| 14:56 ET |
NitroMed Promotes David S. Garvey, Ph.D., to Senior Director of Chemistry and S. William Tam, Ph.D., to Senior Director of Biology
|
|
Jun 18, 97
|
| 11:29 ET |
RTP Pharma Inc. Announces C$3 Million Investment by Societe generale de Finacement du Quebec
|
|
Jun 13, 97
|
| 08:37 ET |
AutoImmune Inc. Announces Corporate Restructuring
|
|
Jun 11, 97
|
| 08:59 ET |
Mark A. Soufleris Joins Nabi as Vice President of Marketing
|
|
Jun 10, 97
|
| 08:59 ET |
ArQule, Inc. and FibroGen, Incorporated Announce Collaboration for Discovery and Development of Anti-Fibrotics
|
|
| 08:29 ET |
NitroMed Announces Broad Patent on Nitric Oxide Delivery Compounds
|
|
Jun 09, 97
|
| 09:05 ET |
Triangle Pharmaceuticals Raises $29 Million in Private Placement of Common Stock
|
|
| 08:29 ET |
NetGenics Closes $6.5 Million Financing for Development of Bioinformatics Software to Accelerate Drug Discovery
|
|
Jun 06, 97
|
| 08:25 ET |
Aksys, Ltd. Announces Product Development Update
|
|
| 07:00 ET |
Aksys, Ltd. Announces Product Development Update
|
|
Jun 05, 97
|
| 10:29 ET |
Inflazyme Announces Award of Australian Patent
|
|
Jun 04, 97
|
| 09:59 ET |
Nabi Endows Chair at University of Virginia Health Sciences Center for Organ Transplant Research
|
|
Jun 03, 97
|
| 06:59 ET |
Aronex Pharmaceuticals, Inc. Appoints Alza Corporation's James R. Butler to its Board Of Directors
|
|
Jun 02, 97
|
| 09:14 ET |
NeoTherapeutics Provides Update on Canadian Clinical Trial
|
|
May 30, 97
|
| 08:29 ET |
ProScript Achieves Milestone Under Hoechst Marion Roussel Collaboration Agreement
|
|
May 29, 97
|
| 08:59 ET |
ArQule Elects Three New Members to its Scientific Advisory Board
|
|
May 28, 97
|
| 09:04 ET |
Inflazyme Announces Positive Preclinical Results For Apanol(TM)
|
|
| 08:29 ET |
ProScript Receives SBIR Grant for Novel Malaria Treatment and Licenses Technology for Treatment of Parasitic Diseases
|
|
May 27, 97
|
| 08:59 ET |
Dyax Corp. and Argonex, Inc. Establish Collaboration to Develop Novel Tools for Urokinase Purification
|
|
May 22, 97
|
| 16:29 ET |
Dr. J. Richard Crout Joins GelTex Board of Directors
|
|
| 08:29 ET |
Dr. Robert R. Fike Joins Epic Therapeutics as Vice President of Research and Development and Chief Scientific Officer
|
|
May 21, 97
|
| 09:59 ET |
Nabi Acquires Autoplex(R) T from Baxter Healthcare Corporation
|
|
May 20, 97
|
| 10:59 ET |
Experimental Technology Enables First Successful Bone Marrow Transplantation Using Cells Grown Outside Cancer Patient's Body, Loyola Study Finds
|
|
| 08:29 ET |
Genome Therapeutics Names Joseph Pane as Vice President, Human Resources and Christopher Taylor as Director, Investor Relations
|
|
May 19, 97
|
| 13:14 ET |
Aronex Presents Results for Anti-Cancer Agent Annamycin at ASCO Conference
|
|
| 09:56 ET |
NitroMed Announces Promotion of Dr. L. Gordon Letts to Senior Vice President and Chief Scientific Officer
|
|
| 08:27 ET |
Largest Study to Date Defines Important Role of Ovarian and Breast Cancer Histories in Identifying BRCA1 Gene Test Candidates
|
|
May 18, 97
|
| 12:49 ET |
Largest Study to Date Defines Important Role of Ovarian and Breast Cancer Histories in Identifying BRCA1 Gene Test Candidates
|
|
May 16, 97
|
| 11:10 ET |
EcoScience Announces Fiscal 1997 Third Quarter Results
|
|
| 08:59 ET |
NeoTherapeutics, Inc. Reports Financial Results for Three Months Ended March 31, 1997
|
|
May 14, 97
|
| 11:14 ET |
Aronex Pharmaceuticals, Inc. Provides Clinical Development Update for Nyotran(TM)
|
|
May 12, 97
|
| 08:59 ET |
Promising Data Presented On New Complex Carbohydrate Anti-Fungal Agent
|
|
| 08:16 ET |
AutoImmune Announces Preliminary Results from Two Phase II Clinical Trials of Colloral(R) for Rheumatoid Arthritis
|
|
| 07:29 ET |
Genome Therapeutics Signs Bayer AG as Subscriber to Its Proprietary Microbial Genomics Database
|
|
May 08, 97
|
| 09:59 ET |
NeoTherapeutics Establishes $100K Fellowship at Reeve-Irvine Research Center
|
|
May 07, 97
|
| 08:29 ET |
BioTransplant Incorporated Reports Financial Results for the First Fiscal Quarter Ended March 31, 1997
|
|
May 06, 97
|
| 08:29 ET |
Neose Technologies, Inc. Begins Phase II Clinical Trials On Anti-Ulcer Drug
|
|
| 08:29 ET |
Triangle Pharmaceuticals, Inc. Reports Financial Results for First Quarter 1997
|
|
| 07:30 ET |
Myriad Genetics, Inc. Reports Results for Third Quarter of Fiscal 1997
|
|
May 05, 97
|
| 08:59 ET |
Dyax Corp.'s Phage Display License Program Gains Momentum with Signing of 20th License
|
|
| 08:29 ET |
CytoMed Initiates Phase II Clinical Trials of CMI-392 for the Treatment of Psoriasis
|
|
| 08:29 ET |
Stem Cell Sciences and Genentech Enter Evaluation and Option Agreement for Embryonic Stem Cell Renewal Factor
|
|
May 01, 97
|
| 09:40 ET |
Feinstein Partners Now Feinstein Kean Partners Name Change and Reorganization Reflects Growth of Firm
|
|
| 09:11 ET |
Virus Research Institute, Inc. Reports 1997 First Quarter Results
|
|
| 08:29 ET |
MetaMorphix Collaborators at Johns Hopkins Discover Gene That Specifically Regulates Muscle Growth
|
|
| 08:29 ET |
Virus Research Institute, Inc. Reports Year End Results
|
|
| 08:14 ET |
AutoImmune Inc. Reports First Quarter 1997 Results
|
|
Apr 30, 97
|
| 13:10 ET |
New Brunswick Scientific Co., Inc. Reports First Quarter 1997 Results
|
|
| 09:14 ET |
ArQule, Inc. and Genzyme General Establish Partnership for Discovery and Development of Novel Drug Candidates
|
|
| 08:29 ET |
Julie Neumann Named Director, Finance And Administration Of Acacia Biosciences
|
|
| 07:00 ET |
Aronex Pharmaceuticals, Inc. Reports First Quarter 1997 Results
|
|
| 07:00 ET |
Myriad Genetics Granted Patent on MTS1 Melanoma Gene
|
|
Apr 29, 97
|
| 17:59 ET |
ChiRex Reports Financial Results For First Quarter 1997
|
|
| 08:29 ET |
IGG International Acquires Exclusive License to Agrogene Ltd. Carbohydrate Compounds
|
|
Apr 28, 97
|
| 16:29 ET |
GelTex Pharmaceuticals Reports First Quarter 1997 Results
|
|
| 09:28 ET |
NeoTherapeutics Names Stephen Runnels Executive Vice President
|
|
| 08:29 ET |
Cambridge NeuroScience, Inc. Announces the Promotion of Two Senior Executives
|
|
Apr 25, 97
|
| 13:59 ET |
ChiRex Raises $4.7 Million Through Exercise Of Over-Allotment Option
|
|
| 08:49 ET |
Aksys, LTD. Names Carl Kjellstrand, M.D., Ph.D., Vice President, Medical Affairs
|
|
Apr 24, 97
|
| 16:01 ET |
Nabi Reports First Quarter 1997 Financial Results
|
|
| 09:59 ET |
Dr. Walter M. Lovenberg Appointed Chairman of the Inflazyme Board of Directors 30 years Experience in Healthcare, Including Marion Merrell Dow Inc.
|
|
| 08:59 ET |
Dyax Raises $13.5 Million in Private Financing
|
|
| 08:59 ET |
Neose Technologies Reports First Quarter Financial Results; Company Selects First Glycoscience Research Award Recipients
|
|
| 08:29 ET |
Aksys, LTD. Names Carl Kjellstrand, M.D., Ph.D., Vice President, Medical Affairs
|
|
Apr 23, 97
|
| 08:08 ET |
Cambridge NeuroScience Reports First Quarter 1997 Financial Results
|
|
| 08:06 ET |
Cambridge NeuroScience Reports First Quarter 1997 Financial Results
|
|
Apr 22, 97
|
| 08:59 ET |
Aksys, Ltd. Reports Financial Results For The First Quarter Ended March 31, 1997
|
|
Apr 21, 97
|
| 13:02 ET |
Neurotech Completes Funding to Develop New Cellular Vectors for Gene Therapy
|
|
| 07:30 ET |
AutoImmune Announces Results From Phase III Clinical Trial Of Myloral(R) For Multiple Sclerosis
|
|
Apr 18, 97
|
| 10:04 ET |
Recent Trials Confirm IGGI's Naturally-Derived Elexa Protects Tomatoes And Apple Seedlings From Fungal Disease
|
|
Apr 17, 97
|
| 09:10 ET |
Inflazyme and SuperGen Consummate Licensing Agreement For Anti-Cancer Drugs
|
|
| 08:59 ET |
ArQule, Inc. Reports Financial Results for the First Quarter Ended March 31, 1997
|
|
| 08:44 ET |
Paul J. Mellett Joins GelTex as Vice President of Administration and Finance and Chief Financial Officer
|
|
| 08:29 ET |
NitroMed and Cordis Form Collaboration for the Development of Novel Cardiovascular Products
|
|
Apr 16, 97
|
| 08:59 ET |
Dyax Corp. Establishes European Collaboration to Develop Therapeutics to Treat Pulmonary Disorders
|
|
| 08:29 ET |
Virus Research Institute's Adjumer(TM) Vaccine Delivery System Successfully Completes Phase I Trial For Influenza
|
|
Apr 15, 97
|
| 08:32 ET |
BioTransplant Announces Patent Allowance Covering Integral Part of Xenotransplantation Technology
|
|
| 08:32 ET |
Myriad Provides Update on its Genetic Laboratories and BRACAnalysis(TM)
|
|
| 07:29 ET |
Genome Therapeutics Corp. and Creighton University Enter Into Collaboration to Characterize Genes Associated with Osteoporosis
|
|
Apr 14, 97
|
| 08:29 ET |
ImmunoGen Compound Eradicates Human Small-Cell Lung Cancer Tumors in Mice
|
|
| 08:29 ET |
ProScript Announces Three Key Appointments
|
|
| 08:29 ET |
Proscript Licenses Cell Cycle Regulation Technology from Harvard Medical School
|
|
Apr 10, 97
|
| 12:16 ET |
Dyax Corp. Names Steven Bernitz Vice President of Business Development, Separations Division
|
|
| 12:10 ET |
Dyax Corp. Names Henry Blair Chairman and Chief Executive Officer
|
|
| 07:52 ET |
Genome Therapeutics and Astra Research Center Boston Announce First Target From Their H. Pylori Genome Alliance Has Entered High-Throughput Screening
|
|
Apr 09, 97
|
| 17:38 ET |
ChiRex Sells Its Acetaminophen Business To Rhone-Poulenc Chimie
|
|
| 07:29 ET |
Genome Therapeutics and Astra Research Center Boston Announce First Target From Their H. Pylori Genome Alliance Has Entered High-Throughput Screening
|
|
Apr 08, 97
|
| 08:29 ET |
Bruce Cohen Named New President and CEO of Acacia Biosciences
|
|
| 08:29 ET |
GelTex Announces Positive Preliminary Phase IIc Results for RenaGel(R) Phosphate Binder
|
|
Apr 07, 97
|
| 08:35 ET |
NitroMed Enters Alliance to Develop New Generation of Nonsteroidal Anti-Inflammatory Drugs
|
|
| 08:29 ET |
Triangle Pharmaceuticals Exercises Option to Acquire MKC-442
|
|
Apr 04, 97
|
| 17:50 ET |
ArQule, Inc. Announces $24 Million Follow-On Public Offering
|
|
Apr 03, 97
|
| 14:09 ET |
ChiRex Inc. Announces Rights Dividend Pursuant to Stockholders Rights Plan
|
|
| 08:29 ET |
Endogen's Profits Jump 53% For Third Quarter
|
|
Apr 02, 97
|
| 14:04 ET |
NeoTherapeutics' Files Investigational New Drug Application with FDA For Lead Compound, AIT-082
|
|
| 08:29 ET |
Neose Technologies, Inc. Receives $9.4 Million In Financing Through Montgomery County Development Authority
|
|
Mar 31, 97
|
| 08:29 ET |
Genome Therapeutics Reports Fiscal 1997 Second Quarter Results
|
|
| 08:29 ET |
Pharmadigm Initiates Phase II Clinical Trial of Lead Therapeutic Product, PB005, in Burn Patients
|
|
Mar 28, 97
|
| 08:29 ET |
Genome Therapeutics Appoints Christopher Kelly as Senior Vice President of Business Development
|
|
Mar 27, 97
|
| 16:59 ET |
Myriad Genetics and M. D. Anderson Cancer Center Publish Discovery of a Major Gene for Brain Cancer
|
|
| 15:04 ET |
Aronex and Genzyme Announce Atragen(TM) Developments
|
|
| 08:40 ET |
Next Generation Chiral Manufacturing Technology Introduced At Chirex's International Conference
|
|
Mar 26, 97
|
| 08:45 ET |
NABI Announces that Data Board Has Recommended Discontinuing Enrollment in NIH HIV-IG(TM) Trial Due to Success of AZT in Reducing HIV Vertical Transmission
|
|
| 08:29 ET |
IGG International, Inc. Enters Clinical Trials With Lead Carbohydrate Compound to Prevent Various Forms of Cancer
|
|
Mar 25, 97
|
| 08:29 ET |
Triangle Pharmaceuticals, Inc. Announces the Appointment of Two Senior Executives
|
|
Mar 24, 97
|
| 15:55 ET |
NeoTherapeutics' New Class of Alzheimer's Drug Begins Patient Trials in Canada
|
|
Mar 20, 97
|
| 08:29 ET |
NeoTherapeutics, Inc. Reports Fourth Quarter and Fiscal 1996 Financial Results
|
|
Mar 19, 97
|
| 09:06 ET |
Apex Announces Preliminary Results from Phase I/II Trial of PHP to Treat Hypotension IN Septic Shock
|
|
| 08:29 ET |
Pharmadigm Names Max Link, Ph.D., to Chairman of the Board
|
|
| 06:59 ET |
Aronex Expands Management Team
|
|
Mar 18, 97
|
| 08:29 ET |
Triangle Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year Ended December 31, 1996
|
|
Mar 17, 97
|
| 08:32 ET |
Phytera, Inc. Acquires Auda Pharmaceuticals, ApS, a Danish Combinatorial Chemistry Company
|
|
Mar 14, 97
|
| 10:50 ET |
IGG International, Inc. Completes $2.6 Million Fundraising Effort
|
|
Mar 13, 97
|
| 08:29 ET |
Aronex Announces Preliminary Phase I Clinical Trial Results for Annamycin
|
|
Mar 11, 97
|
| 16:31 ET |
Aastrom Biosciences, Inc. and Cobe BCT Initiate Stem Cell Clinical Trial in Europe
|
|
| 16:20 ET |
ArQule Appoints Peter V. Pallai, Ph.D., formerly of Boehringer Ingelheim, as Director of Medicinal Chemistry
|
|
| 13:43 ET |
Novo Nordisk and Dyax Corp. Announce Collaboration on Novel Research Tools to Accelerate Drug Development
|
|
Mar 10, 97
|
| 16:29 ET |
GelTex Pharmaceuticals Reports Positive Results from Second Phase III Clinical Trial for RenaGel(R) Phosphate Binder
|
|
| 08:33 ET |
Genome Therapeutics and Versicor Announce Corporate Partnership to Develop Novel Anti-Infectives
|
|
Mar 07, 97
|
| 15:48 ET |
ArQule, Inc. Files Registration Statement with SEC for Secondary Public Offering
|
|
Mar 06, 97
|
| 12:10 ET |
New Class Of Alzheimer's Drug Cleared For Clinical Testing In Canada
|
|
| 08:29 ET |
Virus Research Institute Plans Phase II Efficacy Trial of its Rotavirus Vaccine Based on Preliminary Results of Phase I/II Study
|
|
Mar 05, 97
|
| 16:25 ET |
Transcend Therapeutics, Inc. Files Registration Statement for Initial Public Offering of 2 Million Shares
|
|
Mar 04, 97
|
| 08:15 ET |
AutoImmune Inc. Reports 1996 Fourth Quarter and Year End Financial Results; Myloral(R) Phase III, Colloral(R) Phase II Studies Near Completion
|
|
Mar 03, 97
|
| 16:29 ET |
GelTex Pharmaceuticals Issued First U.S. Patent Covering CholestaGel(R) Non-Absorbed Cholesterol Reducer
|
|
| 08:29 ET |
New Brunswick Scientific Co., Inc. Declares 10 Percent Stock Dividend
|
|
Feb 28, 97
|
| 10:02 ET |
Michael Rosenblatt, M.D. Joins Genome Therapeutics' Board of Directors
|
|
Feb 27, 97
|
| 11:33 ET |
IGG International, Inc. Announces Key Patent on a Novel Immunotherapeutic Agent with Anti-Cancer and Anti-Viral Activity
|
|
| 08:29 ET |
BioTransplant Incorporated Reports Financial Results for the Year and Fourth Quarter Ended December 31, 1996
|
|
Feb 26, 97
|
| 16:44 ET |
ChiRex Files S-1 Registration Statement for Public Offering of 3.5 Million Shares
|
|
| 08:29 ET |
Investigational New Drug Application filed in Canada For NeoTherapeutics' Lead Compound, AIT-082
|
|
Feb 25, 97
|
| 08:29 ET |
5th Annual European Life Sciences Partnering Conference To Showcase Emerging Medical/Biotechnology Companies
|
|
| 08:29 ET |
Cambridge NeuroScience, Inc. Receives Additional $3,960,000 through Exercise of Over-Allotment Option
|
|
Feb 24, 97
|
| 16:29 ET |
GelTex Pharmaceuticals Reports 1996 Fourth Quarter and Year End Results
|
|
Feb 21, 97
|
| 11:12 ET |
ChiRex Report Reports Fiscal 1996 Fourth Quarter and Year End Results
|
|
| 08:29 ET |
IGG International, Inc. Appoints David R. Elmaleh, Ph.D. to Science Advisory Board
|
|
| 07:30 ET |
ChiRex Report Reports Fiscal 1996 Fourth Quarter and Year End Results
|
|
Feb 20, 97
|
| 15:59 ET |
NABI Reports 1996 Financial Results
|
|
Feb 19, 97
|
| 07:30 ET |
Aronex Pharmaceuticals, Inc. Reports Fourth Quarter and Year End 1996 Results
|
|
Feb 14, 97
|
| 08:29 ET |
ArQule, Inc. Reports Financial Results for Fourth Quarter and Year Ended December 31, 1996
|
|
Feb 13, 97
|
| 13:59 ET |
Virus Research Institute, Inc. Reports Year End Results
|
|
| 11:09 ET |
New Brunswick Scientific Co., Inc. Reports Fiscal 1996 Fourth Quarter and Year End Results
|
|
| 08:29 ET |
Donald R. Conklin Joins BioTransplant Board of Directors
|
|
Feb 12, 97
|
| 11:24 ET |
EcoScience Announces First Quarterly Operating Profit in Company History Achieved in Fiscal 1997 Second Quarter
|
|
| 08:59 ET |
MetaMorphix Appoints Larry Ellingsworth, Ph.D., Executive Vice President and Chief Scientific Officer; Closes Second Round Financing
|
|
Feb 11, 97
|
| 08:13 ET |
Myriad Genetics, Inc. Reports Results for Second Quarter of Fiscal 1997
|
|
Feb 10, 97
|
| 17:17 ET |
Endogen Retires $1.8 Million in Debt from Acquisition of T Cell Diagnostics, Issues 389,347 Shares of Common Stock
|
|
Feb 06, 97
|
| 08:44 ET |
Neose Reports Fourth Quarter and 1996 Year End Financial Results
|
|
Feb 05, 97
|
| 19:11 ET |
Instrumentation Laboratory Announces Preliminary Results for Fiscal Year 1996
|
|
Feb 04, 97
|
| 09:18 ET |
AASTROM Biosciences, Inc. Announces Initial Public Offering
|
|
Feb 03, 97
|
| 11:05 ET |
ChiRex Signs Agreement With Cell Therapeutics To Manufacture Bulk Lisofylline
|
|
| 08:29 ET |
Myriad Genetics Announces Patent on AGT Hypertension Gene Mutation
|
|
Jan 31, 97
|
| 08:29 ET |
Cambridge NeuroScience, Inc. Completes Public Offering of 2,400,000 Shares of Common Stock at $11 per Share
|
|
Jan 30, 97
|
| 08:32 ET |
Aksys, Ltd. Reports Financial Results For The Fourth Quarter Ended December 31, 1996
|
|
Jan 27, 97
|
| 18:32 ET |
Cambridge NeuroScience Reports Fourth Quarter and Year-End 1996 Financial Results
|
|
Jan 25, 97
|
| 12:59 ET |
Combination HIV-IG/Monoclonal Antibody Dose Highly Neutralizes AIDS Virus, Preclinical Study Finds
|
|
| 08:30 ET |
Combination HIV-IG/Monoclonal Antibody Dose Highly Neutralizes AIDS Virus, Preclinical Study Finds
|
|
Jan 24, 97
|
| 09:59 ET |
Neose Technologies. Inc., Announces Effective Registration Statement for Sale of 1,250,000 Shares at $17.50 Per Share
|
|
| 08:43 ET |
Neose Technologies. Inc., Announces Effective Registration Statement for Sale of 1,250,000 Shares at $17.50 Per Share
|
|
Jan 23, 97
|
| 08:45 ET |
Genome Therapeutics Appoints Head of Functional Genomics From Bristol-Myers Squibb Pharmaceutical Research Institute
|
|
| 08:44 ET |
IGG International, Inc. Submits Lead Agricultural Compound for EPA Review
|
|
Jan 22, 97
|
| 17:00 ET |
GelTex Announces Preliminary CholestaGel(R) Data
|
|
| 10:19 ET |
Phytera Names Two European Executives to Board of Directors
|
|
| 08:29 ET |
Identification Of Brain Cancer Gene Announced By Myriad Genetics
|
|
| 08:29 ET |
Virus Research Institute, Inc. Names Robert J. Hennessey to Board Of Directors
|
|
Jan 21, 97
|
| 15:45 ET |
NABI Announces that the National Institutes of Health will Continue HIV-IG (TM) Trial Following Interim Efficacy Review
|
|
| 08:29 ET |
ArQule, Inc. Extends Collaborative Drug Discovery Agreement with Abbott Laboratories
|
|
| 08:29 ET |
Pharmadigm's DHEA Protects Against Vascular Damage Following Reperfusion Injury
|
|
Jan 17, 97
|
| 08:52 ET |
Triangle Pharmaceuticals Reports Preliminary Clinical Results for Anti-HIV Drug MKC-442
|
|
Jan 13, 97
|
| 10:59 ET |
Neose Technologies, Inc. Files Registration Statement with SEC for Proposed Sale to Selected Institutional Investors
|
|
| 08:29 ET |
Endogen, Inc. Announces Strong Second Quarter Results
|
|
| 08:29 ET |
IGG International, Inc. To Begin Clinical Trials on Lead Carbohydrate Compound To Prevent Metastasis
|
|
| 06:59 ET |
Aronex Announces Licensing Agreement with Boehringer Mannheim to Develop and Commercialize AR209 for Cancer
|
|
Jan 10, 97
|
| 08:29 ET |
Aksys, Ltd. Announces Issuance of U.S. Patent for Hot Water Disinfection of Dialysis Machines
|
|
Jan 09, 97
|
| 08:59 ET |
Genome Therapeutics Reports Fiscal 1997 First Quarter Results
|
|
| 08:29 ET |
Aquila QS-21 Adjuvant Key Component of Promising Malaria Vaccine Reported in The New England Journal of Medicine
|
|
Jan 08, 97
|
| 16:59 ET |
GelTex Pharmaceuticals Reports Positive Preliminary Phase III Clinical Results for RenaGel(R) Phosphate Binder
|
|
| 08:07 ET |
AutoImmune Provides Update of Clinical Trial Programs for Oral Tolerance Pharmaceuticals
|
|
| 08:05 ET |
Therion Biologics Initiates Phase I Trials with Three Melanoma Therapeutics in Collaboration with the National Cancer Institute
|
|
Jan 06, 97
|
| 07:59 ET |
ArQule Forms Five-Year Collaboration with Monsanto to Develop Novel Agrochemicals
|
|
Dec 31, 96
|
| 08:21 ET |
Cambridge NeuroScience and Gladstone Institutes Collaborate to Develop Novel Approach to Alzheimer's Disease
|
|
Dec 19, 96
|
| 17:02 ET |
ChemGenics Pharmaceuticals Files for Initial Public Offering of 2,500,000 Shares of Common Stock
|
|
| 15:50 ET |
Cambridge NeuroScience, Inc. Files Registration Statement with SEC for Public Offering
|
|
Dec 18, 96
|
| 09:29 ET |
Phytera Announces New Appointments:
|
|
| 09:29 ET |
Phytera Completes $12.35 Million European Financing
|
|
Dec 16, 96
|
| 14:41 ET |
ArQule, Inc. Reports Financial Results for Third Quarter and Nine Month Period Ended September 30, 1996
|
|
Dec 12, 96
|
| 08:29 ET |
New Brunswick Scientific Receives Over $2 Million in Orders for Bioprocess Equipment from Chiron and Viragen
|
|
| 08:14 ET |
Triangle Pharmaceuticals, Inc. Reports Financial Results for Third Quarter and Nine Month Period Ended September 30, 1996
|
|
Dec 11, 96
|
| 08:29 ET |
Epic Therapeutics Announces First Patent for Water-Based Microsphere Sustained Release Drug Delivery Technology
|
|
| 08:29 ET |
Neose Technologies Announces Key Patent Expanding Protection over the Manufacture of Biologically Important Complex Carbohydrates
|
|
Dec 10, 96
|
| 08:28 ET |
Myriad Genetics Accelerates Brain Cancer Gene Discovery Program
|
|
Dec 09, 96
|
| 08:29 ET |
GastroMARK(R) Imaging Agent Cleared for Marketing in U.S.
|
|
Dec 04, 96
|
| 13:59 ET |
Safeskin Corporation Files Registration Statement with SEC for Secondary Public Offering
|
|
| 08:44 ET |
ETEX Marketing Alliance with Merck KGaA
|
|
| 07:44 ET |
Triangle Pharmaceuticals, Inc. Raises Additional $3,326,520 Through Exercise of Over-Allotment Option
|
|
Dec 03, 96
|
| 08:59 ET |
Research Triangle Pharmaceuticals (RTP) Gains $6.3 Million in Financing
|
|
| 08:29 ET |
ChemGenics and American Home Products Announce Collaboration in Antibacterial Drug Discovery
|
|
Dec 02, 96
|
| 15:59 ET |
GelTex's Partner, Chugai Pharmaceutical, Initiates Phase I Clinical Trials in Japan of RenaGel(R) Phosphate Binder
|
|
| 08:29 ET |
Princeton Research Breaks New Ground in Carbohydrate-Based Drug Discovery
|
|
Nov 25, 96
|
| 16:15 ET |
Myriad Genetics, Inc. Withdraws Public Offering
|
|
| 12:54 ET |
Advanced Magnetics, Inc. Signs Distribution Agreement with Pharmagenesis, Inc. for Feridex I.V.(TM) Liver Contrast Agent
|
|
Nov 21, 96
|
| 10:16 ET |
NABI Awarded $57 Million Three-Year Plasma Supply Contract with Korea Green Cross Corporation
|
|
| 08:28 ET |
Dyax Corp. Receives Third Fundamental U.S. Patent Covering Phage Display Technology
|
|
| 05:30 ET |
Cambridge Neuroscience and Allergan Collaborate to Develop Treatments For Ophthalmic Diseases
|
|
Nov 20, 96
|
| 09:27 ET |
Aronex Reports Interim Clinical Results from Phase II/III Candidemia Trial of Nyotran(TM)
|
|
| 08:29 ET |
Neose Technologies Reports Preliminary Phase I Data on Anti-Ulcer Drug
|
|
| 06:59 ET |
Aronex Reports Interim Clinical Results from Phase II/III Candidemia Trial of Nyotran(TM)
|
|
| 06:59 ET |
PerSeptive Biosystems Reports Fourth Quarter Fiscal 1996 Results
|
|
Nov 19, 96
|
| 08:29 ET |
ArQule, Inc. Raises Additional $4.5 Million Through Exercise of Over-Allotment
|
|
Nov 18, 96
|
| 16:31 ET |
NeoTherapeutics, Inc. Research Findings Support Upcoming Clinical Trials for Novel Therapeutic for the Treatment of Alzheimer's Disease
|
|
| 14:27 ET |
EcoScience Posts Record Revenues, Significant Reduction in Operating Loss for the First Quarter of Fiscal 1997
|
|
| 09:28 ET |
National Cancer Institute and Dana-Farber/Partners Cancer Care Begin Phase I Clinical Trials with Therion Biologics' Vaccine for Prostate Cancer
|
|
Nov 15, 96
|
| 08:29 ET |
Myriad Genetics, Inc. Files Registration Statement with SEC for Public Offering
|
|
Nov 14, 96
|
| 08:29 ET |
Paradigm Biosciences, Inc. Changes Name to Pharmadigm, Inc.; Appoints New Vice President of Clinical Research and Affairs, Chief Financial Officer
|
|
Nov 12, 96
|
| 11:59 ET |
NeoTherapeutics, Inc. Reports Financial Results for Nine Months Ended September 30, 1996
|
|
| 08:29 ET |
BioTransplant Incorporated Reports Financial Results for the Third Fiscal Quarter Ended September 30, 1996
|
|
Nov 11, 96
|
| 11:20 ET |
Cambridge NeuroScience Reports Third Quarter 1996 Financial Results
|
|
| 09:52 ET |
Myriad Genetics, Inc. Reports Results for First Quarter of Fiscal 1997
|
|
| 06:59 ET |
Aronex Reports Preliminary Clinical Results on its HIV Integrase Inhibitor, Zintevir(TM)
|
|
Nov 08, 96
|
| 08:28 ET |
Advanced Magnetics, Inc. Receives US Patent for Targeted Drug Delivery
|
|
Nov 06, 96
|
| 08:39 ET |
Advanced Magnetics, Inc. Reports Fourth Fiscal Quarter and Year End Results
|
|
| 08:29 ET |
Virus Research Institute, Inc. Reports Financial Results for Third Quarter Ended September 30, 1996
|
|
Nov 01, 96
|
| 08:35 ET |
New Brunswick Scientific Co., Inc. Reports Third Quarter 1996 Results
|
|
| 08:28 ET |
Triangle Pharmaceuticals, Inc. Announces Initial Public Offering of 4,200,000 Shares of Common Stock at $10.00 Per Share
|
|
Oct 31, 96
|
| 08:14 ET |
AutoImmune Inc. Reports Third Quarter 1996 Results
|
|
Oct 30, 96
|
| 08:29 ET |
Aksys, Ltd. Adopts A Preferred Share Purchase Rights Plan
|
|
Oct 29, 96
|
| 16:14 ET |
NABI Reports Results for Third Quarter and Nine Months 1996
|
|
| 09:29 ET |
CytoMed Appoints Colin Scott Vice President, Clinical Development
|
|
Oct 28, 96
|
| 08:33 ET |
GelTex Pharmaceuticals Reports 1996 Third Quarter Results
|
|
Oct 25, 96
|
| 08:29 ET |
Aksys, Ltd. Reports Financial Results For The Third Quarter Ended September 30, 1996
|
|
| 08:15 ET |
Targeted Genetics Announces Positive Phase I AAV-CFTR Trials in Cystic Fibrosis
|
|
Oct 24, 96
|
| 08:32 ET |
Neose Technologies Reports Third Quarter Financial Results
|
|
| 07:00 ET |
Aronex Pharmaceuticals, Inc. Reports Third Quarter 1996 Results
|
|
Oct 23, 96
|
| 09:59 ET |
Therion Biologics Corporation raises $4 million in financing
|
|
| 08:32 ET |
Genome Therapeutics Corp. Reports Fiscal 1996 Earnings Of $0.11 Per Share
|
|
Oct 22, 96
|
| 09:55 ET |
EcoScience Announces U.S. Commercial Launch of Bio-Blast(TM) Biological Termiticide in Partnership with Terminix International
|
|
| 08:28 ET |
Paradigm Biosciences Reports Novel DNA Vaccine Technology Induces Immune Response Against Primary Herpes Simplex II Infection
|
|
Oct 16, 96
|
| 17:26 ET |
ArQule, Inc. Completes $30 Million Initial Public Offering
|
|
Oct 15, 96
|
| 13:20 ET |
Endogen, Inc. Announces First Quarter Financial Results
|
|
| 12:18 ET |
Advanced Magnetics, Inc. Announces Receipt of $5 Million Milestone Payment for U.S. Introduction of Feridex I.V.(TM) Contrast Agent
|
|
| 08:33 ET |
Exelixis Appoints George Scangos, Ph.D., as President and CEO
|
|
Oct 11, 96
|
| 16:29 ET |
NeoTherapeutics, Inc. Raises Additional $1,520,000 Through Exercise of Over-allotment
|
|
| 08:59 ET |
Middlesex Sciences, Inc. Changes Name to Epic Therapeutics, Inc.
|
|
| 08:29 ET |
Myriad Genetics Advances Gene Discovery Program in Leukemia
|
|
Oct 10, 96
|
| 08:29 ET |
Dyax Corp. Appoints Craig N. Hess as Senior Vice President, Operations, Separations Division
|
|
Oct 09, 96
|
| 09:59 ET |
CytoMed Appoints Richard Woodrich Executive Vice President and COO
|
|
| 08:48 ET |
NABI to Report Non-Recurring Charge for Third Quarter 1996
|
|
Oct 08, 96
|
| 10:03 ET |
Variagenics Appoints Fred Ledley, M.D. President and COO
|
|
Oct 07, 96
|
| 16:37 ET |
ProScript Licenses Inhibitors of Ras Processing and Acquires Novel MMPIs
|
|
| 13:26 ET |
Dyax Signs Additional Licensees to its Fundamental Phage Display Patents
|
|
| 08:37 ET |
ProScript and Hoffmann-La Roche to Develop Compounds for Treatment of Cancer Cachexia (Muscle Wasting)
|
|
| 08:29 ET |
BioTransplant Announces Four Patent Allowances Covering Integral Parts of Company's Core Transplantation Technologies
|
|
| 08:29 ET |
ProScript and Hoffmann-La Roche to Develop Compounds for Treatment of Cancer Cachexia (Muscle Wasting)
|
|
Oct 04, 96
|
| 08:29 ET |
IGG International, Inc. Reports Results of Independent Field Test on Natural Agricultural Fungicide Compound
|
|
Oct 03, 96
|
| 08:59 ET |
EcoScience Raises $1.3 Million in a Private Placement of Common Stock
|
|
| 08:29 ET |
Dyax Corp. Announces Four Scientific Appointments
|
|
Sep 30, 96
|
| 08:29 ET |
Dyax Corp. Receives SBIR Grant to Develop Novel Imaging Agents for Inflammation Based on Phage Display Technology
|
|
| 08:29 ET |
Roche Bioscience and ArQule Form Collaboration
|
|
Sep 27, 96
|
| 12:55 ET |
IGG International Appoints Richard A. Salter, VP, Corporate Development and John K. Pool, Director, European Operations
|
|
| 09:29 ET |
NABI Granted Japanese Patent for HIV-IG(TM) in Prevention of HIV Transmission
|
|
Sep 26, 96
|
| 10:10 ET |
NeoTherapeutics, Inc. Announces Initial Public Offering of 2,500,000 Units at $7.60 Per Unit
|
|
| 09:30 ET |
PerSeptive Biosystems Announces New Perfusion Chromatography(R) Patent
|
|
| 08:30 ET |
Myriad to Introduce Integrated BRCA1 and BRCA2 Genetic Test Ahead of Schedule
|
|
| 08:29 ET |
Neose Technologies Announces Key Patent for Technology that Enables Highly Efficient Manufacturing of Complex Carbohydrates
|
|
Sep 25, 96
|
| 08:29 ET |
IGG International, Inc. Reports Significant Results on Natural Agricultural Fungicide Compound
|
|
Sep 20, 96
|
| 20:45 ET |
EcoScience Corporation Announces Continued Significant Improvements in Financial Results for the Fourth Quarter and Fiscal 1996
|
|
| 10:59 ET |
Aksys, Ltd. Announces FDA Response to 510(K) Filing
|
|
Sep 18, 96
|
| 10:37 ET |
Aronex Presents Results for Antifungal Drug Nyotran at ICAAC
|
|
| 09:04 ET |
NABI Announces Positive Interim Data from Phase II Dosing Studies of StaphVAX(TM)
|
|
| 08:29 ET |
Cambridge NeuroScience Inc. Appoints Director, Marketing to Initiate Marketing Plan for Cerestat(R)
|
|
Sep 17, 96
|
| 11:54 ET |
Aronex Reports Results for Lead Anti-HIV Integrase Inhibitor Compound
|
|
| 08:29 ET |
EcoScience Expands Postharvest Biofungicides Program with an Award from the USDA of a $175,000 SBIR Phase II Grant
|
|
Sep 16, 96
|
| 13:33 ET |
CytoMed Announces Additions to Board of Directors:
|
|
| 12:35 ET |
Virus Research Institute's Vaccine Delivery System in Phase I Trial for Influenza
|
|
| 08:29 ET |
Genome Therapeutics Appoints Gregory H. Hamm as V.P., Bioinformatics and Jen-i Mao, Ph.D. as V.P., Genomics and Technology Development
|
|
Sep 12, 96
|
| 10:51 ET |
Aprogenex Announces Collaboration with AmCell
|
|
| 07:59 ET |
Aronex Receives $2 Million Advance Milestone Payment from Genzyme Corporation
|
|
Sep 10, 96
|
| 08:29 ET |
Aksys, Ltd. Names Jeff Barrett Vice President, Manufacturing
|
|
Sep 09, 96
|
| 08:44 ET |
Massachusetts Biotechnology Enters New Commercial Phase with Six Recent Product Approvals, Mass. Biotech Council Survey Indicates
|
|
| 08:29 ET |
Genome Therapeutics Reaches Third Milestone in Alliance with Schering-Plough; Receives $1 Million Payment
|
|
Sep 05, 96
|
| 08:29 ET |
BioTransplant and Activated Cell Therapy Sign Agreement for Bone Marrow Purification Device
|
|
Sep 04, 96
|
| 08:29 ET |
Genome Therapeutics Appoints Chief Scientific Officer From Bristol-Myers Squibb Pharmaceutical Research Institute
|
|
| 08:29 ET |
Max Link Joins Paradigm Board of Directors
|
|
Sep 03, 96
|
| 18:23 ET |
PerSeptive Biosystems, Inc. Announces Departure of Robert Anacone
|
|
| 08:32 ET |
Advanced Magnetics, Inc. and Berlex Laboratories, Inc. Announce FDA Approval for Feridex I.V.(TM) Liver Contrast Agent
|
|
| 08:29 ET |
ArQule, Inc. Offering 2 Million Shares
|
|
Aug 29, 96
|
| 10:32 ET |
Scientists Report Follow-up Data For Phase I/II Trials with BioTransplant's BTI-322 for Organ Transplant Rejection
|
|
| 09:59 ET |
Scientists Report Novel Method of Creating Specific Transplant Tolerance in Model of Organ Transplantation
|
|
Aug 28, 96
|
| 12:36 ET |
Aprogenex Announces Agreement with BioSeparations
|
|
| 11:17 ET |
NABI Appoints David D. Muth, Formerly of Johnson & Johnson, as Senior Vice President, Business Development
|
|
Aug 27, 96
|
| 08:29 ET |
Advanced Magnetics, Inc. Signs Distribution Agreement for Feridex I.V.(TM) Liver Contrast Agent in South Korea
|
|
Aug 22, 96
|
| 08:51 ET |
Boehringer Ingelheim Invests an Additional $10 Million In Cambridge Neuroscience
|
|
| 08:29 ET |
Endogen, Inc. Reports Fiscal Year-End 1996 Financial Results
|
|
Aug 21, 96
|
| 10:20 ET |
Myriad Genetics, Inc. Reports Year End Results
|
|
Aug 20, 96
|
| 08:29 ET |
EcoScience Announces the International Expansion of Shipments of Bio-Blast(TM) Biological Termiticide
|
|
Aug 19, 96
|
| 12:29 ET |
NABI Commences Expanded Clinical Program for New H-BIG(R) Formulation for Hepatitis B Prophylaxis
|
|
Aug 13, 96
|
| 08:35 ET |
EcoScience Sells A $1 Million Advanced Technology Sorting and Grading System to Dole Foods
|
|
| 08:32 ET |
Pharmaceutical Resources Reports Third Quarter and Nine Months 1996 Results
|
|
Aug 08, 96
|
| 08:41 ET |
Cambridge NeuroScience Reports Second Quarter 1996 Financial Results
|
|
Aug 07, 96
|
| 17:31 ET |
Pharmaceutical Resources, Inc. Announces Cost Reduction Initiatives
|
|
Aug 06, 96
|
| 08:29 ET |
GelTex Pharmaceuticals Appoints Timothy P. Noyes as Director of Marketing
|
|
Aug 02, 96
|
| 09:20 ET |
AKSYS, LTD. REPORTS FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 1996
|
|
Aug 01, 96
|
| 11:19 ET |
VIRUS RESEARCH INSTITUTE, INC. REPORTS FINANCIAL RESULTS FOR SECOND QUARTER ENDED JUNE 30, 1996
|
|
| 11:11 ET |
CHIRON MAKES MILESTONE EQUITY INVESTMENT IN CYTOMED BASED ON PROGRESS IN COMPLEMENT INHIBITOR PROGRAM
|
|
| 10:30 ET |
BIOTRANSPLANT INCORPORATED REPORTS FINANCIAL RESULTS FOR THE SECOND FISCAL QUARTER ENDED JUNE 30, 1996
|
|
| 09:40 ET |
ARONEX PHARMACEUTICALS, INC. REPORTS SECOND QUARTER 1996 RESULTS
|
|
| 08:14 ET |
AUTOIMMUNE INC. REPORTS SECOND QUARTER 1996 FINANCIAL RESULTS
|
|
Jul 30, 96
|
| 17:39 ET |
NABI ISSUES STATEMENT REGARDING FDA LETTER; ERRORS CITED WERE ALL INTERNAL AND HAD BEEN CORRECTED
|
|
| 08:33 ET |
BASF BIORESEARCH AND ARES-SERONO ENTER MANUFACTURING AGREEMENT FOR RECOMBINANT HUMAN GROWTH HORMONE
|
|
Jul 29, 96
|
| 16:15 ET |
NABI REPORTS SECOND QUARTER 1996 FINANCIAL RESULTS WITH 19% SALES GROWTH AND INCREASING EARNINGS TREND
|
|
| 09:36 ET |
GELTEX PHARMACEUTICALS REPORTS 1996 SECOND QUARTER RESULTS
|
|
Jul 26, 96
|
| 08:29 ET |
IBEX TECHNOLOGIES APPOINTS TWO NEW SENIOR EXECUTIVES
|
|
Jul 25, 96
|
| 08:59 ET |
NEW BRUNSWICK SCIENTIFIC CO., INC. REPORTS SECOND QUARTER 1996 RESULTS
|
|
Jul 19, 96
|
| 09:09 ET |
NEUTRALASE(TM) DOSING BEGINS IN U.S. CARDIAC BYPASS SURGERY TRIAL
|
|
Jul 18, 96
|
| 08:35 ET |
VIRUS RESEARCH INSTITUTE BEGINS PHASE I/II TRIAL OF ITS ROTAVIRUS VACCINE
|
|
| 08:29 ET |
MYRIAD BEGINS BETA TESTING OF BRACAONE(TM) FOR BREAST AND OVARIAN CANCER GENETIC SUSCEPTIBILITY
|
|
Jul 17, 96
|
| 08:55 ET |
AKSYS, LTD. ANNOUNCES 510(K) FILING OF AKSYS PHD(TM) SYSTEM ACCEPTED BY FDA FOR FORMAL REVIEW
|
|
May 26, 09
|
| 13:30 ET |
International Isotopes Inc Signs Agreement with Bracco Diagnostics Inc.
|
|